Research on focus group discussions with the elderly
Authors | Type of article | Purpose | Key content/findings |
---|---|---|---|
Gray [ ] | Discussion paper | To explore how Thai people define “older persons” and what perceived psychosocial and health impacts may occur if the idea of an “older person” is redefined | The perceived current definition of “older persons” is those aged 60 and older, and this carries with it both negative and positive connotations. Most participants felt that it would be appropriate to consider a revised definition of an “older person” if the following criteria were taken into consideration: (1) chronological age only but raising the age to 65 or 70; (2) chronological age and positive attributes (3) positive attributes only and (4) no criteria at all |
Sutipan and Intarakamhang [ ] | Discussion paper | To identify the healthy lifestyle needs of hypertensive elderly and to explore the barriers and facilitators associated with healthy lifestyle behaviors | Participants identified barriers that included a lack of healthcare concerns, a lack of motivation, their perceived poor physical and mental health and inadequate community resources. Facilitators possessing knowledge of hypertension, as well as relevant family support, were also identified. The findings are thought to be useful in terms of the planning and development of an effectively tailored program to promote healthy lifestyle behavior (HLB) |
1 Stalmeijer RE , McNaughton N , Van Mook WN . Using focus groups in medical education research: AMEEguide no. 91 . Med Teacher . 2014 Nov ; 36 ( 11 ): 923 - 939 , doi: 10.3109/0142159x.2014.917165 .
2 Barbour RS . Focus groups . In: Bourgeault I , Dingwall R , de Vries R , editors. The SAGE handbook of qualitative methods in health research . Los Angeles : Sage ; 2010 . 327 - 352 .
3 Kinsella KG , Velkoff VA . An aging world: 2001 , Washington, DC : US Government Printing Office ; 2001 .
4 World Health Organization [WHO] . Ageing and health . [updated 2018 Feb 5; cited 2019 April 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health .
5 Dilshad RM , Latif MI . Focus group interview as a tool for qualitative research: an analysis . Pakistan J Soc Sci . 2013 ; 33 ( 1 ): 191 - 198 .
6 Webb C , Doman M . Conducting focus groups: experiences from nursing research . Junctures J Themat Dialogue . 2008 ; 10 : 51 - 60 . [cited 2019 April 1]. Available from: https://junctures.org/index.php/junctures/article/view/49/394 .
7 Kidd PS , Parshall MB . Getting the focus and the group: enhancing analytical rigor in focus group research . Qual Health Res . 2000 May ; 10 ( 3 ): 293 - 308 , doi: 10.1177/104973200129118453 .
8 Jamieson L , Williams LM . Focus group methodology: explanatory notes for the novice nurse researcher . Contemp Nurs . 2003 Jun ; 14 ( 3 ): 271 - 280 , doi: 10.5172/conu.14.3.271 .
9 Doody O , Slevin E , Taggart L . Preparing for and conducting focus groups in nursing research: part 2 . Br J Nurs . 2013 Feb ; 22 ( 3 ): 170 - 173 , doi: 10.12968/bjon.2013.22.3.170 .
10 Packer-Muti B. Conducting a focus group . Qual Rep . 2010 ; 15 ( 4 ): 1023 - 1026 .
11 Othaganont P , Kongvattananon P . The effects of using a knowledge management development program on knowledge management behaviors for the health promotion of elderly leaders in the Romyen community: research project . Pathumthani : Faculty of Nursing, Thammasat University ; 2018 .
12 Moher D , Liberati A , Tetzlaff J , Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement . PLoS Med . 2009 Jul ; 6 ( 7 ): e1000097 . doi: 10.1371/journal.pmed.1000097 .
13 Shaha M , Wenzel J , Hill EE . Planning and conducting focus group research with nurses . Nurse Res . 2011 ; 18 ( 2 ): 77 - 87 , doi: 10.7748/nr2011.01.18.2.77.c8286 .
14 Jayasekara RS . Focus groups in nursing research: methodological perspectives . Nurs.Outlook . 2012 Nov-Dec ; 60 ( 6 ): 411 - 416 , doi: 10.1016/j.outlook.2012.02.001 .
15 O'Connor C , Murphy S . Novice researchers' reflection on conducting a focus group . J PerioperPract . 2009 May ; 19 ( 5 ): 143 - 147 , doi: 10.1177/175045890901900504 .
16 Wilson R , Slaughter SE , Forbes D , Hanson HM , Khadaroo RG . Experiences of a novice researcher conducting focus group interviews . International Journal of Nursing Student Scholarship . 2016 ; 3 : 1-11 .
17 Pawi Putit Z , Buncuan J . Challenges in conducting focus group: moderators' experiences in Nursing . Journal of Malaysia Nurses Association . 2010 ; 5 : 2 - 9 .
18 Stancanelli J . Conducting an online focus group . Qual Rep . 2010 ; 15 ( 3 ): 761 - 765 .
19 Gray RS , Pattaravanich U , Chamchan C , Prasartkul P . Perceived negative and positive impacts of redefining older persons in Thailand . Journal of Population and Social Studies . 2015 ; 23 ( 1 ): 73 - 85 .
20 Sutipan P , Intarakamhang U . Healthy lifestyle behavioral needs among the elderly with hypertension in Chiang Mai, Thailand , International Journal of Behavioral Science . 2017 ; 12 ( 1 ): 1 - 2 .
21 Reichstadt J , Depp CA , Palinkas LA , Folsom DP , Jeste DV . Building blocks of successful aging: a focus group study of older adults' perceived contributors to successful aging . Am J Geriatr Psychiatry , 2007 Mar ; 15 ( 3 ): 194 - 201 , doi: 10.1097/JGP.0b013e318030255f .
22 Nagle B , Williams N . Methodology brief: introduction to the focus group . Center for Assessment, Planning and Accountability ; 2013 . [cited 2019 April 2]. Available from: http://www.mmgconnect.com/projects/userfiles/file/focusgroupbrief.pdf .
23 Curtis E , Redmond R . Focus groups in nursing research , Nurse Res . 2007 ; 14 ( 2 ): 25 - 37 , doi: 10.7748/nr2007.01.14.2.25.c6019 .
24 Mack N , Woodsong C , MacQueen KM , Guest G and Namey E . Qualitative research methods: a data collector's field guide . North Carolina, US : Family Health International ; 2005 .
25 Watson M , Peacock S , Jones D . The analysis of interaction in online focus groups . Int J TherRehabil . 2006 ; 13 ( 12 ): 551 - 557 , doi: 10.12968/ijtr.2006.13.12.22471 .
26 Woodyatt CR , Finneran CA , Stephenson R . In-person versus online focus group discussions: a comparative analysis of data quality . Qual Health Res . 2016 May ; 26 ( 6 ): 741 - 749 , doi: 10.1177/1049732316631510 .
27 Thrul J , Belohlavek A , Hambrick D , Kaur M , Ramo DE . Conducting online focus groups on Facebook to inform health behavior change interventions: two case studies and lessons learned . Internet Interv . 2017 Sep ; 9 : 106 - 111 , doi: 10.1016/j.invent.2017.07.005 .
Related articles, all feedback is valuable.
Please share your general feedback
Contact Customer Support
College & Research Libraries ( C&RL ) is the official, bi-monthly, online-only scholarly research journal of the Association of College & Research Libraries, a division of the American Library Association.
C&RL is now on Instragram! Follow us today.
María Evelia Emerson is Student Success Librarian and Assistant Professor at the University of Illinois Urbana-Champaign, email: [email protected] .
C&RL News
ALA JobLIST
Advertising Information
María Evelia Emerson *
Academic libraries need to have a stronger understanding of how to best support multiracial college students. The purpose of this study was to learn if multiracial students viewed their academic library as a place that increased their sense of belonging. Through interviews and a focus group with multiracial undergraduate students at the University of Illinois Urbana-Champaign (UIUC), the author learned that the interviewed students viewed the library in a positive manner but did not feel like it increased their sense of belonging on campus. Suggestions on how to increase their sense of belonging from students are included in the discussion.
“In America, you don’t get to decide what race you are. It is decided for you.”
~ Chimamanda Ngozi Adichie, Americanah 1
In 1967, the Supreme Court officially legalized interracial marriage in the case of Loving vs. Commonwealth of Virginia . Although there were interracial couples and multiracial individuals well before 1967, the legalization of interracial marriage was certainly a contributing factor in American society becoming to become less monoracial—a trend that continues today. However, “multiracial” as an identity often remains unacknowledged. For example, it was not until the year 2000 that the US Census allowed citizens the option to select more than one racial category, 2 and there are still official documents today, in 2024, that restrict users to select only one race. However, the US Census shows a substantial increase in individuals identifying as “multiracial” (categorized as “two or more races” in the census). 3 In 2010, nine million people selected “multiracial,” while in 2020, the percentage increased by 276 percent, meaning 33.8 million people selected multiracial. 4
Although the multiracial identity is still not commonly recognized, individuals who identify as multiracial still experience daily reminders that much of society views them as outsiders. Questions and statements such as: “What are you?”; “Where are you from?”; and “I never saw you as…” are common experiences for people from multiracial backgrounds. These questions make it clear to the person on the receiving end that they are racially ambiguous and that others will decide what race they are for them. Niall Singh, an artist of mixed Indian and Scottish heritage, said in an interview with Mixed Messages (a weekly newsletter about the mixed-race experience) that, “often my perspective of how I see myself has been defined by white people, because they’re the ones who most frequently tell me what they think I look like.” 5
The author of this article identifies as multiracial and believes there needs to be a better understanding and awareness of the multiracial population, particularly since more people are identifying with this demographic. The author conducted a series of one-on-one interviews, and also led a focus group of seven undergraduate students who self-identified as multiracial at the University of Illinois Urbana-Champaign (UIUC). The purpose of the interviews and focus group was to learn if the interviewed students viewed their academic library as a place that increased their sense of belonging at UIUC, and to learn more about ways academic libraries can support multiracial students.
For the purpose of this article, the term “multiracial” can be defined as a person who identifies with two or more racial groups. Other terms commonly used are biracial, mixed-race, and racially mixed. Although “multiracial” is the predominant term used throughout the article, other terms are used interchangeably. Sense of belonging, a term categorized as a social need in Abraham Maslow’s work “A Theory of Human Motivation,” 6 can be defined as a human emotional need to feel accepted and supported by members of a group; it contributes to one’s physical and mental well-being.
The University of Illinois Urbana-Champaign is a public, land grant institution, and is in the twin cities of Urbana and Champaign in southeast Illinois. UIUC is the flagship institution of the University of Illinois system and is an R1 research university. The University Library is one of the largest academic libraries in the United States. The undergraduate student body makeup at UIUC in the fall of 2022 is 38.87 percent Caucasian, 21.73 percent Asian American, 13.49 percent Hispanic, 5.81 percent African American, .03 percent Native Hawaiian or Pacific Islander, .03 percent Native American, 15.2 percent International, and 1.3 percent unknown. 7 Starting in 2010, students at UIUC could select “multiracial” as their racial identity; in 2010, 560 (1.6%) undergraduate students selected multiracial for their racial demographic, and in 2022, the number increased to 1,233 (3.53%). 8 With the continual increase in students identifying as mixed-race, there is a need for academic libraries to have a better understanding of how to better support the students of this demographic.
Libraries have been viewed, or strive to be seen, as safe spaces for their users. The American Library Association has a “Code of Ethics” that, when practiced, strives to make libraries a safe space where censorship is resisted, information is accessible, and patron privacy is upheld, among other principles. In the summer of 2021, a ninth principle was added to the code, stating that libraries, “work to recognize and dismantle systemic and individual biases [and] to confront inequity and oppression.” 9 Libraries can contribute to fulfilling these principles in different ways, such as implementing different book displays, programs, initiatives, and resources that represent the different backgrounds and needs of library users. 10 While there is an abundance of literature that discusses different ways that libraries attempt to be more inclusive, there is a definite research gap about the role of academic libraries in their support of multiracial students, particularly regarding these students’ sense of belonging.
The majority of literature involving mixed-raced populations references the groundbreaking and foundational work of Maria Root and Kristen Renn; the author drew upon these works in some of their interview and focus group questions for this study. Root, a leading expert on mixed-race people, has conducted research on multiracial identity and experiences, providing a spotlight on the complexity—and always evolving identity development—of mixed-race people, as well as the need for society to have a much stronger understanding of multiracial experiences. Through her work with mixed-race individuals, Root established that racial identity development for multiracial individuals is fluid instead of rigid. 11 Her “Bill of Rights for Racially Mixed People,” a document written to affirm mixed-race identity, also acknowledges this by stating that mixed-raced individuals have the right, “to identify…differently in different situations,” and “to change my identity over my lifetime—and more than once.” 12
Similar to Root, Renn has researched the racial identity development of biracial and mixed-race people, but focuses specifically on college students. 13 Renn drew on Urie Bronfenbrenner’s ecological theory of human development 14 for its flexibility of identity development, stating that, “…the attempt to explore the cumulative, interactive influences of overlapping social settings, some or all of which may be sending contradictory messages regarding racial identity and identification, calls for more theoretical flexibility than the racial identity development models…” 15
For the literature review, the author focused on how higher education institutions supported mixed-race students, and then looked at the role academic libraries play regarding a sense of belonging for students. Lastly, she looked at the literature to learn more about the programs and research conducted in academic libraries, so these institutions have a better understanding of the sense of belonging for multiracial students.
There is a large body of research that focuses on multiracial students in higher education. Many of these articles focus on the mental health and well-being of multiracial students. Michael T. West and Cara S. Maffini discussed how college is a normal time for students to explore their identity more, continuing that students also, “may begin to question and reflect on how their previous or current identity, which has been shaped by their past experiences (e.g., family, hometown), can be integrated with their new experiences.” 16 Some articles investigate ways to provide coping strategies and therapy exercises to mixed-race students, such as venting sessions to process their emotions that stem from the complexity of a multiracial identity. 17 Samuel D. Museus, Susan A. Lambe Sariñana, and Tasha Kawamata Ryan suggested that providing more learning opportunities on college campuses, “might simultaneously serve as a productive way to educate campus communities about multiracial issues and an effective coping strategy for mixed-race students.” 18 Other articles focus on a particular student demographic, such as Black and white individuals, 19 or students of Asian descent. 20
Research on multiracial students is especially prevalent in student affairs literature. 21 There is also literature on different experiences that multiracial students encountered in their college campuses. Haley K.M. Okamoto analyzed the challenges and identity development multiracial college students experienced, highlighting the need of work like this because, “while racial identity has certainly made its way into higher education curriculums, racial identity is still often conceptualized as singular and static.” 22 Some higher education institutions, such as Stanford University and Yale University, are starting to include the topic of multiracialism in their curriculum; however, this is still a field that is missing from most institutions.
While many academic libraries aim to be seen as a safe place for students, they are not always successful in this endeavor. This is especially true for marginalized students since libraries have a history of whiteness in their profession, buildings, collections, policies, and treatment of users. Myrna Morales, Em Claire Knowles, and Chris Bourg argue that, “academic librarians are perhaps uniquely equipped and empowered to define and redefine systems of knowledge that convey ‘truths’ about what we know about the world and how that knowledge is organized and evaluated,” 23 yet diversity initiatives often fail to consider how their own policies, standards, and practices impact their students and colleagues.
The profession of librarianship is also an overwhelmingly white, female-dominated field; in 2021, over 83 percent of librarians identified as white, and 83.2 percent identified as women in 2020. 24 This lack of diversity in library staff negatively impacts students not only due to insufficient representation in the programs and collections, but also in the librarians themselves, who may serve as partners and mentors to students. Brook et al. discuss how the library centers whiteness in public services, stating that, “when students cannot see themselves and their values represented in the library, be that in the staff, the policies, the services, or the space, then it is easy to understand why they might not use the library.” 25 Lack of diversity in the library profession impacts BIPOC librarians as well as students. Recent library literature highlights the problems of working in predominantly white spaces and discusses steps to decenter whiteness in the library profession. 26
Academic libraries play a prominent role in student success, and can help students by providing support and a sense of community during their time in college. This is especially important since college is a time when students—especially underrepresented students—may experience imposter syndrome, which contributes to a lower retention rate. Imposter syndrome, originally called imposter phenomenon, is a term coined by psychologists Clance and Imes in their 1978 study, “The Imposter Phenomenon in High Achieving Women: Dynamics and Therapeutic Intervention.” 27 Clance and Imes researched how high achieving women often feel like they are not qualified to belong in a workplace or education setting; however, their study excluded many other groups, “namely women of color and people of various income levels, genders, and professional backgrounds.” 28 Tulshyan and Burey argue that this study overlooked how institutions and workplaces cultivate these feelings of inadequacy, and that, “leaders must create a culture for women and people of color that addresses systemic bias and racism.” 29
Focusing on academic libraries, Ramsey and Brown argue that these types of institutions can assist students in overcoming imposter syndrome by creating inclusive spaces to, “help enhance a sense of belonging in their students, which can counter the ‘outsider’ feelings inherent in imposter syndrome.” 30 Oliveira also presents the different ways that academic libraries contribute to student retention and discusses the themes of social learning spaces, library use, and information literacy, which can assist with the college transition process and increase student retention. 31
Academic libraries engage with students and attempt to promote diversity and inclusivity in different ways, such as displays, exhibits, relationships, and visibility of collections. 32 However, the majority of these initiatives and programs focus on underrepresented groups, typically through the lens of a singular identity perspective and experience. For example, Bucy’s article focused on the Native American student experience in the academic library, 33 and Couture et al. discussed their work with first-generation students. 34 While these groups are underrepresented and often misunderstood student populations whose experiences are essential to understand, much of the literature still presents these groups from a homogeneous perspective, which creates a barrier to understanding the complexity and intersectionality that occurs with many students.
Although most library programs and incentives focus on homogeneous groups, some academic libraries have seen the importance of acknowledging and supporting multiracial students. The University of Michigan Library designed a library program specifically geared towards mixed-race students, including a faculty panel titled, “ Multiracial in a Monoracial World: Interraciality Informing Academic Work ,” and film screenings on mixed-race experiences. 35 There are also several articles that address some of the behind-the-scenes work that libraries can do to become more inclusive. Beall discussed creative ways that the Dewey Decimal Classification system and MARC records can become more inclusive of racially mixed people, 36 while Furner discussed using critical race theory as a way to evaluate bibliographic classification schemes. 37
The study, which was conducted during the spring semester of 2022, was designed in two parts: individual interviews with undergraduate students who self-identified as mixed-race, followed by a focus group of the same individuals. The questions asked in the one-on-one interviews were focused on the participant’s individual journey of their mixed-race identity, as well as their experiences in libraries, particularly the University of Illinois Library. The focus group questions pertained to how academic libraries can increase a sense of belonging among their multiracial students. Approval for the study was sent to the campus Institutional Review Board in November of 2021, and it obtained approval in December 2021.
Students qualified for the study if they were an undergraduate student at UIUC and identified with two or more races. The study was advertised through: the library’s social media accounts, email recruitment to the campus’ culture houses, emails to registered student organizations, and the weekly campus newsletter. As an incentive to participate, students received a $30 gift card to Amazon upon completing both the individual interview and the focus group. Funding was provided for up to twenty students to participate in the study. Since this was a qualitative study, the initial goal of twenty students (which is only 1.62 percent of the multiracial student population at UIUC) was chosen, as it is a manageable number of interviews to work through and sufficient for identifying common themes.
Interested students first had to complete a pre-screening questionnaire (Appendix A) to ensure that they qualified for the study. Thirteen students originally responded and completed the pre-screening form; eleven students qualified for the study. Those who did not qualify identified with only one race. Students were sent a consent form to sign; several students chose not to participate at that point in the process, resulting in the final number of participants being seven. Table 1 provides information about the racial background each of the students selected on the pre-screening questionnaire (Appendix A).
Table 1 | |
Study Participant Racial Background | |
Student | Races Selected |
Student #1 | Asian/Caucasian |
Student #2 | Asian/Caucasian |
Student #3 | Asian Caucasian |
Student #4 | Asian Caucasian |
Student #5 | Asian Caucasian |
Student #6 | Asian Middle Eastern or Northern African |
Student #7 | Hispanic, Latinx, or Spanish Black or African American Caucasian Write in your own answer: Multiracial |
The seven students represented only .05 percent of the multiracial population at UIUC. Of the seven students, 71 percent selected the racial background of Asian and Caucasian from the pre-screening questionnaire. While the participating students represent a very small sample, themes were easily identified, and similar experiences were described from the individual conversations and focus group with the participants. There are also future plans to expand this study to see if the answers are representative of a larger population.
It is important to note that Hispanic, Latinx, and Spanish are not races, but ethnicities. People who identify as Hispanic, Latinx, or Spanish are defined by the U.S. census to be, “a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin regardless of race.” 38 However, for the purpose of this study, students could select this as a race they identify with to align with university data as much as possible.
One-on-one interviews and a focus group were chosen as the qualitative research methods for the study. The personal interviews allowed the author to learn more about individuals’ personal experiences and thoughts regarding their multiracial identity, while the focus group helped participants hear other students’ thoughts, and to share similarities or differences in those opinions. Focus groups also allowed participants to work off each other and brainstorm different ways that libraries could be more inclusive of their identities. Since the study was conducted during the COVID-19 pandemic, Zoom was chosen as the format for the interviews and focus group to ensure safety. Meeting via Zoom also allowed for more flexibility with scheduling around participating students’ classes, jobs, and extracurricular activities. Study participants also had the choice of having the camera on or off while in the interviews and focus group to help participants feel more at ease while engaging with the author. All participants decided to have their cameras off during the interviews and focus group. Before conducting the one-on-one interviews and focus groups, the author also consulted with some of her colleagues to learn more about best practices for leading these conversations.
Questions for both the one-on-one interviews and the focus group were designed in several different ways. First, the author drew from her own experiences as a multiracial individual and designed some questions that she felt would provide a foundation on how study participants viewed their mixed-race identities, as well as how others may perceive them and how that impacts their day-to-day lives. The author shared these questions with another multiracial colleague to discuss if they felt the questions would help provide information that the author hoped to learn about multiracial students and libraries. Second, the author designed questions that would provide foundational information about students’ usage of libraries to gain a better understanding of ways students utilize, spend time in, and view the library. Lastly, the author incorporated some of the work of Renn and Root into the interview questions, specifically questions number three and four (Appendix B). The author drew from Root’s Bill of Rights to design question three, which asked about being incorrectly identified as a mixed-race individual, as well as Renn’s work on racial identity development to craft question number four. 39 The question preparation for the interview and focus group was conducted over several afternoons, in addition to being revised a few times based on discussion with the author’s colleague, as well as the literature review.
The one-on-one interviews lasted between fifteen minutes to forty-five minutes; each student was asked the same set of questions, included in appendices B and C. Each interview was recorded with the student’s consent, and the audio recording was transcribed using the NVivo transcription service. After all the personal interviews were complete, a focus group with all seven participants took place over Zoom, moderated by the author. The focus group session was fifty minutes long, recorded with the participants’ consent, and transcribed using the same software as the personal interviews. While almost all the participants expressed their thoughts verbally, one student participated more frequently using the chat function in Zoom. At the end of the focus group, each participant was sent a $30 Amazon gift card to their university email account.
After the audio recordings of the personal interviews and focus group were transcribed, the author identified recurrent themes that occurred in the conversations. The transcriptions of the interviews and focus group—along with the chat transcript of the focus group—were printed and read several times in order to find recurring experiences, thoughts, and keywords from the study participants, which were then color-coded into categories. Quotes were also pulled from the interviews and focus group, and were color-coded into the appropriate category that supported the recognized themes. There were some outliers within the identified themes, which are included in the findings section of this article. The outliers, though few, are important to include since they highlight how everyone’s multiracial journeys are different, even if there is overlap within their experiences. An afternoon was set aside to conduct and complete the qualitative data coding process of the seven interviews and one focus group.
Themes of identity challenges, feelings of erasure, and the desire to find community, all emerged from the individual interviews and focus group. Participants discussed how these themes tied into their experiences on campus and in the academic library. Overall, students in this study viewed the University of Illinois Library as a neutral place on campus, which served as a location to study and to provide academic resources rather than a place that fostered a sense of belonging, community, and support. All the participants used the library at a minimum of a few hours a week, and none of them had experiences where they felt unwelcome in the University of Illinois Library.
The author defined the themes from the study as follows:
One of the questions in the individual interviews focused on their journey with their multiracial identity. All participants did have at least one time in their lives where they struggled with their mixed identity. Family relationships, growing up in a predominantly white neighborhood or schools, and misidentification of their identities all contributed to the confusion and difficulties they experienced in their multiracial identity journeys. One participant stated, “If you are multiracial then you are in a constant state of flux in between those ethnic distinctions.”
Many participants discussed how people are often confused about how to view them. Several told stories about how it is common for people to guess what they “are.” While some of the students said that they understand people are curious and normally mean well, others expressed frustration. One student said, “sometimes it’s fine, but sometimes it’s kind of weird when they just keep guessing. Like, it’s not a game.” Another student remarked during the focus group that they wish others knew that “I am many things, right? …I just wish that people would respect the multifaceted nature and mind of that.”
When asked about how the library did or did not contribute to their identity journey, many of the students did not feel like they had resources available to support them or provide more information about their identity. A few participants talked about a time in the library when they stumbled upon a book that told a story about a mixed-race individual, and they were excited to read it because they could hear about someone else’s multiracial identity journey. However, these were isolated incidents, and the students discussed how overall there is a lack of resources that could support or assist them in learning more about being multiracial. During the focus group, one student said, “I haven’t really seen many materials that do represent multiracial groups, and I think that would be great for increasing our sense of belonging.” Others agreed with the statement and talked about how more awareness of the topic and resources could help themselves and other students.
Many of the study participants also described the feelings of imposter syndrome, or having to choose one race over another, on multiple occasions in their lives. However, one student discussed a positive experience of not needing to choose their race describing a non-UIUC library where the library was, “full of people from different backgrounds using different languages…we were all respecting one another…and it made me feel like I didn’t have to choose one of my races over the other.” This experience highlights the relief from not having to choose between races, and the potential support academic libraries can provide by having a more heterogeneous environment.
Despite the challenges and complexities that can come with identifying as mixed-race, all the participants said that they felt being multiracial made them more empathetic and understanding of people. They also felt like it helped them learn how to better navigate differences of opinions and backgrounds. One participant of the study said that being multiracial is, “definitely a blessing. It’s more like it turns into a blessing once you realize how to manage that in your life. If you want to make it a blessing, you can make it a blessing.”
All the participants discussed how they felt that their multiracial identity is often ignored, or erased, both by institutions and people in their lives. The lack of multiracial options in surveys and forms, the erasure of their identity in conversations with friends and classmates (and sometimes even families), the absence of multiracial topics in educational settings, and the lack of acknowledgment of the multiracial identity in libraries were discussed in the personal interviews and focus group. One student talked about a time they felt ignored when they went to [Library] to find something to read, and found books organized by different race and sexual orientation identities: “But I didn’t see the mixed section, so that was just something that was like…I am that, it would have been cool to have at least a few books to look through because [multiracial] is an identity.”
This anecdote ties into the recurring theme regarding the visibility of heritage and history months, as well as spotlighting authors from a variety of backgrounds. Study participants discussed seeing library displays promoting different books, authors, histories, or celebrations of specific groups, yet none for multiracial identities. Many of the participants acknowledged that there is no multiracial identity month to highlight, yet it is an identity that libraries can still put a spotlight on; doing so would help them feel more seen. One of the participants did not completely agree that mixed-race identities are erased, but instead were more misunderstood by their peers, remarking, “I think a lot of the time the way it [being multiracial] works is that it’s acknowledged but not necessarily respected.” This response was shared in the focus group and, upon hearing that, many of the other participants remarked on how they feel like the mixed-race experience is misunderstood by many; in an individual interview, a participant said that often people get confused about being multiracial because, “it’s like they only see one side of things.” Several remarked that they felt that with more resources in the library and discussions about the mixed-race experience, others could begin to have a better understanding of the complexity and varied experiences and journeys that occur with that identity. During the focus group, participants talked about when they felt most at home and safe; feelings of acceptance, respect, understanding, and acknowledgment of all parts of their racial background contributed to an increased sense of belonging. One participant said, “I feel most comfortable when people acknowledge both my Polish and Chinese side because I feel like it’s pretty easy…for like other people to kind of dismiss whichever culture or race that you look less like.” None of the participants identified their academic library (or any library) as a place where they felt at home. For participants, the library was viewed as a neutral building to in which to study, find resources for their classes, and receive research support. It was not seen as a support system, nor as campus resource that could contribute to their sense of belonging and/or understanding of their place on campus.
Very few students felt that they had a multiracial community; most participants felt alone in their identity, though some did actively seek out other multiracial individuals. Some students mentioned siblings who they could talk about their identity with, but others remarked on how their families ignored that part of their children’s identity. This would sometimes happen for different reasons; some participants discussed how their parents are immigrants and were told to “Americanize” their children, while others acknowledged family tensions due to race. One participant said they were, “sort of whitewashed by my dad because he, I don’t know, but he liked to promote my whiteness over anything else.”
When asked about finding community in the library, the students commented on how they found library spaces that worked well for their academic needs, but they did not typically find people or resources that could relate to their mixed-race experience. Regarding library staff, some of the participants felt like they saw themselves represented by the library student workers, but other participants did not feel represented in that sense. As already mentioned, some of the participants reflected on the time they found a library resource about, or written by, someone with a mixed-race background. However, one student thought of a particular example with a book when asked about community and discussed their excitement over finding a book that was about a character with the same racial makeup as themselves. While this student may have not found a multiracial community in person, they did think of one instance in which a library resource provided a small community to them.
In both the interviews and the focus group, participants brought up other campus resources which could serve as possible places of community and/or increase a sense of belonging, such as culture houses and student organizations. However, several of the participants still struggled with finding a community within culture houses because they felt the houses did not relate to their multiracial experience, and better served students who identified with one racial background. Several students also discussed the various student organizations on campus that are for students from different racial and ethnic groups, but felt that one’s appearance and skin tone impacted whether a multiracial student could participate and feel welcomed in these groups. One student reflected on their experience in the focus group and said that, “even though my lived experiences are not necessarily indicative of my ethnic background, it still exists.” The focus group discussed whether there was a student organization for multiracial students; the majority of the students believed one did not exist on the campus, but several other students said there used to be one, but that it had disbanded for unknown reasons.
The struggle of not belonging to any specific group was discussed by almost all the participants. One participant said, “I feel like even though I say I can connect to more people I still feel like there is some disconnect, and I don’t belong in a particular group.” This feeling was brought up several times regarding library displays, with one student noting, “all of these displays are for specific cultures and I’m just feeling like I didn’t really fit into any of those categories.” Several participants stated that, even among mixed-race individuals, it is rare to find someone else with the same exact background as you, or with the same lived experiences. However, the one commonality of the multiracial community is the shared experience of not belonging to one single racial group. One study participant said that, “even if you come from a different background, you still have this one shared identity of being multiracial, multicultural.”
All the participants of this study use the UIUC libraries to support their academic needs. All of them spent at least a couple hours a week studying in the library, while others spent close to fifteen hours a week. Several of the participants used their hometown’s public libraries, and one student mentioned using their high school library. While the results of this study were not a negative reflection of the University of Illinois Library, or of libraries in general, it was discovered that the participating students did not view their academic library as a place to increase their sense of belonging at UIUC.
Overall, students described using libraries for research and scholarship, although several participants did go to the library to find leisure books to read. Similar to other experiences in their lives, participants did not feel like their multiracial identity was acknowledged within the library, especially in ways that other cultures and races have been acknowledged, such as through various displays and collections. Many of the participants talked about specific library displays. The library’s display for Black History Month frequently came up, and another student talked about a display that highlighted Arab women authors. While the students were not surprised about not finding a display about multiracialism, several expressed a desire to see that part of their identity acknowledged in that specific way.
An unexpected perspective that emerged with several study participants was the belief that libraries are neutral. Because of this belief, many of the participants felt that the library did not have a responsibility to support their sense of belonging; one participant said, “I have no problems with them [libraries] because they take such a neutral stance on everything. And that’s fine…but if part of their goal was to be more inclusive, then, you know, I probably expect a bit more.” Another student remarked that, “libraries aren’t political places,” and many participants stated that, while they did not see their own representation in the library, they did not believe it was part of the library’s responsibilities to increase their sense of belonging. Several of the study participants said that they had a very neutral stance on the library, and many participants reflected on how they associate the library with a physical space to study in. These observations from the interviews and focus group are important because they show that the University of Illinois Library is not as inclusive as it—according to the library’s mission statement—strives to be. 40 Instead, the study participants believe that the mission of the library is to solely provide resources and services in an unbiased way.
There has been a great deal of criticism of the idea that libraries are neutral institutions 41 because libraries uphold white supremacy; this relates back to the issue of whiteness in academic libraries, and how the systemic inequalities in library policies and structures need to be addressed for academic libraries to become more inclusive. While the University of Illinois Library mission statement has language that communicate the necessity and importance of supporting student needs through library collections and services, it does not include active language against neutrality in libraries. By adopting more active language against neutrality in its mission statement, as well as continuing to include more services and collection items that are more inclusive and accessible, the library may begin to change students’ perspective of the library from a neutral space to one that is more inclusive space.
Academic libraries are a place where students can grow not only through scholarly resources, but through the programs, space, staff, and exhibits offered. It is important for academic libraries to explore ways to reach out to, and connect with, students who have intersectional identities and who are seeking places and communities that make them feel less alone.
The author learned from the discussion with the participating students that, while they viewed the library in a positive manner, they did not feel like it increased their sense of belonging on campus. Instead, they viewed it as a physical space to study in, with several of them viewing libraries as neutral spaces whose purpose is meant only to provide academic support. While none of the students felt unwelcomed in the University of Illinois Library, they did acknowledge that they felt erasure of their multiracial identity in the library as they did with many other places on campus.
With the population of the United States continuing to become more diverse, there needs to be more attention on, and awareness of, multiracial identities to combat the erasure of this demographic. Being multiracial brings about a wealth of complexities, including identity challenges and a lack of a sense of belonging. Mixed-race individuals have unique experiences that all contribute to their sense of self, but the complexity of this identity also allows for more empathy and support for others.
Themes of identity challenges, erasure, and finding community all emerged from conversations with participants, and will be used in guiding questions and discussions for the next steps of this study. Additionally, the idea of academic libraries as neutral places will be explored more in-depth to gain a stronger understanding of how students view the purpose of academic libraries. This study is only a small sampling from one university, and it will next be expanded to explore the experiences of a larger sampling of multiracial students in higher education on a national level. With a larger sample size, more information, experiences, and reflections will be gathered, which will provide a stronger understanding and will continue the conversation of how academic libraries can best support this group of students and increase their sense of belonging on their campuses.
The author wishes to acknowledge the Research and Publication Committee of the University of Illinois at Urbana-Champaign Library, which provided support for the completion of this research. Additionally, thank you to Emma Saito Lincoln for her help in constructing the questions designed for this study. Lastly, thank you to Jen-chien Yu for her help in learning about the interview process and focus groups.
1. Chimamanda Ngozi Adichie, Americanah (New York: Anchor Books, 2014).
2. “Frequently Asked Questions (FAQs) about Race,” U.S. Census Bureau, last modified December 3, 2021. https://www.census.gov/topics/population/race/about/faq.html .
3. “Improved Race and Ethnicity Measures Reveal U.S. Population is Much More Multiracial,” U.S. Census Bureau, last modified June 10, 2022, https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html .
4. U.S. Census Bureau, “Improved Race and Ethnicity.”
5. Isabella Silvers, “Niall Singh: ‘Often, How I See Myself Has Been Defined by White People,’” Mixed Messages , July 4, 2022, https://mixedmessages.substack.com/p/niall-singh-often-how-i-see-myself .
6. A.H. Maslow, “A Theory of Human Motivation,” Psychological Review 50, no. 4 (1943): 370–396, https://doi.org/10.1037/h0054346 .
7. “University of Illinois Student Enrollment,” Division of Management Information, last modified September 7, 2022, https://dmi.illinois.edu/stuenr/#ethgen .
8. Division of Management, “University of Illinois.”
9. “Professional Ethics,” American Library Association, last modified June 29, 2021, https://www.ala.org/tools/ethics .
10. Sabrina Thomas and Kacy J. Lovelace, “Combining Efforts: Libraries as Mental Health Safe Spaces,” College and Research Libraries News 80, no. 10 (2019): 546–48, https://doi.org/10.5860/crln.80.10.546 ; Lisa Gay-Milliken and Jeffrey DiScala, “Going beyond Book Displays: Providing Safe Spaces for LGBTQ Youth,” Knowledge Quest 48, no. 3 (2020): 10–12, http://www.library.illinois.edu.proxy2.library.illinois.edu/proxy/go.php?url=https://search-ebsco-host.com.proxy2.library.illinois.edu/login.aspx?direct=true&db=eric&AN=EJ1238793&site=eds-live&scope=site ; Stephanie Everett, “Visualizing the Silent Dialogue About Race: Diversity Outreach in an Academic Library,” Journal of Academic Librarianship 44, no. 4 (2018): 518–26, https://doi.org/10.1016/j.acalib.2018.04.002 ; Margaret K. Merga. “Libraries as Wellbeing Supportive Spaces in Contemporary Schools,” Journal of Library Administration 61, no. 6 (2021): 659–75, https://doi.org/10.1080/01930826.2021.1947056 ; Kelsey Keyes. “Welcoming Spaces: Supporting Parenting Students at the Academic Library,” Journal of Academic Librarianship 43, no. 4 (2017): 319–28. .
11. Maria P.P. Root, ed., The Multiracial Experience: Racial Borders as the New Frontier , (London: Sage, 1996).
12. Maria P.P. Root, “A Bill of Rights for Racially Mixed People,” Embracing Diversity, last modified December 10, 2018, https://www.safehousealliance.org/wp-content/uploads/2012/10/A-Bill-of-Rights-for-Racially-Mixed-People.pdf .
13. Kristen A. Renn, “Patterns of Situational Identity Among Biracial and Multiracial College Students,” The Review of Higher Education 23, no. 4 (2000): 399–420, https://doi.org/10.1353/rhe.2000.0019 ; Kristen A. Renn, “Research on Biracial and Multiracial Identity Development: Overview and Synthesis,” New Directions for Student Services, no. 123 (2008): 13–21, https://doi.org/10.1002/ss.282 .
14. Urie Bronfenbrenner, The Ecology of Human Development: Experiments by Nature and Design (Cambridge, Mass: Harvard University Press, 1979).
15. Kristen A. Renn, “Understanding the Identities of Mixed-Race College Students through a Developmental Ecology Lens,” Journal of College Student Development 44, no. 3 (2003): 383–403, https://doi.org/10.1353/csd.2003.0032 .
16. Michael T. West and Cara S. Maffini, “‘What Are You?’ Conceptualizing the Complexities of Bicultural and Biracial College Student Experiences,” Journal of College Counseling 22, no. 2 (2019): 164–178, https://doi.org/10.1002/jocc.12128 .
17. Derrick A. Paladino and Harrison Davis Jr., “Counseling and Outreach Strategies for Assisting Multiracial College Students,” Journal of College Student Psychotherapy 20, no. 3 (2006): 19–31, https://doi.org/10.1300/J035v20n03_03 .
18. Samuel D. Museus, Susan A. Lambe Sariñana, and Tasha Kawamata Ryan, “A Qualitative Examination of Multiracial Students’ Coping Responses to Experiences with Prejudice and Discrimination in College,” Journal of College Student Development 56, no. 4 (2015): 331–348, https://psycnet.apa.org/doi/10.1353/csd.2015.0041 .
19. Elizabeth M. Lusk et al., “Biracial Identity and its Relation to Self-Esteem and Depression in Mixed Black/White Biracial Individuals,” Journal of Ethnic & Cultural Diversity in Social Work 19, no. 2: (2010):109–26, https://doi.org/10.1080/15313201003771783 .
20. Shinwoo Choi et al., “Sense of Belonging, Racial Microaggressions, and Depressive Symptoms Among Students of Asian Descent in the United States,” Smith College Studies in Social Work 91, no. 2 (2021): 115–41, https://doi.org/10.1080/00377317.2021.1882922 .
21. Nana Osei-Kofi, “Identity, Fluidity, and Groupism: The Construction of Multiraciality in Education Discourse,” Review of Education, Pedagogy, and Cultural Studies 34, no. 5 (2012): 245–257, https://doi.org/10.1080/10714413.2012.732782 ; Aurora Chang, “Multiracial Matters–Disrupting and Reinforcing the Racial Rubric in Educational Discourse,” Race Ethnicity and Education 19, no. 4 (2016): 706–30, https://doi.org/10.1080/13613324.2014.885427 ; Jackie Hyman, “The New Multiracial Student: Where Do We Start?,” The Vermont Connection 31, no. 1 (2010): 14, https://scholarworks.uvm.edu/tvc/vol31/iss1/14 ; Angela H. Kellogg and Debora L. Liddell, “‘Not Half but Double’: Exploring Critical Incidents in the Racial Identity of Multiracial College Students,” Journal of College Student Development 53, no. 4 (2012): 524–41, https://doi.org/10.1353/csd.2012.0054 ; Samuel D. Museus, April L. Yee, and Susan A. Lambe, “Multiracial in a Monoracial World: Student Stories of Racial Dissolution on the Colorblind Campus,” About Campus 16, no. 4 (2011): 20–25, https://doi.org/10.1002/abc.20070 .
22. Haley K.M. Okamoto, “Mixed Plate: Exploring Multiracial Student Identities within Higher Education,” PSU McNair Scholars Online Journal 14, no. 1 (2020): 1–44, https://doi.org/10.15760/mcnair.2020.14.1.4 .
23. Myrna Morale, Em Claire Knowles, and Chris Bourg, “Diversity, Social Justice, and the Future of Libraries,” portal: Libraries and the Academy 14, no. 3 (2014): 439–451, https://doi.org/10.1353/pla.2014.0017 .
24. “Library Professionals: Facts and Figures,” Department for Professional Employees, https://static1.squarespace.com/static/5d10ef48024ce300010f0f0c/t/60c24d4d903e4a17f8629234/1623346509173/Library+Workers+Facts+%26+Figures+2021+%282%29.pdf .
25. Freeda Brook, Dave Ellenwood, and Althea Eannace Lazzaro, “In Pursuit of Antiracist Social Justice: Denaturalizing Whiteness in the Academic Library,” Library Trends 64, no. 2 (2015): 246–84, https://doi.org/10.1353/lib.2015.0048 .
26. Isabel Espinal, Tonia Sutherland, and Charlotte Roh, “A Holistic Approach for Inclusive Librarianship: Decentering Whiteness in Our Profession,” Library Trends 67, no. 1 (2018): 147–62, https://doi.org/10.1353/lib.2018.0030 ; Jennifer Brown et al., “We Here: Speaking Our Truth,” Library Trends 67, no. 1 (2018): 163–81, https://doi.org/10.1353/lib.2018.0031 ; Emily A. Crist and Kelly Clark Keefe, “A Critical Phenomenology of Whiteness in Academic Libraries,” Journal of Academic Librarianship 48, no. 4 (2022): 102557, https://doi.org/10.1016/j.acalib.2022.102557 .
27. Pauline Rose Clance and Suzanne Imes, “The Imposter Phenomenon in High Achieving Women: Dynamics and Therapeutic Intervention,” Psychotherapy: Theory, Research & Practice 15, no. 3 (1978): 241–247, https://doi.org/10.1037/h0086006 .
28. Ruckia Tulshyan and Jodi-Ann Burey, “Stop Telling Women They Have Imposter Syndrome, ” Harvard Business Review , February 11, 2021, https://hbr.org/2021/02/stop-telling-women-they-have-imposter-syndrome .
29. Tulshyan, “Stop Telling.”
30. Elizabeth Ramsey and Deana Brown, “Feeling Like a Fraud: Helping Students Renegotiate Their Academic Identities,” College & Undergraduate Libraries 25, no. 1 (2018): 86–90, https://doi.org/10.1080/10691316.2017.1364080 .
31. Silas M. Oliveira, “The Academic Library’s Role in Student Retention: A Review of the Literature,” Library Review 66, no. 4/5 (2017): 310–29, https://doi.org/10.1108/LR-12-2016-0102 .
32. Everett, “Visualizing,” 518–26; Michelle M. Maloney, “Cultivating Community, Promoting Inclusivity: Collections as Fulcrum for Targeted Outreach,” New Library World 113, no. 5/6 (2012): 281–89; https://doi.org/10.1108/03074801211226364 ; Margaret Adeogun, “Increasing Patron’s Outreach and Engagement through Relationship Marketing: A Case Study,” Journal of Library Administration 62, no. 3 (2022): 359–75, https://doi.org/10.1080/01930826.2022.2043691 ; Paolo P. Gujilde, “Chapter 4: Moving beyond Buzzwords: Belonging in Library Collections,” Advances in Librarianship 48 (April 2021): 35–41, https://doi.org/10.1108/S0065-283020210000048004 .
33. Rosalind Bucy, “Native American Student Experiences of the Academic Library,” College & Research Libraries 83, no. 3 (2022): 416–33, https://doi.org/10.5860/crl.83.3.416 .
34. Juliann Couture et al., “‘We’re Gonna Figure This Out’: First-Generation Students and Academic Libraries,” Portal: Libraries and the Academy 21, no. 1 (2021): 127–47, https://doi.org/10.1353/pla.2021.0009 .
35. Helen Look, “Multiracial Resources in a Monoracially-Organized Library World,” Urban Library Journal 22, no. 2 (2016): 1–6, http://www.library.illinois.edu.proxy2.library.illinois.edu/proxy/go.php?url=https://search-ebscohost-com.proxy2.library.illinois.edu/login.aspx?direct=true&db=lls&AN=119554073&site=eds-live&scope=site .
36. Julianne Beall, “Racially Mixed People, DDC Table 5 Ethnic and National Groups, and MARC 21 Bibliographic Format Field 083,” Cataloging & Classification Quarterly 47, no. 7 (2009): 657–70, https://doi.org/10.1080/01639370903112005 .
37. Jonathan Furner, “Dewey Deracialized: A Critical Race-Theoretic Perspective,” KO Knowledge Organization 34, no. 3 (2007): 144–68, https://doi.org/10.5771/0943-7444-2007-3-144 .
38. “About the Hispanic Population and its Origin,” U.S. Census , last modified April 12, 2022, https://www.census.gov/topics/population/hispanic-origin/about.html .
39. Maria P.P. Root,“A Bill of Rights for Racially Mixed People,” Embracing Diversity , last modified December 10, 2018, https://www.safehousealliance.org/wp-content/uploads/2012/10/A-Bill-of-Rights-for-Racially-Mixed-People.pdf ; Kristen A. Renn, “Research on Biracial and Multiracial Identity Development: Overview and Synthesis,” New Directions for Student Services no. 123 (2008): 13–21, https://doi.org/10.1002/ss.282 .
40. “Strategic Framework,” University Library, University of Illinois, last modified August 26, 2019, https://www.library.illinois.edu/geninfo/libraryinit/strategic-framework-2019/ .
41. J.A. Ferretti, “Neutrality is Polite Oppression: How Critical Librarianship and Pedagogy Principles Counter Neutral Narratives and Benefit the Profession, Critical Librarianship and Pedagogy Symposium (CLAPS), keynote presentation, Nov. 28, 2018, University of Arizona, Tucson, AZ; Anastasia Chiu, Fobazi M. Ettarh, and Jennifer A. Ferretti, “Not the Shark, But the Water: How Neutrality and Vocational Awe Intertwine to Uphold White Supremacy,” In Knowledge Justice: Disrupting Library and Information Studies through Critical Race Theory , eds, Sofia Y. Leung and Jorge R. López-McKnight (Cambridge: MIT Press, 2021), 49–71; Amelia N. Gibson et al., “Libraries on the Frontlines: Neutrality and Social Justice,” Equality, Diversity and Inclusion: An International Journal 36, no. 8 (2017): 751–66, https://doi.org/10.1108/EDI-11-2016-0100 ; Todd Honma. “Trippin’ Over the Color Line: The Invisibility of Race in Library and Information Studies,” InterActions: UCLA Journal of Education and Information Studies 1, no. 2 (2005), https://doi.org/10.5070/D412000540 .
* María Evelia Emerson is Student Success Librarian and Assistant Professor at the University of Illinois Urbana-Champaign, email: [email protected] . ©2024 María Evelia Emerson, Attribution-NonCommercial ( https://creativecommons.org/licenses/by-nc/4.0/ ) CC BY-NC.
Contact ACRL for article usage statistics from 2010-April 2017.
2024 |
January: 0 |
February: 0 |
March: 0 |
April: 0 |
May: 0 |
June: 4 |
July: 415 |
© 2024 Association of College and Research Libraries , a division of the American Library Association
Print ISSN: 0010-0870 | Online ISSN: 2150-6701
ALA Privacy Policy
ISSN: 2150-6701
Reproductive Health volume 21 , Article number: 96 ( 2024 ) Cite this article
93 Accesses
Metrics details
Recent studies revealed an elevated likelihood of unintended pregnancies among women with psychiatric disorders compared to their counterparts without such vulnerability. Despite the importance of understanding family planning decision-making in this group, qualitative inquiries are lacking. This study explored family planning decisions among women with psychiatric disorders.
Utilizing a qualitative approach, three focus group discussions were conducted with purposive sampling: women with a history of unintended pregnancies ( N = 3), women without children ( N = 5), and women with a history of intended pregnancies ( N = 9), all of whom had self-reported psychiatric disorders. Using thematic framework analysis, we investigated the themes “Shadow of the past,” reflecting past experiences, and “Shadow of the future,” reflecting future imaginaries, building upon the existing “Narrative Framework.”
The Narrative Framework formed the foundation for understanding family planning among women with psychiatric disorders. The retrospective dimension of focus group discussions provided opportunities for reflective narratives on sensitive topics, revealing emotions of regret, grief and relief. Childhood trauma, adverse events, and inadequate parenting enriched the "Shadow of the past". The “Shadow of the present” was identified as a novel theme, addressing awareness of psychiatric disorders and emotions toward psychiatric stability. Social influences, stigma, and concerns about transmitting psychiatric disorders shaped future imaginaries in the shadow of the future.
This study enlightens how family planning decision-making in women with psychiatric disorders might be complex, as marked by the enduring impact of past experiences and societal influences in this sample. These nuanced insights underscore the necessity for tailored support for women with psychiatric disorders.
Recent studies show that women with psychiatric disorders are more likely to experience unintended pregnancies. However, the underlying reasons are not fully understood. Understanding those reasons is important to provide better healthcare. Our study explored how women with psychiatric disorders make decisions about family planning.
We had conversations with different groups of women—women with unintended pregnancies, women without children, and women with intended pregnancies—through focus group discussions. We partnered with the Dutch mental health organization MIND to capture diverse opinions. Key themes and categories in the discussions were identified and organized.
We found four main themes: "Shadow of the past" showed how past events, trauma, and lack of knowledge about parenting affect family planning. "Shadow of the present" revealed different feelings about family planning, the importance of the awareness of psychiatric disorders, and uncertainty about decisions. "Shadow of the future" included thoughts about becoming a mother, the impact of social influences, and concerns about passing on psychiatric disorders. "Reflections on the decision" showed how psychiatric disorders, experiences with motherhood, and feelings of regret, grief and relief had an influence on family planning decisions.
In conclusion, our study highlighted the complexity of family planning decisions for women with psychiatric disorders. Past experiences and societal influences, like stigma, play a big role. These insights show the need for personalized family planning support for women with psychiatric disorders.
Peer Review reports
Literature suggests that psychiatric disorders and family planning decision-making are related. Recent studies revealed that women with psychiatric disorders more often experience unintended pregnancies compared to counterparts without such vulnerability [ 1 , 2 , 3 ]. Moreover, childlessness is associated with having chronic illnesses, among which are psychiatric illnesses [ 4 , 5 ]. However, there is limited knowledge about contributing factors that shape family planning decision-making in women with psychiatric disorders [ 6 , 7 ].
Family planning decision-making defines the process through which individuals make choices about whether to have children, when to have them, and how many children to have [ 8 ]. It involves contemplating economic, social, cultural, and health-related factors [ 9 ]. Understanding family planning decision-making is fundamental for estimating the need for contraception, predicting reproductive patterns, and developing programs aimed at preventing unintended pregnancies [ 10 ]. The use of (emergency) contraceptives [ 11 ], improved accessibility to abortion services [ 12 ], and increased understanding of risk factors [ 11 , 13 , 14 ] have reduced unintended pregnancies. However, in 2010–2019, more than half of all pregnancies worldwide were still unintended [ 15 ].
Unintended pregnancies are particularly common among women with psychiatric disorders, reaching rates of up to 65% [ 5 , 16 ]. Aside from difficulties with planning, women with psychiatric disorders face elevated risks of psychiatric problems after pregnancy, leading to additional risks for adverse outcomes for both mothers and children [ 17 , 18 , 19 , 20 ]. The preconception phase is crucial for women planning to conceive by offering an opportunity to enhance nutrition and lifestyle choices to minimize maternal and child health risks [ 21 ]. Pregnancy planning is especially important for women with psychiatric disorders because they may need to make medication adjustments, take precautionary measures regarding the relapse of psychiatric disorders, and optimize mother–child attachment [ 17 , 18 , 19 , 20 ]. Indeed, women with unintended pregnancies encounter significant additional challenges due to the absence of the pregnancy planning phase, such as limited access to prenatal care, financial strain, and emotional stress [ 1 ].
Several frameworks exist for describing the factors that shape family planning decision-making [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. However, most frameworks are past-driven and focus predominantly on cognitive factors [ 29 ]. We hypothesize that these frameworks are inadequate for capturing the uncertainty about the future faced by women with psychiatric disorders. The “Narrative Framework” provides a different perspective on family planning decision-making, particularly amid the amplified uncertainty and stress of the COVID-19 pandemic. It integrates past experiences, psychological predispositions, and socioeconomic factors, termed the “Shadow of the past,” alongside expectations, future imaginaries, and future narratives, termed the “Shadow of the future.” This framework captures decision-making processes by including these elements.
The aim of this qualitative study was to delve into the family planning experiences of women with psychiatric disorders (history of psychiatric disorder and/or current diagnosis). The “Narrative Framework” will provide a foundation for structuring the themes involved in the decision-making process [ 29 ]. The results of this study will contribute to knowledge about family planning decision-making in women with psychiatric disorders.
Study design.
A qualitative study of experiences with family planning in women with self-reported psychiatric disorder(s) was conducted. We adopted a constructionist approach in which we acknowledged the role of society in shaping perspectives on family planning decision-making [ 30 ]. Therefore, focus group discussions were selected as the method of data collection because participants themselves can represent societal influences on each other’s perspectives.
Seventeen volunteers of the Dutch mental health umbrella organization MIND with self-reported psychiatric disorders were included. Participants were recruited from a sample of survey respondents ( n = 378) from MIND [ 5 ]. The survey was conducted to collect quantitative and qualitative information about family planning. Participants were given the option to provide their email address if they wished to participate in a focus group discussion. Both men and women participated in the survey, but to address the current research question, only women were eligible ( n = 17). Prior to participating in the focus groups, and after explanation of the study, all participants signed an informed consent form. Focus group discussion 1 ( n = 3) consisted of women with a history of (initially) unintended pregnancies. Women who experienced an unintended pregnancy but did not remain pregnant (due to miscarriage or abortion) also participated in focus group discussion 1. Focus group discussion 2 ( n = 5) consisted of women who did not have children and who had not been pregnant prior to participation. Focus group discussion 3 ( n = 9) consisted of women with a history of intended pregnancies resulting in one or more children. Purposeful sampling created homogeneous focus group discussions regarding pregnancy intentions, ultimately benefiting the willingness of women to engage in discussions [ 31 ]. Due to the anonymous nature of the survey, it was unclear prior to the focus group discussions which psychiatric disorders the participants had been diagnosed with. Medical records were inaccessible; participants disclosed their psychiatric diagnoses during the focus group discussions. Figure 1 provides an overview of participant inclusion.
Flowchart of participant inclusion. Legend: this figure outlines the participant selection process for the study
Three focus group discussions were held at a central location in the Netherlands (organization MIND, Amersfoort, The Netherlands) between October and November 2021. The interview guide was created based on answers to an earlier survey and consisted of two main research questions, complemented by specific questions per focus group discussion: 1) How does your (history with) psychiatric disorder influence your desire for children? and 2) What is your experience discussing family planning with your mental health professional? The interview guide for each focus group is provided in Additional file 1 . The focus group discussions were held in Dutch and lasted between 120 and 155 min (median duration 123 min). A researcher with lived experience with perinatal mental health problems [ME] led the discussions, [NS] was present to observe and take field notes. Digital research data, including audio recordings and ad verbatim transcripts of the focus group discussions, were pseudonymized and stored in a password-protected file on a secure server of the hospital (OLVG). Paper consent forms are stored in a locked research cabinet of the same hospital. This process ensures that the data is securely stored, and that participants’ anonymity is protected throughout the study.
The focus group discussions were audio-recorded and transcribed ad-verbatim. The transcripts were converted to ATLAS.ti v9 for data analysis. Table 1 summarizes the steps performed during the analysis.
The research team, with backgrounds in psychiatry, obstetrics, neurosciences, and health behavior, ensured a foundation for conducting a nuanced and in-depth qualitative analysis of family planning decision-making, thereby incorporating triangulation. The epistemological approach was clearly stated and closely adhered to, which helped to align the research question with the applied methods. The conclusions were grounded in the evidence through the inclusion of quotations. Providing contextual information, such as the study setting and participant details, enhanced the comprehensibility of the results. Unlike a conventional consensus-reaching method, different interpretations were integrated into the findings to enrich the data analysis process. Utilizing methods of researcher reflexivity, such as memos and field notes, contributed to a reflexive and transparent analytical process. Reflexivity was considered throughout the process, acknowledging that [ME]’s background with lived experience with perinatal mental health problems may have influenced the discussions and interaction with participants, potentially fostering a more open and empathetic environment.
Information about the demographics of the participants ( n = 17) is reported in Table 2 . Ages ranged between 24 and 70 years, with a median age of 57 years. All women had a Dutch background. The participants exhibited diverse occupational backgrounds, with six (35%) declaring themselves unfit for employment for reasons related to their psychiatric disorder(s). A history of pregnancy and psychiatric disorder(s) are described in Table 3 . Mood disorders were the predominant psychiatric disorder ( n = 10), manifesting across all focus group discussions. Subsequently, trauma-related disorders ( n = 8) and anxiety disorders ( n = 6) were the most prevalent.
Our findings are presented within the context of an adapted version of the “Narrative Framework”. While the original framework highlights “ Shadow of the past ” and “ Shadow of the future ” as primary themes, our findings expanded this framework by incorporating two additional themes, namely “ Reflections on the decision ” and “ Shadow of the present ”, which were specifically tailored to our study population. This adaptation is illustrated in Fig. 2 . Each theme includes categories supported by quotations translated into English. Additional file 2 provides the original Dutch quotations.
Framework of family planning decision-making in women with psychiatric disorders. Legend: this figure shows the framework of family planning decision-making with part ( a ) illustrating the Narrative Framework and part ( b ) illustrating the adapted version tailored to women with psychiatric disorders. For each theme categories are listed on the right side of figure b. This figure is reproduced with permission from “Guetto R, Bazzani G, Vignoli D (2022) Narratives of the future and fertility decision-making in uncertain times. An application to the COVID-19 pandemic. Vienna Yearb Popul Res 20:223–260. https://www.jstor.org/stable/27222579 ”
The retrospective nature of the focus group discussions allowed 17 women to delve into reflective narratives concerning sensitive topics regarding their psychiatric disorder(s) and family planning decision-making. The importance of these reflections, amplified by their emotionally charged nature, justifies the creation of a dedicated theme to them, as they were not yet addressed by the Narrative Framework [ 29 ]. Table 4 provides several quotations belonging to this theme.
Reflections on family planning decisions revealed a mix of emotions experienced by the participants. Participants without children often felt grief, yet some also found relief in their decision. This illustrates the complexity of emotions within individuals. The impact of participants' psychiatric disorder(s) on family planning was central in all focus group discussions. For some women, challenges in parenting due to personal circumstances brought feelings of grief and regret. However, positive reflections on motherhood also emerged, particularly from mothers who found fulfillment in motherhood despite initially unintended pregnancies.
Originally, the shadow of the past reflected the impact of life experiences, psychological predispositions, and socioeconomic factors on an individual’s decision about having children [ 29 ]. In our sample, this theme was enriched by the interplay between personal experiences in the women’s upbringing, the perceived parenting skills of their parents, and how those women respond to these experiences. Quotations are provided in Table 5 .
The participants of all focus group discussions spontaneously shared (childhood) trauma and adverse life events when asked about their family planning decision-making, revealing their perceived connection between these experiences and their family planning considerations. They believed that their upbringing impacted their decisions. Lived experience with trauma affected perspectives on family planning differently: some women were motivated to move past their childhood trauma by building a (better) family for themselves by having a child, while other women refrained from having children because of their adverse life events.
This category showed how reflections on their own upbringing, specifically on their parents' parenting skills or the lack thereof, can influence women’s perspectives on having children. The decision to have children became a personal and reflective process shaped by the desire to replicate positive aspects of one's upbringing or breaking away from negative patterns and challenges.
In the Narrative Framework [ 29 ], (socioeconomic) status and personal perceptions bridged the gap between the shadow of the past and the shadow of the future. While socioeconomic factors such as financial considerations or the availability of a (suitable) partner contributed to the decision-making process of the participants, personal perceptions of their psychiatric disorder(s) were pertinent. This led to the extension of the framework with a novel theme: the shadow of the present. This theme incorporates categories relevant to our sample, including awareness of psychiatric disorder(s) and psychiatric stability, which were previously unaddressed in empirical models of family planning (Table 6 ).
Awareness of psychiatric disorder(s) at the time of the decision was a recurrent theme among participants with children. Some participants mentioned the impact of not being aware of their psychiatric disorder at the time of the decision, indicating that they would have made different choices if they had been aware of the diagnosis earlier. For some of the participants, the diagnosis was liberating, explaining the challenges of motherhood.
Psychiatric stability at the time of decision-making was mentioned as one of the factors influencing choices. For some individuals, the stability of symptoms presented an opportunity to pursue parenthood, while for others, psychiatric stability did not hold the same level of deliberative weight. Diverse attitudes toward this issue highlight how some participants experienced resilience by learning from previous experiences, while others did not.
A spectrum of diverse viewpoints on the desire for children was described as a complex array of thoughts, emotions, and perspectives that concurrently coexist, contributing to a fluctuating experience over time and giving rise to feelings of ambivalence and uncertainty. As one participant expressed “childbearing desire is not 100% yes or 100% no,” highlighting nuanced attitudes toward motherhood and childlessness. While ‘perceptions’ were originally emphasized as personal interpretations of past and current experiences [ 29 ] our participants argued that viewpoints on the desire for children change over time.
Opportunities and constraints for childbearing plans resemble the (socioeconomic) status element of the Narrative Framework [ 29 ]. This category includes several factors mentioned as reasons whether to have a child, including maternal age, financial stability or having a (stable) partner.
The shadow of the future emphasizes the importance of expectations and personal narratives in uncertain situations [ 29 ]. Our study shows how social influences, stigma around mental health, and uncertainty about passing on a condition can influence future imaginaries (Table 7 ).
During the focus group discussions, the social system’s impact was heavily discussed. Many expressed frustrations with the lack of support from their social environment for their desire for children, leading to uncertainty about their decision. While personal visions of the future can be influenced by society, personal visions may also differ, thereby placing social influences in the shadow of the future [ 29 ]. Participants’ experiences with stigma due to their psychiatric disorder(s) often leaned toward deciding against having children.
The transgenerational transmission of psychiatric disorder(s) to children was a key theme among participants, as discussed in all focus group discussions. Many participants were conscious of the risk of passing their condition to their offspring, which influenced their decisions against having children or causing regret if transmission occurred. Awareness of the challenges varied, with some participants doubting the possibility of breaking the transmission cycle, while others remained hopeful.
Insecurities about motherhood were deliberated. Participants felt incapable of raising a child for varying reasons, such as difficulty combining motherhood and having psychiatric symptoms. Other participants could rationalize this by referring to ‘other mothers’ without psychiatric disorder(s) who make parenting mistakes. Another participant stated that although her illness was heritable, it also aided her in supporting her child.
This study has provided insights into family planning decision-making among women with psychiatric disorders by extending the Narrative Framework [ 29 ] with two themes. First, we dedicated a theme to reflections on decision-making, which encompasses emotions of grief, relief and regret. Second, we introduced the shadow of the present, which emphasized the impact of psychiatric disorders on decision-making by considering awareness of psychiatric disorders and psychiatric stability. Furthermore, the shadows of the past and future were broadened by integrating categories tailored to women with psychiatric disorders, including trauma, adverse life events, and social influences.
The retrospective nature of the focus group discussions allowed us to reflect on the participants’ family planning decisions, where the emotions of regret, grief and relief emerged. Regret over the delay in childbearing decisions has been described before in couples seeking fertility treatments [ 32 ]. Like our participants, voluntary childless women reported relief, feeling financially unburdened compared to their parenting peers, and enjoying various forms of freedom. However, they also faced stigmatization, and some expressed that their decision was influenced by their concern about potentially transmitting diseases to their children [ 33 ]. We hypothesize that cognitive dissonance, influenced by the type of psychiatric disorder, may contribute to regret in individuals as they grapple with conflicting thoughts and emotions [ 34 ].
Our study enhanced the shadow of the past with insights from 17 women with psychiatric disorder(s), shedding light on the impact of (childhood) trauma and adverse experiences on family planning decision-making. Previous research has shown an increased risk of unintended pregnancy in mothers with adverse childhood experiences [ 35 ]. Furthermore, women with unintended pregnancies reported more psychosocial problems [ 36 ]. Together with our findings, these findings imply that past experiences (related to psychiatric disorders) play a significant role in shaping family planning decisions and outcomes.
In the shadow of the present, we expanded upon the existing themes of (socioeconomic) status and perceptions [ 29 ]. Various enablers and constraints in the decision-making process surfaced, aligning with descriptions in other frameworks [ 22 , 23 , 25 , 26 ], and are therefore not unique to our population. The personal perceptions of our participants were portrayed as a complex array of emotions and thoughts, contributing to a fluctuating experience of family planning marked by ambivalence and uncertainty. Ambivalence toward motherhood in women with severe mental illness has been previously documented [ 37 ]. However, our study focused primarily on ambivalence in decision-making. Surprisingly, participants did not bring up the issue of psychoactive medication usage in relation to family planning. Although most psychotropic medication can be continued during pregnancy, some psychoactive medications can be teratogenic and should be used with caution [ 38 , 39 ]. Also, previous studies showed that (pregnant) women with psychiatric disorders contemplate their medication usage [ 40 ]. Overall, our findings suggest that family planning decision-making is more complex in women with psychiatric disorders than in those without psychiatric disorders, consistent with prior research [ 41 ]. A potential explanation lies in additional factors influencing the decision, such as awareness of the psychiatric disorder and psychiatric stability at the time of the decision.
The notion that social influences, including stigma, shape the shadow of the future through uncertainty is not limited to women with psychiatric disorders. A study on disabled women’s childbirth experiences revealed diverse reactions from their surroundings, leading to heightened fears and a sense of diminished control over their childbirth experiences [ 42 ]. Despite the difference in study populations, similar findings indicate a convergence in the experiences of women. While uncertainty about the future during the COVID-19 pandemic has been noted among the general population [ 28 , 29 ], we specifically examined uncertainty regarding stigma surrounding psychiatric disorders and their potential transmission. Participants' narratives may be influenced by maladaptive prospection seen in persons with psychiatric disorders such as depression and anxiety, which distorts future expectations [ 43 ]. Additionally, the potential of transmitting psychiatric disorders to their children might have intensified feelings of uncertainty about the future and thus made the decision-making process more challenging. This phenomenon is not novel and has been documented in various other hereditary diseases [ 44 , 45 ]. The actual extent of inheritance in psychiatric disorders significantly influences this dynamic. For instance, the estimated heritability for psychotic and neurodevelopmental disorders ranges from 74–85%, whereas for mood and anxiety disorders, it ranges between 37–58% [ 46 ]. The high heritability rate of these disorders aligns with the uncertainty as described in the narratives.
This study provides a nuanced exploration of family planning decision-making in 17 women with psychiatric disorders. The transdiagnostic approach sheds light on overarching issues that were experienced. The use of focus group discussions captured societal dynamics and fostered an interactive environment for reflective perspectives [ 47 , 48 ]. Thematic framework analysis offered a structured examination of identified themes [ 29 ]. However, limitations include the small group of women with unintended pregnancies ( n = 3) and the retrospective nature of reflections, potentially introducing recall bias [ 49 , 50 ]. Moreover, it is important to acknowledge the wide age range of participants, as this may affect the consistency of the data. We addressed the potential recall bias by incorporating the reflective nature of our framework and acknowledging its influence on the findings. The iterative process did not include respondent validation of the findings. To mitigate potential misinterpretations, we involved a researcher with lived experience with perinatal mental health problems.
Furthermore, the utilization of focus groups may restrict the depth of individual analyses. Although all our participants had been known with a psychiatric disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), we hypothesize that within the diverse array of disorders represented, each psychiatric disorder may have impacted family planning decisions in distinct ways. Additionally, the focus groups did not allow for an in-depth examination of the individual socioeconomic status of the women and how this influenced their reproductive desires. Given the established importance of socioeconomic status in the context of unintended pregnancies [ 14 ], it is crucial to consider this factor in individual sessions. Opting for individual interviews could provide a more comprehensive exploration.
Future research could benefit from longitudinal and prospective study designs, allowing examination of family planning decision-making in women with psychiatric disorders considering the fluctuating aspect of family planning. Distinguishing between various psychiatric disorders and their unique impact on decision-making could provide a more nuanced understanding, possibly through individual in-depth interviews. As women with unintended pregnancies and psychiatric disorders may experience more challenges with family planning decision-making, it would be interesting to include these women in future research.
Our study sheds light on family planning decisions among women with psychiatric disorders. Like women without psychiatric disorders, past experiences, socioeconomic status, and perceptions on the desire for children shape decision-making. We found that traumatic events have a lasting impact on family planning choices. Stigma, uncertainty about parenting skills, and concerns about transmitting psychiatric disorder(s) contribute to ambivalence about having children. Feelings of regret, grief and relief regarding these decisions reflect the influence of psychiatric disorders. Our results emphasize that women with psychiatric disorders deserve support tailored to their needs, e.g. the possibility to discuss family planning at perinatal mental health facilities. Moreover, healthcare professionals could consider offering ongoing emotional support beyond the reproductive phase to those reflecting on their family planning decisions.
The dataset(s) supporting the conclusions of this article are included within the article and the additional files. The original data are available upon reasonable request.
Enthoven CA, El MH, Koopman-Verhoeff ME, Jansen W, den Berg MPL, Sondeijker F, Hillegers MHJ, Bijma HH, Jansen PW. Clustering of characteristics associated with unplanned pregnancies: the generation R study. BMC Public Health. 2022;22(1):1957. https://doi.org/10.1186/s12889-022-14342-y .
Article PubMed PubMed Central Google Scholar
Schonewille NN, Rijkers N, Berenschot A, Lijmer JG, van den Heuvel OA, Broekman BFP. Psychiatric vulnerability and the risk for unintended pregnancies, a systematic review and meta-analysis. BMC Pregnancy Childb. 2022;22(1):153. https://doi.org/10.1186/s12884-022-04452-1 .
Article CAS Google Scholar
Gariepy AM, Lundsberg LS, Miller D, Stanwood NL, Yonkers KA. Are pregnancy planning and pregnancy timing associated with maternal psychiatric illness, psychological distress and support during pregnancy? J Affect Disorders. 2016;205:87–94. https://doi.org/10.1016/j.jad.2016.06.058 .
Article PubMed Google Scholar
Liu A, Akimova ET, Ding X, Jukarainen S, Vartiainen P, Kiiskinen T, Kuitunen S, Havulinna AS, Gissler M, Lombardi S, Fall T, Mills MC, Ganna A (2023) The relationship of early-life diseases with lifetime childlessness: Evidence from Finland and Sweden. MedRxiv. 2022.03.25.22272822. https://doi.org/10.1101/2022.03.25.22272822 .
Schonewille NN, van den Eijnden MJM, Jonkman NH, van Kempen AAMW, van Pampus MG, Goedhart FG, van den Heuvel OA, Broekman BFP. Experiences with Family Planning amongst Persons with Mental Health Problems: A Nationwide Patient Survey. Int J Environ Res Public Health. 2023;20(4):3070. https://doi.org/10.3390/ijerph20043070 .
Bagadia A, Nanjundaswamy MH, Ganjekar S, Thippeswamy H, Desai G, Chandra PS. Factors influencing decision-making around pregnancy among women with severe mental illness (SMI): A qualitative study. Int J Soc Psychiatrc. 2020;66(8):792–8. https://doi.org/10.1177/0020764020925104 .
Article Google Scholar
Becker T, Krumm S. Research on family planning issues in women with mental disorders. J Ment Health. 2006;15:383–5. https://doi.org/10.1080/09638230600801488 .
Santelli J, Rochat R, Hatfield-Timajchy K, Gilbert BC, Curtis K, Cabral R, Hirsch JS, Schieve L. The measurement and meaning of unintended pregnancy. Perspect Sex Repro H. 2003;35(2):94–101. https://doi.org/10.1363/3509403 .
Santelli J, Lindberg LD, Orr MG, Finer LB, Speizer I. Toward a multidimensional measure of pregnancy intentions: evidence from the United States. Stud Family Plann. 2009;40(2):87–100. https://doi.org/10.1111/j.1728-4465.2009.00192.x .
Klerman LV. The Intendedness of Pregnancy: A Concept in Transition. Matern Child Hlth J. 2000;4(3):155–62. https://doi.org/10.1023/A:1009534612388 .
Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008–2011. New Eng J Med. 2016;374(9):843–52. https://doi.org/10.1056/NEJMsa1506575 .
Article CAS PubMed Google Scholar
Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):e380–9. https://doi.org/10.1016/S2214-109X(18)30029-9 .
Goshu YA, Yitayew AE. Prevalence and determinant factors of unintended pregnancy among pregnant women attending antenatal clinics of Addis Zemen hospital. PLoS ONE. 2019;14(1):e0210206. https://doi.org/10.1371/journal.pone.0210206 .
Article CAS PubMed PubMed Central Google Scholar
Thaxton L, Espey E. Family Planning American Style Redux: Unintended Pregnancy Improves, Barriers Remain. Obstet Gynecol Clin North Am. 2017;44(1):41–56. https://doi.org/10.1016/j.ogc.2016.11.001 .
Bearak J, Popinchalk A, Ganatra B, Moller AB, Tunçalp Ö, Beavin C, Kwok L, Alkema L. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob Health. 2020;8(9):e1152–61. https://doi.org/10.1016/S2214-109X(20)30315-6 .
Dossett EC, Castañeda-Cudney SL, Nguyen MT, Olgun M, Wang J, Myrick KJ, Hallmark L, Saks ER. Reproductive psychiatric advance directives: promoting autonomy for perinatal people with serious mental illness diagnoses. Arch Women Ment Hlth. 2023. https://doi.org/10.1007/s00737-023-01382-5 .
Kent A. Psychiatric disorders in pregnancy. Obstet Gynaecol Reprod Med. 2011;21(11):317–22. https://doi.org/10.1016/j.ogrm.2011.09.002 .
Miller L. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophrenia Bull. 1997;23(4):623–35. https://doi.org/10.1093/schbul/23.4.623 .
Mohamed MA, Elhelbawy A, Khalid M, AbdAllatif LA, Lialy HE. Effects of bipolar disorder on maternal and fetal health during pregnancy: a systematic review. BMC Pregnancy Childb. 2023;23(1):617. https://doi.org/10.1186/s12884-023-05924-8 .
Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ. Episodes of Mood Disorders in 2,252 Pregnancies and Postpartum Periods. Am J Psychiatry. 2011;168(11):1179–85. https://doi.org/10.1176/appi.ajp.2011.11010148 .
Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, Poston L, Barrett G, Crozier SR, Barker M, Kumaran K, Yajnik CS, Baird J, Mishra GD. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet. 2018;391(10132):1830–41. https://doi.org/10.1016/S0140-6736(18)30311-8 .
Ajzen I. The theory of planned behavior. Organ Behav Hum. 1991;50(2):179–211. https://doi.org/10.1016/0749-5978(91)90020-T .
Ajzen I, Klobas J (2013) Fertility intentions: An approach based on the theory of planned behaviour. Demogr Res 29(8):203–232. https://www.demographic-research.org/special/16/8/.
Miller W. Personality traits and developmental experiences as antecedents of childbearing motivation. Demography. 1992;29(2):265–85.
Miller W. Childbearing motivations, desires, and intentions: a theoretical framework. Genet Soc Gen Psychol Monogr. 1994;120(2):223–58.
CAS PubMed Google Scholar
Miller W, Severy L, Pasta D. A framework for modelling fertility motivation in couples. Pop Stud. 2004;58(2):193–205. https://doi.org/10.1080/0032472042000213712 .
Ganle JK, Apolot RR, Rugoho T, Sumankuuro J. ‘They are my future’: childbearing desires and motivations among women with disabilities in Ghana - implications for reproductive healthcare. Reprod Health. 2020;17(1):151. https://doi.org/10.1186/s12978-020-01000-y .
Vignoli D, Bazzani G, Guetto R, Minello A, Pirani E (2020) Uncertainty and Narratives of the Future: A Theoretical Framework for Contemporary Fertility. In: Schoen R (eds) Analyzing Contemporary Fertility, The Springer Series on Demographic Methods and Population Analysis, vol 51 Springer, Cham, pp 25–47.
Guetto R, Bazzani G, Vignoli D (2022) Narratives of the future and fertility decision-making in uncertain times. An application to the COVID-19 pandemic. Vienna Yearb Popul Res 20(1):223–260. https://econpapers.repec.org/RePEc:vid:yearbk:v:20:y:2022:i:1:oid:0x003d3ca9.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. https://doi.org/10.1191/1478088706qp063oa .
Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research. Adm Policy Ment Health. 2015;42(5):533–44. https://doi.org/10.1007/s10488-013-0528-y .
Adachi T, Endo M, Ohashi K. Regret over the delay in childbearing decision negatively associates with life satisfaction among Japanese women and men seeking fertility treatment: A cross-sectional study. BMC Public Health. 2020;20(1):886. https://doi.org/10.1186/s12889-020-09025-5 .
Mollen D. Voluntarily Childfree Women: Experiences and Counseling Considerations. J Ment Health Couns. 2006;28(3):269–82. https://doi.org/10.17744/mehc.28.3.39w5h93mreb0mk4f .
Baumann T, Piesbergen C, Vant E, Tominschek I. Kognitive Dissonanz nach Entscheidungen und psychische Erkrankungen: Explorative Untersuchung von Patienten mit Zwangsstörung oder Depressionen. Psychotherapeut. 2014;59(2):130–7. https://doi.org/10.1007/s00278-013-0988-2 .
Testa A, Jackson DB, Ganson KT, Nagata JM. Maternal adverse childhood experiences and pregnancy intentions. Ann Epidemiol. 2021;64:47–52. https://doi.org/10.1016/j.annepidem.2021.09.011 .
Dijkstra CI, Dalmijn EW, Bolt SH, Groenhof F, Peters LL, Jansen DEMC. Women with unwanted pregnancies, their psychosocial problems, and contraceptive use in primary care in Northern Netherlands: insights from a primary care registry database. Fam Pract. 2023;40(5–6):648–54. https://doi.org/10.1093/fampra/cmad036 .
Banerjee D, Arasappa R, Chandra PS, Desai G. “It seemed like my fault for wanting to become a mother …”—Experiences and perceptions related to motherhood in women with severe mental illness. Asia-Pac Psychiat. 2022;14(4):e12519. https://doi.org/10.1111/appy.12519 .
Damkier P, Videbech P. The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review. CNS Drugs. 2018;32(4):351–66. https://doi.org/10.1007/s40263-018-0517-5 .
Kautzky A, Slamanig R, Unger A, Höflich A. Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis. Acta Psychiatr Scand. 2022;145(1):6–28. https://doi.org/10.1111/acps.13367 .
Stevens AWMM, Daggenvoorde TH, van der Klis SMD, Kupka RW, Goossens PJJ. Thoughts and Considerations of Women With Bipolar Disorder About Family Planning and Pregnancy: A Qualitative Study. J Am Psychiatr Nurses Assoc. 2018;24(2):118–26. https://doi.org/10.1177/1078390317711251 .
Ross NE, Webster TG, Tastenhoye CA, Hauspurg AK, Foust JE, Gopalan PR, Friedman SH. Reproductive Decision-Making Capacity in Women With Psychiatric Illness: A Systematic Review. J Acad Consult Liaison Psychiatry. 2022;63(1):61–70. https://doi.org/10.1016/j.jaclp.2021.08.007 .
Walsh-Gallagher D, Sinclair M, Conkey RM. The ambiguity of disabled women’s experiences of pregnancy, childbirth and motherhood: A phenomenological understanding. Midwifery. 2012;28(2):156–62. https://doi.org/10.1016/j.midw.2011.01.003 .
Seligman MEP, Railton P, Baumeister RF, Sripada C. Navigating Into the Future or Driven by the Past. Perspect Psychol Sci. 2013;8(2):119–41. https://doi.org/10.1177/1745691612474317 .
Severijns Y, de Die-Smulders CEM, Gültzow T, de Vries H, van Osch LADM. Hereditary diseases and child wish: exploring motives, considerations, and the (joint) decision-making process of genetically at-risk couples. J Community Genet. 2021;12(3):325–35. https://doi.org/10.1007/s12687-021-00510-x .
Fahy N, Rice C, Lahiri N, Desai R, Stott J. Genetic risk for Huntington Disease and reproductive decision-making: A systematic review. Clin Genet. 2023;104(2):147–62. https://doi.org/10.1111/cge.14345 .
Andreassen OA, Hindley GFL, Frei O, Smeland OB. New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. World Psychiatry. 2023;22(1):4–24. https://doi.org/10.1002/wps.21034 .
Krueger RA, Casey MA. Focus Groups: a practical guide for applied research. 4th ed. Thousand Oaks: SAGE Publications; 2009. p. 219. Available from: https://books.google.nl/books?id=ySKeSZeWywMC .
Tausch AP, Menold N. Methodological Aspects of Focus Groups in Health Research: Results of Qualitative Interviews With Focus Group Moderators. Glob Qual Nurs Res. 2016. https://doi.org/10.1177/2333393616630466 .
Guzzo KB, Hayford SR. Revisiting Retrospective Reporting of First-Birth Intendedness. Matern Child Hlth J. 2014;18(9):2141–7. https://doi.org/10.1007/s10995-014-1462-7 .
Chamberlin S, Njerenga S, Smith-Greenaway E, Yeatman S. Women’s Life Experiences and Shifting Reports of Pregnancy Planning. Matern Child Hlth J. 2022;26(8):1719–26. https://doi.org/10.1007/s10995-022-03447-w .
Download references
We express our gratitude to all the women who participated in the focus group discussions. Additionally, we extend our appreciation to Yente Dubbeldam for her contribution to data cleaning and analysis.
This research was funded by ZonMw, grant number 554002007.
Authors and affiliations.
Department of Psychiatry and Medical Psychology, OLVG, Oosterpark 9, Amsterdam, 1091 AC, The Netherlands
Shahenda A. I. H. Ahmad, Jorina Holtrop, Birit F. P. Broekman & Noralie N. Schonewille
Team Knowledge, Innovation and Research, MIND, Stationsplein 125, Amersfoort, 3818 LE, The Netherlands
Monique J. M. van den Eijnden
Department of Research and Epidemiology, OLVG, Oosterpark 9, Amsterdam, 1091 AC, The Netherlands
Nini H. Jonkman
Department of Gynecology and Obstetrics, OLVG, Oosterpark 9, Amsterdam, 1091 AC, The Netherlands
Maria G. van Pampus
Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands
Odile A. van den Heuvel, Birit F. P. Broekman & Noralie N. Schonewille
Department of Anatomy and Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands
Odile A. van den Heuvel
Compulsivity, Impulsivity and Attention Program, Amsterdam Neuroscience, Amsterdam, The Netherlands
Amsterdam Public Health, Mental Health Program, Amsterdam UMC, Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands
Birit F. P. Broekman & Noralie N. Schonewille
You can also search for this author in PubMed Google Scholar
Conceptualization, funding, design and methodology, ME, BB and NS; focus group discussions, ME and NS; study and analytic design advice, NJ; formal analysis, all authors (SA, JH, ME, NJ, MP, OH, BB, NS); original draft preparation, SA and JH; review and editing, all authors (SA, JH, ME, NJ, MP, OH, BB, NS); visualization, SA; supervision, BB and NS.
Correspondence to Noralie N. Schonewille .
Ethics approval and consent to participate.
The study was conducted in accordance with the Declaration of Helsinki and declared as not part of the Human Subjects Research Law by Medical Ethics Research Committee United Nieuwegein, protocol code W21.215, date of declaration 24–09-2021. Local approval was granted by OLVG Hospital. Written informed consent was obtained from all the subjects involved in the focus group discussions.
All subjects involved in the focus groups have provided consent for publication.
The authors declare that they have no competing interests.
Publisher’s note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1: this file provides the interview guides for the three focus group discussions., additional file 2: this file provides the original quotations for each theme per category in dutch language., rights and permissions.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Reprints and permissions
Cite this article.
Ahmad, S.A.I.H., Holtrop, J., van den Eijnden, M.J.M. et al. Family planning decision-making in relation to psychiatric disorders in women: a qualitative focus group study. Reprod Health 21 , 96 (2024). https://doi.org/10.1186/s12978-024-01836-8
Download citation
Received : 28 March 2024
Accepted : 24 June 2024
Published : 02 July 2024
DOI : https://doi.org/10.1186/s12978-024-01836-8
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
ISSN: 1742-4755
BMC Nursing volume 23 , Article number: 452 ( 2024 ) Cite this article
362 Accesses
Metrics details
The central component in impactful healthcare decisions is evidence. Understanding how nurse leaders use evidence in their own managerial decision making is still limited. This mixed methods systematic review aimed to examine how evidence is used to solve leadership problems and to describe the measured and perceived effects of evidence-based leadership on nurse leaders and their performance, organizational, and clinical outcomes.
We included articles using any type of research design. We referred nurses, nurse managers or other nursing staff working in a healthcare context when they attempt to influence the behavior of individuals or a group in an organization using an evidence-based approach. Seven databases were searched until 11 November 2021. JBI Critical Appraisal Checklist for Quasi-experimental studies, JBI Critical Appraisal Checklist for Case Series, Mixed Methods Appraisal Tool were used to evaluate the Risk of bias in quasi-experimental studies, case series, mixed methods studies, respectively. The JBI approach to mixed methods systematic reviews was followed, and a parallel-results convergent approach to synthesis and integration was adopted.
Thirty-one publications were eligible for the analysis: case series ( n = 27), mixed methods studies ( n = 3) and quasi-experimental studies ( n = 1). All studies were included regardless of methodological quality. Leadership problems were related to the implementation of knowledge into practice, the quality of nursing care and the resource availability. Organizational data was used in 27 studies to understand leadership problems, scientific evidence from literature was sought in 26 studies, and stakeholders’ views were explored in 24 studies. Perceived and measured effects of evidence-based leadership focused on nurses’ performance, organizational outcomes, and clinical outcomes. Economic data were not available.
This is the first systematic review to examine how evidence is used to solve leadership problems and to describe its measured and perceived effects from different sites. Although a variety of perceptions and effects were identified on nurses’ performance as well as on organizational and clinical outcomes, available knowledge concerning evidence-based leadership is currently insufficient. Therefore, more high-quality research and clinical trial designs are still needed.
The study was registered (PROSPERO CRD42021259624).
Peer Review reports
Global health demands have set new roles for nurse leaders [ 1 ].Nurse leaders are referred to as nurses, nurse managers, or other nursing staff working in a healthcare context who attempt to influence the behavior of individuals or a group based on goals that are congruent with organizational goals [ 2 ]. They are seen as professionals “armed with data and evidence, and a commitment to mentorship and education”, and as a group in which “leaders innovate, transform, and achieve quality outcomes for patients, health care professionals, organizations, and communities” [ 3 ]. Effective leadership occurs when team members critically follow leaders and are motivated by a leader’s decisions based on the organization’s requests and targets [ 4 ]. On the other hand, problems caused by poor leadership may also occur, regarding staff relations, stress, sickness, or retention [ 5 ]. Therefore, leadership requires an understanding of different problems to be solved using synthesizing evidence from research, clinical expertise, and stakeholders’ preferences [ 6 , 7 ]. If based on evidence, leadership decisions, also referred as leadership decision making [ 8 ], could ensure adequate staffing [ 7 , 9 ] and to produce sufficient and cost-effective care [ 10 ]. However, nurse leaders still rely on their decision making on their personal [ 11 ] and professional experience [ 10 ] over research evidence, which can lead to deficiencies in the quality and safety of care delivery [ 12 , 13 , 14 ]. As all nurses should demonstrate leadership in their profession, their leadership competencies should be strengthened [ 15 ].
Evidence-informed decision-making, referred to as evidence appraisal and application, and evaluation of decisions [ 16 ], has been recognized as one of the core competencies for leaders [ 17 , 18 ]. The role of evidence in nurse leaders’ managerial decision making has been promoted by public authorities [ 19 , 20 , 21 ]. Evidence-based management, another concept related to evidence-based leadership, has been used as the potential to improve healthcare services [ 22 ]. It can guide nursing leaders, in developing working conditions, staff retention, implementation practices, strategic planning, patient care, and success of leadership [ 13 ]. Collins and Holton [ 23 ] in their systematic review and meta-analysis examined 83 studies regarding leadership development interventions. They found that leadership training can result in significant improvement in participants’ skills, especially in knowledge level, although the training effects varied across studies. Cummings et al. [ 24 ] reviewed 100 papers (93 studies) and concluded that participation in leadership interventions had a positive impact on the development of a variety of leadership styles. Clavijo-Chamorro et al. [ 25 ] in their review of 11 studies focused on leadership-related factors that facilitate evidence implementation: teamwork, organizational structures, and transformational leadership. The role of nurse managers was to facilitate evidence-based practices by transforming contexts to motivate the staff and move toward a shared vision of change.
As far as we are aware, however, only a few systematic reviews have focused on evidence-based leadership or related concepts in the healthcare context aiming to analyse how nurse leaders themselves uses evidence in the decision-making process. Young [ 26 ] targeted definitions and acceptance of evidence-based management (EBMgt) in healthcare while Hasanpoor et al. [ 22 ] identified facilitators and barriers, sources of evidence used, and the role of evidence in the process of decision making. Both these reviews concluded that EBMgt was of great importance but used limitedly in healthcare settings due to a lack of time, a lack of research management activities, and policy constraints. A review by Williams [ 27 ] showed that the usage of evidence to support management in decision making is marginal due to a shortage of relevant evidence. Fraser [ 28 ] in their review further indicated that the potential evidence-based knowledge is not used in decision making by leaders as effectively as it could be. Non-use of evidence occurs and leaders base their decisions mainly on single studies, real-world evidence, and experts’ opinions [ 29 ]. Systematic reviews and meta-analyses rarely provide evidence of management-related interventions [ 30 ]. Tate et al. [ 31 ] concluded based on their systematic review and meta-analysis that the ability of nurse leaders to use and critically appraise research evidence may influence the way policy is enacted and how resources and staff are used to meet certain objectives set by policy. This can further influence staff and workforce outcomes. It is therefore important that nurse leaders have the capacity and motivation to use the strongest evidence available to effect change and guide their decision making [ 27 ].
Despite of a growing body of evidence, we found only one review focusing on the impact of evidence-based knowledge. Geert et al. [ 32 ] reviewed literature from 2007 to 2016 to understand the elements of design, delivery, and evaluation of leadership development interventions that are the most reliably linked to outcomes at the level of the individual and the organization, and that are of most benefit to patients. The authors concluded that it is possible to improve individual-level outcomes among leaders, such as knowledge, motivation, skills, and behavior change using evidence-based approaches. Some of the most effective interventions included, for example, interactive workshops, coaching, action learning, and mentoring. However, these authors found limited research evidence describing how nurse leaders themselves use evidence to support their managerial decisions in nursing and what the outcomes are.
To fill the knowledge gap and compliment to existing knowledgebase, in this mixed methods review we aimed to (1) examine what leadership problems nurse leaders solve using an evidence-based approach and (2) how they use evidence to solve these problems. We also explored (3) the measured and (4) perceived effects of the evidence-based leadership approach in healthcare settings. Both qualitative and quantitative components of the effects of evidence-based leadership were examined to provide greater insights into the available literature [ 33 ]. Together with the evidence-based leadership approach, and its impact on nursing [ 34 , 35 ], this knowledge gained in this review can be used to inform clinical policy or organizational decisions [ 33 ]. The study is registered (PROSPERO CRD42021259624). The methods used in this review were specified in advance and documented in a priori in a published protocol [ 36 ]. Key terms of the review and the search terms are defined in Table 1 (population, intervention, comparison, outcomes, context, other).
In this review, we used a mixed methods approach [ 37 ]. A mixed methods systematic review was selected as this approach has the potential to produce direct relevance to policy makers and practitioners [ 38 ]. Johnson and Onwuegbuzie [ 39 ] have defined mixed methods research as “the class of research in which the researcher mixes or combines quantitative and qualitative research techniques, methods, approaches, concepts or language into a single study.” Therefore, we combined quantitative and narrative analysis to appraise and synthesize empirical evidence, and we held them as equally important in informing clinical policy or organizational decisions [ 34 ]. In this review, a comprehensive synthesis of quantitative and qualitative data was performed first and then discussed in discussion part (parallel-results convergent design) [ 40 ]. We hoped that different type of analysis approaches could complement each other and deeper picture of the topic in line with our research questions could be gained [ 34 ].
Inclusion and exclusion criteria of the study are described in Table 1 .
A three-step search strategy was utilized. First, an initial limited search with #MEDLINE was undertaken, followed by analysis of the words used in the title, abstract, and the article’s key index terms. Second, the search strategy, including identified keywords and index terms, was adapted for each included data base and a second search was undertaken on 11 November 2021. The full search strategy for each database is described in Additional file 1 . Third, the reference list of all studies included in the review were screened for additional studies. No year limits or language restrictions were used.
The database search included the following: CINAHL (EBSCO), Cochrane Library (academic database for medicine and health science and nursing), Embase (Elsevier), PsycINFO (EBSCO), PubMed (MEDLINE), Scopus (Elsevier) and Web of Science (academic database across all scientific and technical disciplines, ranging from medicine and social sciences to arts and humanities). These databases were selected as they represent typical databases in health care context. Subject headings from each of the databases were included in the search strategies. Boolean operators ‘AND’ and ‘OR’ were used to combine the search terms. An information specialist from the University of Turku Library was consulted in the formation of the search strategies.
All identified citations were collated and uploaded into Covidence software (Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia www.covidence.org ), and duplicates were removed by the software. Titles and abstracts were screened and assessed against the inclusion criteria independently by two reviewers out of four, and any discrepancies were resolved by the third reviewer (MV, KH, TL, WC). Studies meeting the inclusion criteria were retrieved in full and archived in Covidence. Access to one full-text article was lacking: the authors for one study were contacted about the missing full text, but no full text was received. All remaining hits of the included studies were retrieved and assessed independently against the inclusion criteria by two independent reviewers of four (MV, KH, TL, WC). Studies that did not meet the inclusion criteria were excluded, and the reasons for exclusion were recorded in Covidence. Any disagreements that arose between the reviewers were resolved through discussions with XL.
Eligible studies were critically appraised by two independent reviewers (YT, SH). Standardized critical appraisal instruments based on the study design were used. First, quasi-experimental studies were assessed using the JBI Critical Appraisal Checklist for Quasi-experimental studies [ 44 ]. Second, case series were assessed using the JBI Critical Appraisal Checklist for Case Series [ 45 ]. Third, mixed methods studies were appraised using the Mixed Methods Appraisal Tool [ 46 ].
To increase inter-reviewer reliability, the review agreement was calculated (SH) [ 47 ]. A kappa greater than 0.8 was considered to represent a high level of agreement (0–0.1). In our data, the agreement was 0.75. Discrepancies raised between two reviewers were resolved through discussion and modifications and confirmed by XL. As an outcome, studies that met the inclusion criteria were proceeded to critical appraisal and assessed as suitable for inclusion in the review. The scores for each item and overall critical appraisal scores were presented.
For data extraction, specific tables were created. First, study characteristics (author(s), year, country, design, number of participants, setting) were extracted by two authors independently (JC, MV) and reviewed by TL. Second, descriptions of the interventions were extracted by two reviewers (JV, JC) using the structure of the TIDIeR (Template for Intervention Description and Replication) checklist (brief name, the goal of the intervention, material and procedure, models of delivery and location, dose, modification, adherence and fidelity) [ 48 ]. The extractions were confirmed (MV).
Third, due to a lack of effectiveness data and a wide heterogeneity between study designs and presentation of outcomes, no attempt was made to pool the quantitative data statistically; the findings of the quantitative data were presented in narrative form only [ 44 ]. The separate data extraction tables for each research question were designed specifically for this study. For both qualitative (and a qualitative component of mixed-method studies) and quantitative studies, the data were extracted and tabulated into text format according to preplanned research questions [ 36 ]. To test the quality of the tables and the data extraction process, three authors independently extracted the data from the first five studies (in alphabetical order). After that, the authors came together to share and determine whether their approaches of the data extraction were consistent with each other’s output and whether the content of each table was in line with research question. No reason was found to modify the data extraction tables or planned process. After a consensus of the data extraction process was reached, the data were extracted in pairs by independent reviewers (WC, TY, SH, GL). Any disagreements that arose between the reviewers were resolved through discussion and with a third reviewer (MV).
We were not able to conduct a meta-analysis due to a lack of effectiveness data based on clinical trials. Instead, we used inductive thematic analysis with constant comparison to answer the research question [ 46 , 49 ] using tabulated primary data from qualitative and quantitative studies as reported by the original authors in narrative form only [ 47 ]. In addition, the qualitizing process was used to transform quantitative data to qualitative data; this helped us to convert the whole data into themes and categories. After that we used the thematic analysis for the narrative data as follows. First, the text was carefully read, line by line, to reveal topics answering each specific review question (MV). Second, the data coding was conducted, and the themes in the data were formed by data categorization. The process of deriving the themes was inductive based on constant comparison [ 49 ]. The results of thematic analysis and data categorization was first described in narrative format and then the total number of studies was calculated where the specific category was identified (%).
The method of reporting stakeholders’ involvement follows the key components by [ 50 ]: (1) people involved, (2) geographical location, (3) how people were recruited, (4) format of involvement, (5) amount of involvement, (6) ethical approval, (7) financial compensation, and (8) methods for reporting involvement.
In our review, stakeholder involvement targeted nurses and nurse leader in China. Nurse Directors of two hospitals recommended potential participants who received a personal invitation letter from researchers to participate in a discussion meeting. Stakeholders’ participation was based on their own free will. Due to COVID-19, one online meeting (1 h) was organized (25 May 2022). Eleven participants joined the meeting. Ethical approval was not applied and no financial compensation was offered. At the end of the meeting, experiences of stakeholders’ involvement were explored.
The meeting started with an introductory presentation with power points. The rationale, methods, and preliminary review results were shared with the participants [ 51 ].The meeting continued with general questions for the participants: (1) Are you aware of the concepts of evidence-based practice or evidence-based leadership?; (2) How important is it to use evidence to support decisions among nurse leaders?; (3) How is the evidence-based approach used in hospital settings?; and (4) What type of evidence is currently used to support nurse leaders’ decision making (e.g. scientific literature, organizational data, stakeholder views)?
Two people took notes on the course and content of the conversation. The notes were later transcripted in verbatim, and the key points of the discussions were summarised. Although answers offered by the stakeholders were very short, the information was useful to validate the preliminary content of the results, add the rigorousness of the review, and obtain additional perspectives. A recommendation of the stakeholders was combined in the Discussion part of this review increasing the applicability of the review in the real world [ 50 ]. At the end of the discussion, the value of stakeholders’ involvement was asked. Participants shared that the experience of participating was unique and the topic of discussion was challenging. Two authors of the review group further represented stakeholders by working together with the research team throughout the review study.
From seven different electronic databases, 6053 citations were identified as being potentially relevant to the review. Then, 3133 duplicates were removed by an automation tool (Covidence: www.covidence.org ), and one was removed manually. The titles and abstracts of 3040 of citations were reviewed, and a total of 110 full texts were included (one extra citation was found on the reference list but later excluded). Based on the eligibility criteria, 31 studies (32 hits) were critically appraised and deemed suitable for inclusion in the review. The search results and selection process are presented in the PRISMA [ 52 ] flow diagram Fig. 1 . The full list of references for included studies can be find in Additional file 2 . To avoid confusion between articles of the reference list and studies included in the analysis, the studies included in the review are referred inside the article using the reference number of each study (e.g. ref 1, ref 2).
Search results and study selection and inclusion process [ 52 ]
The studies had multiple purposes, aiming to develop practice, implement a new approach, improve quality, or to develop a model. The 31 studies (across 32 hits) were case series studies ( n = 27), mixed methods studies ( n = 3) and a quasi-experimental study ( n = 1). All studies were published between the years 2004 and 2021. The highest number of papers was published in year 2020.
Table 2 describes the characteristics of included studies and Additional file 3 offers a narrative description of the studies.
Quasi-experimental studies.
We had one quasi-experimental study (ref 31). All questions in the critical appraisal tool were applicable. The total score of the study was 8 (out of a possible 9). Only one response of the tool was ‘no’ because no control group was used in the study (see Additional file 4 for the critical appraisal of included studies).
Case series studies . A case series study is typically defined as a collection of subjects with common characteristics. The studies do not include a comparison group and are often based on prevalent cases and on a sample of convenience [ 53 ]. Munn et al. [ 45 ] further claim that case series are best described as observational studies, lacking experimental and randomized characteristics, being descriptive studies, without a control or comparator group. Out of 27 case series studies included in our review, the critical appraisal scores varied from 1 to 9. Five references were conference abstracts with empirical study results, which were scored from 1 to 3. Full reports of these studies were searched in electronic databases but not found. Critical appraisal scores for the remaining 22 studies ranged from 1 to 9 out of a possible score of 10. One question (Q3) was not applicable to 13 studies: “Were valid methods used for identification of the condition for all participants included in the case series?” Only two studies had clearly reported the demographic of the participants in the study (Q6). Twenty studies met Criteria 8 (“Were the outcomes or follow-up results of cases clearly reported?”) and 18 studies met Criteria 7 (“Q7: Was there clear reporting of clinical information of the participants?”) (see Additional file 4 for the critical appraisal of included studies).
Mixed-methods studies involve a combination of qualitative and quantitative methods. This is a common design and includes convergent design, sequential explanatory design, and sequential exploratory design [ 46 ]. There were three mixed-methods studies. The critical appraisal scores for the three studies ranged from 60 to 100% out of a possible 100%. Two studies met all the criteria, while one study fulfilled 60% of the scored criteria due to a lack of information to understand the relevance of the sampling strategy well enough to address the research question (Q4.1) or to determine whether the risk of nonresponse bias was low (Q4.4) (see Additional file 4 for the critical appraisal of included studies).
The intervention of program components were categorized and described using the TiDier checklist: name and goal, theory or background, material, procedure, provider, models of delivery, location, dose, modification, and adherence and fidelity [ 48 ]. A description of intervention in each study is described in Additional file 5 and a narrative description in Additional file 6 .
In line with the inclusion criteria, data for the leadership problems were categorized in all 31 included studies (see Additional file 7 for leadership problems). Three types of leadership problems were identified: implementation of knowledge into practice, the quality of clinical care, and resources in nursing care. A narrative summary of the results is reported below.
Eleven studies (35%) aimed to solve leadership problems related to implementation of knowledge into practice. Studies showed how to support nurses in evidence-based implementation (EBP) (ref 3, ref 5), how to engage nurses in using evidence in practice (ref 4), how to convey the importance of EBP (ref 22) or how to change practice (ref 4). Other problems were how to facilitate nurses to use guideline recommendations (ref 7) and how nurses can make evidence-informed decisions (ref 8). General concerns also included the linkage between theory and practice (ref 1) as well as how to implement the EBP model in practice (ref 6). In addition, studies were motivated by the need for revisions or updates of protocols to improve clinical practice (ref 10) as well as the need to standardize nursing activities (ref 11, ref 14).
Thirteen (42%) focused on solving problems related to the quality of clinical care. In these studies, a high number of catheter infections led a lack of achievement of organizational goals (ref 2, ref 9). A need to reduce patient symptoms in stem cell transplant patients undergoing high-dose chemotherapy (ref 24) was also one of the problems to be solved. In addition, the projects focused on how to prevent pressure ulcers (ref 26, ref 29), how to enhance the quality of cancer treatment (ref 25) and how to reduce the need for invasive constipation treatment (ref 30). Concerns about patient safety (ref 15), high fall rates (ref 16, ref 19), dissatisfaction of patients (ref 16, ref 18) and nurses (ref 16, ref 30) were also problems that had initiated the projects. Studies addressed concerns about how to promote good contingency care in residential aged care homes (ref 20) and about how to increase recognition of human trafficking problems in healthcare (ref 21).
Nurse leaders identified problems in their resources, especially in staffing problems. These problems were identified in seven studies (23%), which involved concerns about how to prevent nurses from leaving the job (ref 31), how to ensure appropriate recruitment, staffing and retaining of nurses (ref 13) and how to decrease nurses’ burden and time spent on nursing activities (ref 12). Leadership turnover was also reported as a source of dissatisfaction (ref 17); studies addressed a lack of structured transition and training programs, which led to turnover (ref 23), as well as how to improve intershift handoff among nurses (ref 28). Optimal design for new hospitals was also examined (ref 27).
Out of 31 studies, 17 (55%) included all four domains of an evidence-based leadership approach, and four studies (13%) included evidence of critical appraisal of the results (see Additional file 8 for the main features of evidence-based Leadership) (ref 11, ref 14, ref 23, ref 27).
Twenty-seven studies (87%) reported how organizational evidence was collected and used to solve leadership problems (ref 2). Retrospective chart reviews (ref 5), a review of the extent of specific incidents (ref 19), and chart auditing (ref 7, ref 25) were conducted. A gap between guideline recommendations and actual care was identified using organizational data (ref 7) while the percentage of nurses’ working time spent on patient care was analyzed using an electronic charting system (ref 12). Internal data (ref 22), institutional data, and programming metrics were also analyzed to understand the development of the nurse workforce (ref 13).
Surveys (ref 3, ref 25), interviews (ref 3, ref 25) and group reviews (ref 18) were used to better understand the leadership problem to be solved. Employee opinion surveys on leadership (ref 17), a nurse satisfaction survey (ref 30) and a variety of reporting templates were used for the data collection (ref 28) reported. Sometimes, leadership problems were identified by evidence facilitators or a PI’s team who worked with staff members (ref 15, ref 17). Problems in clinical practice were also identified by the Nursing Professional Council (ref 14), managers (ref 26) or nurses themselves (ref 24). Current practices were reviewed (ref 29) and a gap analysis was conducted (ref 4, ref 16, ref 23) together with SWOT analysis (ref 16). In addition, hospital mission and vision statements, research culture established and the proportion of nursing alumni with formal EBP training were analyzed (ref 5). On the other hand, it was stated that no systematic hospital-specific sources of data regarding job satisfaction or organizational commitment were used (ref 31). In addition, statements of organizational analysis were used on a general level only (ref 1).
Twenty-six studies (84%) reported the use of scientific evidence in their evidence-based leadership processes. A literature search was conducted (ref 21) and questions, PICO, and keywords were identified (ref 4) in collaboration with a librarian. Electronic databases, including PubMed (ref 14, ref 31), Cochrane, and EMBASE (ref 31) were searched. Galiano (ref 6) used Wiley Online Library, Elsevier, CINAHL, Health Source: Nursing/Academic Edition, PubMed, and the Cochrane Library while Hoke (ref 11) conducted an electronic search using CINAHL and PubMed to retrieve articles.
Identified journals were reviewed manually (ref 31). The findings were summarized using ‘elevator speech’ (ref 4). In a study by Gifford et al. (ref 9) evidence facilitators worked with participants to access, appraise, and adapt the research evidence to the organizational context. Ostaszkiewicz (ref 20) conducted a scoping review of literature and identified and reviewed frameworks and policy documents about the topic and the quality standards. Further, a team of nursing administrators, directors, staff nurses, and a patient representative reviewed the literature and made recommendations for practice changes.
Clinical practice guidelines were also used to offer scientific evidence (ref 7, ref 19). Evidence was further retrieved from a combination of nursing policies, guidelines, journal articles, and textbooks (ref 12) as well as from published guidelines and literature (ref 13). Internal evidence, professional practice knowledge, relevant theories and models were synthesized (ref 24) while other study (ref 25) reviewed individual studies, synthesized with systematic reviews or clinical practice guidelines. The team reviewed the research evidence (ref 3, ref 15) or conducted a literature review (ref 22, ref 28, ref 29), a literature search (ref 27), a systematic review (ref 23), a review of the literature (ref 30) or ‘the scholarly literature was reviewed’ (ref 18). In addition, ‘an extensive literature review of evidence-based best practices was carried out’ (ref 10). However, detailed description how the review was conducted was lacking.
A total of 24 studies (77%) reported methods for how the views of stakeholders, i.e., professionals or experts, were considered. Support to run this study was received from nursing leadership and multidisciplinary teams (ref 29). Experts and stakeholders joined the study team in some cases (ref 25, ref 30), and in other studies, their opinions were sought to facilitate project success (ref 3). Sometimes a steering committee was formed by a Chief Nursing Officer and Clinical Practice Specialists (ref 2). More specifically, stakeholders’ views were considered using interviews, workshops and follow-up teleconferences (ref 7). The literature review was discussed with colleagues (ref 11), and feedback and support from physicians as well as the consensus of staff were sought (ref 16).
A summary of the project findings and suggestions for the studies were discussed at 90-minute weekly meetings by 11 charge nurses. Nurse executive directors were consulted over a 10-week period (ref 31). An implementation team (nurse, dietician, physiotherapist, occupational therapist) was formed to support the implementation of evidence-based prevention measures (ref 26). Stakeholders volunteered to join in the pilot implementation (ref 28) or a stakeholder team met to determine the best strategy for change management, shortcomings in evidence-based criteria were discussed, and strategies to address those areas were planned (ref 5). Nursing leaders, staff members (ref 22), ‘process owners (ref 18) and program team members (ref 18, ref 19, ref 24) met regularly to discuss the problems. Critical input was sought from clinical educators, physicians, nutritionists, pharmacists, and nurse managers (ref 24). The unit director and senior nursing staff reviewed the contents of the product, and the final version of clinical pathways were reviewed and approved by the Quality Control Commission of the Nursing Department (ref 12). In addition, two co-design workshops with 18 residential aged care stakeholders were organized to explore their perspectives about factors to include in a model prototype (ref 20). Further, an agreement of stakeholders in implementing continuous quality services within an open relationship was conducted (ref 1).
In five studies (16%), a critical appraisal targeting the literature search was carried out. The appraisals were conducted by interns and teams who critiqued the evidence (ref 4). In Hoke’s study, four areas that had emerged in the literature were critically reviewed (ref 11). Other methods were to ‘critically appraise the search results’ (ref 14). Journal club team meetings (ref 23) were organized to grade the level and quality of evidence and the team ‘critically appraised relevant evidence’ (ref 27). On the other hand, the studies lacked details of how the appraisals were done in each study.
Perceived effects of evidence-based leadership on nurses’ performance.
Eleven studies (35%) described perceived effects of evidence-based leadership on nurses’ performance (see Additional file 9 for perceived effects of evidence-based leadership), which were categorized in four groups: awareness and knowledge, competence, ability to understand patients’ needs, and engagement. First, regarding ‘awareness and knowledge’, different projects provided nurses with new learning opportunities (ref 3). Staff’s knowledge (ref 20, ref 28), skills, and education levels improved (ref 20), as did nurses’ knowledge comprehension (ref 21). Second, interventions and approaches focusing on management and leadership positively influenced participants’ competence level to improve the quality of services. Their confidence level (ref 1) and motivation to change practice increased, self-esteem improved, and they were more positive and enthusiastic in their work (ref 22). Third, some nurses were relieved that they had learned to better handle patients’ needs (ref 25). For example, a systematic work approach increased nurses’ awareness of the patients who were at risk of developing health problems (ref 26). And last, nurse leaders were more engaged with staff, encouraging them to adopt the new practices and recognizing their efforts to change (ref 8).
Nine studies (29%) described the perceived effects of evidence-based leadership on organizational outcomes (see Additional file 9 for perceived effects of evidence-based leadership). These were categorized into three groups: use of resources, staff commitment, and team effort. First, more appropriate use of resources was reported (ref 15, ref 20), and working time was more efficiently used (ref 16). In generally, a structured approach made implementing change more manageable (ref 1). On the other hand, in the beginning of the change process, the feedback from nurses was unfavorable, and they experienced discomfort in the new work style (ref 29). New approaches were also perceived as time consuming (ref 3). Second, nurse leaders believed that fewer nursing staff than expected left the organization over the course of the study (ref 31). Third, the project helped staff in their efforts to make changes, and it validated the importance of working as a team (ref 7). Collaboration and support between the nurses increased (ref 26). On the other hand, new work style caused challenges in teamwork (ref 3).
Five studies (16%) reported the perceived effects of evidence-based leadership on clinical outcomes (see Additional file 9 for perceived effects of evidence-based leadership), which were categorized in two groups: general patient outcomes and specific clinical outcomes. First, in general, the project assisted in connecting the guideline recommendations and patient outcomes (ref 7). The project was good for the patients in general, and especially to improve patient safety (ref 16). On the other hand, some nurses thought that the new working style did not work at all for patients (ref 28). Second, the new approach used assisted in optimizing patients’ clinical problems and person-centered care (ref 20). Bowel management, for example, received very good feedback (ref 30).
The measured effects on nurses’ performance.
Data were obtained from 20 studies (65%) (see Additional file 10 for measured effects of evidence-based leadership) and categorized nurse performance outcomes for three groups: awareness and knowledge, engagement, and satisfaction. First, six studies (19%) measured the awareness and knowledge levels of participants. Internship for staff nurses was beneficial to help participants to understand the process for using evidence-based practice and to grow professionally, to stimulate for innovative thinking, to give knowledge needed to use evidence-based practice to answer clinical questions, and to make possible to complete an evidence-based practice project (ref 3). Regarding implementation program of evidence-based practice, those with formal EBP training showed an improvement in knowledge, attitude, confidence, awareness and application after intervention (ref 3, ref 11, ref 20, ref 23, ref 25). On the contrary, in other study, attitude towards EBP remained stable ( p = 0.543). and those who applied EBP decreased although no significant differences over the years ( p = 0.879) (ref 6).
Second, 10 studies (35%) described nurses’ engagement to new practices (ref 5, ref 6, ref 7, ref 10, ref 16, ref 17, ref 18, ref 21, ref 25, ref 27). 9 studies (29%) studies reported that there was an improvement of compliance level of participants (ref 6, ref 7, ref 10, ref 16, ref 17, ref 18, ref 21, ref 25, ref 27). On the contrary, in DeLeskey’s (ref 5) study, although improvement was found in post-operative nausea and vomiting’s (PONV) risk factors documented’ (2.5–63%), and ’risk factors communicated among anaesthesia and surgical staff’ (0–62%), the improvement did not achieve the goal. The reason was a limited improvement was analysed. It was noted that only those patients who had been seen by the pre-admission testing nurse had risk assessments completed. Appropriate treatment/prophylaxis increased from 69 to 77%, and from 30 to 49%; routine assessment for PONV/rescue treatment 97% and 100% was both at 100% following the project. The results were discussed with staff but further reasons for a lack of engagement in nursing care was not reported.
And third, six studies (19%) reported nurses’ satisfaction with project outcomes. The study results showed that using evidence in managerial decisions improved nurses’ satisfaction and attitudes toward their organization ( P < 0.05) (ref 31). Nurses’ overall job satisfaction improved as well (ref 17). Nurses’ satisfaction with usability of the electronic charting system significantly improved after introduction of the intervention (ref 12). In handoff project in seven hospitals, improvement was reported in all satisfaction indicators used in the study although improvement level varied in different units (ref 28). In addition, positive changes were reported in nurses’ ability to autonomously perform their job (“How satisfied are you with the tools and resources available for you treat and prevent patient constipation?” (54%, n = 17 vs. 92%, n = 35, p < 0.001) (ref 30).
Thirteen studies (42%) described the effects of a project on organizational outcomes (see Additional file 10 for measured effects of evidence-based leadership), which were categorized in two groups: staff compliance, and changes in practices. First, studies reported improved organizational outcomes due to staff better compliance in care (ref 4, ref 13, ref 17, ref 23, ref 27, ref 31). Second, changes in organization practices were also described (ref 11) like changes in patient documentation (ref 12, ref 21). Van Orne (ref 30) found a statistically significant reduction in the average rate of invasive medication administration between pre-intervention and post-intervention ( p = 0.01). Salvador (ref 24) also reported an improvement in a proactive approach to mucositis prevention with an evidence-based oral care guide. On the contrary, concerns were also raised such as not enough time for new bedside report (ref 16) or a lack of improvement of assessment of diabetic ulcer (ref 8).
A variety of improvements in clinical outcomes were reported (see Additional file 10 for measured effects of evidence-based leadership): improvement in patient clinical status and satisfaction level. First, a variety of improvement in patient clinical status was reported. improvement in Incidence of CAUTI decreased 27.8% between 2015 and 2019 (ref 2) while a patient-centered quality improvement project reduced CAUTI rates to 0 (ref 10). A significant decrease in transmission rate of MRSA transmission was also reported (ref 27) and in other study incidences of CLABSIs dropped following of CHG bathing (ref 14). Further, it was possible to decrease patient nausea from 18 to 5% and vomiting to 0% (ref 5) while the percentage of patients who left the hospital without being seen was below 2% after the project (ref 17). In addition, a significant reduction in the prevalence of pressure ulcers was found (ref 26, ref 29) and a significant reduction of mucositis severity/distress was achieved (ref 24). Patient falls rate decreased (ref 15, ref 16, ref 19, ref 27).
Second, patient satisfaction level after project implementation improved (ref 28). The scale assessing healthcare providers by consumers showed improvement, but the changes were not statistically significant. Improvement in an emergency department leadership model and in methods of communication with patients improved patient satisfaction scores by 600% (ref 17). In addition, new evidence-based unit improved patient experiences about the unit although not all items improved significantly (ref 18).
To ensure stakeholders’ involvement in the review, the real-world relevance of our research [ 53 ], achieve a higher level of meaning in our review results, and gain new perspectives on our preliminary findings [ 50 ], a meeting with 11 stakeholders was organized. First, we asked if participants were aware of the concepts of evidence-based practice or evidence-based leadership. Responses revealed that participants were familiar with the concept of evidence-based practice, but the topic of evidence-based leadership was totally new. Examples of nurses and nurse leaders’ responses are as follows: “I have heard a concept of evidence-based practice but never a concept of evidence-based leadership.” Another participant described: “I have heard it [evidence-based leadership] but I do not understand what it means.”
Second, as stakeholder involvement is beneficial to the relevance and impact of health research [ 54 ], we asked how important evidence is to them in supporting decisions in health care services. One participant described as follows: “Using evidence in decisions is crucial to the wards and also to the entire hospital.” Third, we asked how the evidence-based approach is used in hospital settings. Participants expressed that literature is commonly used to solve clinical problems in patient care but not to solve leadership problems. “In [patient] medication and care, clinical guidelines are regularly used. However, I am aware only a few cases where evidence has been sought to solve leadership problems.”
And last, we asked what type of evidence is currently used to support nurse leaders’ decision making (e.g. scientific literature, organizational data, stakeholder views)? The participants were aware that different types of information were collected in their organization on a daily basis (e.g. patient satisfaction surveys). However, the information was seldom used to support decision making because nurse leaders did not know how to access this information. Even so, the participants agreed that the use of evidence from different sources was important in approaching any leadership or managerial problems in the organization. Participants also suggested that all nurse leaders should receive systematic training related to the topic; this could support the daily use of the evidence-based approach.
To our knowledge, this article represents the first mixed-methods systematic review to examine leadership problems, how evidence is used to solve these problems and what the perceived and measured effects of evidence-based leadership are on nurse leaders and their performance, organizational, and clinical outcomes. This review has two key findings. First, the available research data suggests that evidence-based leadership has potential in the healthcare context, not only to improve knowledge and skills among nurses, but also to improve organizational outcomes and the quality of patient care. Second, remarkably little published research was found to explore the effects of evidence-based leadership with an efficient trial design. We validated the preliminary results with nurse stakeholders, and confirmed that nursing staff, especially nurse leaders, were not familiar with the concept of evidence-based leadership, nor were they used to implementing evidence into their leadership decisions. Our data was based on many databases, and we screened a large number of studies. We also checked existing registers and databases and found no registered or ongoing similar reviews being conducted. Therefore, our results may not change in the near future.
We found that after identifying the leadership problems, 26 (84%) studies out of 31 used organizational data, 25 (81%) studies used scientific evidence from the literature, and 21 (68%) studies considered the views of stakeholders in attempting to understand specific leadership problems more deeply. However, only four studies critically appraised any of these findings. Considering previous critical statements of nurse leaders’ use of evidence in their decision making [ 14 , 30 , 31 , 34 , 55 ], our results are still quite promising.
Our results support a previous systematic review by Geert et al. [ 32 ], which concluded that it is possible to improve leaders’ individual-level outcomes, such as knowledge, motivation, skills, and behavior change using evidence-based approaches. Collins and Holton [ 23 ] particularly found that leadership training resulted in significant knowledge and skill improvements, although the effects varied widely across studies. In our study, evidence-based leadership was seen to enable changes in clinical practice, especially in patient care. On the other hand, we understand that not all efforts to changes were successful [ 56 , 57 , 58 ]. An evidence-based approach causes negative attitudes and feelings. Negative emotions in participants have also been reported due to changes, such as discomfort with a new working style [ 59 ]. Another study reported inconvenience in using a new intervention and its potential risks for patient confidentiality. Sometimes making changes is more time consuming than continuing with current practice [ 60 ]. These findings may partially explain why new interventions or program do not always fully achieve their goals. On the other hand, Dubose et al. [ 61 ] state that, if prepared with knowledge of resistance, nurse leaders could minimize the potential negative consequences and capitalize on a powerful impact of change adaptation.
We found that only six studies used a specific model or theory to understand the mechanism of change that could guide leadership practices. Participants’ reactions to new approaches may be an important factor in predicting how a new intervention will be implemented into clinical practice. Therefore, stronger effort should be put to better understanding the use of evidence, how participants’ reactions and emotions or practice changes could be predicted or supported using appropriate models or theories, and how using these models are linked with leadership outcomes. In this task, nurse leaders have an important role. At the same time, more responsibilities in developing health services have been put on the shoulders of nurse leaders who may already be suffering under pressure and increased burden at work. Working in a leadership position may also lead to role conflict. A study by Lalleman et al. [ 62 ] found that nurses were used to helping other people, often in ad hoc situations. The helping attitude of nurses combined with structured managerial role may cause dilemmas, which may lead to stress. Many nurse leaders opt to leave their positions less than 5 years [ 63 ].To better fulfill the requirements of health services in the future, the role of nurse leaders in evidence-based leadership needs to be developed further to avoid ethical and practical dilemmas in their leadership practices.
It is worth noting that the perceived and measured effects did not offer strong support to each other but rather opened a new venue to understand the evidence-based leadership. Specifically, the perceived effects did not support to measured effects (competence, ability to understand patients’ needs, use of resources, team effort, and specific clinical outcomes) while the measured effects could not support to perceived effects (nurse’s performance satisfaction, changes in practices, and clinical outcomes satisfaction). These findings may indicate that different outcomes appear if the effects of evidence-based leadership are looked at using different methodological approach. Future study is encouraged using well-designed study method including mixed-method study to examine the consistency between perceived and measured effects of evidence-based leadership in health care.
There is a potential in nursing to support change by demonstrating conceptual and operational commitment to research-based practices [ 64 ]. Nurse leaders are well positioned to influence and lead professional governance, quality improvement, service transformation, change and shared governance [ 65 ]. In this task, evidence-based leadership could be a key in solving deficiencies in the quality, safety of care [ 14 ] and inefficiencies in healthcare delivery [ 12 , 13 ]. As WHO has revealed, there are about 28 million nurses worldwide, and the demand of nurses will put nurse resources into the specific spotlight [ 1 ]. Indeed, evidence could be used to find solutions for how to solve economic deficits or other problems using leadership skills. This is important as, when nurses are able to show leadership and control in their own work, they are less likely to leave their jobs [ 66 ]. On the other hand, based on our discussions with stakeholders, nurse leaders are not used to using evidence in their own work. Further, evidence-based leadership is not possible if nurse leaders do not have access to a relevant, robust body of evidence, adequate funding, resources, and organizational support, and evidence-informed decision making may only offer short-term solutions [ 55 ]. We still believe that implementing evidence-based strategies into the work of nurse leaders may create opportunities to protect this critical workforce from burnout or leaving the field [ 67 ]. However, the role of the evidence-based approach for nurse leaders in solving these problems is still a key question.
This study aimed to use a broad search strategy to ensure a comprehensive review but, nevertheless, limitations exist: we may have missed studies not included in the major international databases. To keep search results manageable, we did not use specific databases to systematically search grey literature although it is a rich source of evidence used in systematic reviews and meta-analysis [ 68 ]. We still included published conference abstract/proceedings, which appeared in our scientific databases. It has been stated that conference abstracts and proceedings with empirical study results make up a great part of studies cited in systematic reviews [ 69 ]. At the same time, a limited space reserved for published conference publications can lead to methodological issues reducing the validity of the review results [ 68 ]. We also found that the great number of studies were carried out in western countries, restricting the generalizability of the results outside of English language countries. The study interventions and outcomes were too different across studies to be meaningfully pooled using statistical methods. Thus, our narrative synthesis could hypothetically be biased. To increase transparency of the data and all decisions made, the data, its categorization and conclusions are based on original studies and presented in separate tables and can be found in Additional files. Regarding a methodological approach [ 34 ], we used a mixed methods systematic review, with the core intention of combining quantitative and qualitative data from primary studies. The aim was to create a breadth and depth of understanding that could confirm to or dispute evidence and ultimately answer the review question posed [ 34 , 70 ]. Although the method is gaining traction due to its usefulness and practicality, guidance in combining quantitative and qualitative data in mixed methods systematic reviews is still limited at the theoretical stage [ 40 ]. As an outcome, it could be argued that other methodologies, for example, an integrative review, could have been used in our review to combine diverse methodologies [ 71 ]. We still believe that the results of this mixed method review may have an added value when compared with previous systematic reviews concerning leadership and an evidence-based approach.
Our mixed methods review fills the gap regarding how nurse leaders themselves use evidence to guide their leadership role and what the measured and perceived impact of evidence-based leadership is in nursing. Although the scarcity of controlled studies on this topic is concerning, the available research data suggest that evidence-based leadership intervention can improve nurse performance, organizational outcomes, and patient outcomes. Leadership problems are also well recognized in healthcare settings. More knowledge and a deeper understanding of the role of nurse leaders, and how they can use evidence in their own managerial leadership decisions, is still needed. Despite the limited number of studies, we assume that this narrative synthesis can provide a good foundation for how to develop evidence-based leadership in the future.
Based on our review results, several implications can be recommended. First, the future of nursing success depends on knowledgeable, capable, and strong leaders. Therefore, nurse leaders worldwide need to be educated about the best ways to manage challenging situations in healthcare contexts using an evidence-based approach in their decisions. This recommendation was also proposed by nurses and nurse leaders during our discussion meeting with stakeholders.
Second, curriculums in educational organizations and on-the-job training for nurse leaders should be updated to support general understanding how to use evidence in leadership decisions. And third, patients and family members should be more involved in the evidence-based approach. It is therefore important that nurse leaders learn how patients’ and family members’ views as stakeholders are better considered as part of the evidence-based leadership approach.
Future studies should be prioritized as follows: establishment of clear parameters for what constitutes and measures evidence-based leadership; use of theories or models in research to inform mechanisms how to effectively change the practice; conducting robust effectiveness studies using trial designs to evaluate the impact of evidence-based leadership; studying the role of patient and family members in improving the quality of clinical care; and investigating the financial impact of the use of evidence-based leadership approach within respective healthcare systems.
The authors obtained all data for this review from published manuscripts.
World Health Organization. State of the world’s nursing 2020: investing in education, jobs and leadership. 2020. https://www.who.int/publications/i/item/9789240003279 . Accessed 29 June 2024.
Hersey P, Campbell R. Leadership: a behavioral science approach. The Center for; 2004.
Cline D, Crenshaw JT, Woods S. Nurse leader: a definition for the 21st century. Nurse Lead. 2022;20(4):381–4. https://doi.org/10.1016/j.mnl.2021.12.017 .
Article Google Scholar
Chen SS. Leadership styles and organization structural configurations. J Hum Resource Adult Learn. 2006;2(2):39–46.
Google Scholar
McKibben L. Conflict management: importance and implications. Br J Nurs. 2017;26(2):100–3.
Article PubMed Google Scholar
Haghgoshayie E, Hasanpoor E. Evidence-based nursing management: basing Organizational practices on the best available evidence. Creat Nurs. 2021;27(2):94–7. https://doi.org/10.1891/CRNR-D-19-00080 .
Majers JS, Warshawsky N. Evidence-based decision-making for nurse leaders. Nurse Lead. 2020;18(5):471–5.
Tichy NM, Bennis WG. Making judgment calls. Harvard Business Rev. 2007;85(10):94.
Sousa MJ, Pesqueira AM, Lemos C, Sousa M, Rocha Á. Decision-making based on big data analytics for people management in healthcare organizations. J Med Syst. 2019;43(9):1–10.
Guo R, Berkshire SD, Fulton LV, Hermanson PM. %J L in HS. Use of evidence-based management in healthcare administration decision-making. 2017;30(3): 330–42.
Liang Z, Howard P, Rasa J. Evidence-informed managerial decision-making: what evidence counts?(part one). Asia Pac J Health Manage. 2011;6(1):23–9.
Hasanpoor E, Janati A, Arab-Zozani M, Haghgoshayie E. Using the evidence-based medicine and evidence-based management to minimise overuse and maximise quality in healthcare: a hybrid perspective. BMJ evidence-based Med. 2020;25(1):3–5.
Shingler NA, Gonzalez JZ. Ebm: a pathway to evidence-based nursing management. Nurs 2022. 2017;47(2):43–6.
Farokhzadian J, Nayeri ND, Borhani F, Zare MR. Nurse leaders’ attitudes, self-efficacy and training needs for implementing evidence-based practice: is it time for a change toward safe care? Br J Med Med Res. 2015;7(8):662.
Article PubMed PubMed Central Google Scholar
American Nurses Association. ANA leadership competency model. Silver Spring, MD; 2018.
Royal College of Nursing. Leadership skills. 2022. https://www.rcn.org.uk/professional-development/your-career/nurse/leadership-skills . Accessed 29 June 2024.
Kakemam E, Liang Z, Janati A, Arab-Zozani M, Mohaghegh B, Gholizadeh M. Leadership and management competencies for hospital managers: a systematic review and best-fit framework synthesis. J Healthc Leadersh. 2020;12:59.
Liang Z, Howard PF, Leggat S, Bartram T. Development and validation of health service management competencies. J Health Organ Manag. 2018;32(2):157–75.
World Health Organization. Global Strategic Directions for Nursing and Midwifery. 2021. https://apps.who.int/iris/bitstream/handle/10665/344562/9789240033863-eng.pdf . Accessed 29 June 2024.
NHS Leadership Academy. The nine leadership dimensions. 2022. https://www.leadershipacademy.nhs.uk/resources/healthcare-leadership-model/nine-leadership-dimensions/ . Accessed 29 June 2024.
Canadian Nurses Association. Evidence-informed decision-making and nursing practice: Position statement. 2018. https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Evidence_informed_Decision_making_and_Nursing_Practice_position_statement_Dec_2018.pdf . Accessed 29 June 2024.
Hasanpoor E, Hajebrahimi S, Janati A, Abedini Z, Haghgoshayie E. Barriers, facilitators, process and sources of evidence for evidence-based management among health care managers: a qualitative systematic review. Ethiop J Health Sci. 2018;28(5):665–80.
PubMed PubMed Central Google Scholar
Collins DB, Holton EF III. The effectiveness of managerial leadership development programs: a meta-analysis of studies from 1982 to 2001. Hum Res Dev Q. 2004;15(2):217–48.
Cummings GG, Lee S, Tate K, Penconek T, Micaroni SP, Paananen T, et al. The essentials of nursing leadership: a systematic review of factors and educational interventions influencing nursing leadership. Int J Nurs Stud. 2021;115:103842.
Clavijo-Chamorro MZ, Romero-Zarallo G, Gómez-Luque A, López-Espuela F, Sanz-Martos S, López-Medina IM. Leadership as a facilitator of evidence implementation by nurse managers: a metasynthesis. West J Nurs Res. 2022;44(6):567–81.
Young SK. Evidence-based management: a literature review. J Nurs Adm Manag. 2002;10(3):145–51.
Williams LL. What goes around comes around: evidence-based management. Nurs Adm Q. 2006;30(3):243–51.
Fraser I. Organizational research with impact: working backwards. Worldviews Evidence-Based Nurs. 2004;1:S52–9.
Roshanghalb A, Lettieri E, Aloini D, Cannavacciuolo L, Gitto S, Visintin F. What evidence on evidence-based management in healthcare? Manag Decis. 2018;56(10):2069–84.
Jaana M, Vartak S, Ward MM. Evidence-based health care management: what is the research evidence available for health care managers? Eval Health Prof. 2014;37(3):314–34.
Tate K, Hewko S, McLane P, Baxter P, Perry K, Armijo-Olivo S, et al. Learning to lead: a review and synthesis of literature examining health care managers’ use of knowledge. J Health Serv Res Policy. 2019;24(1):57–70.
Geerts JM, Goodall AH, Agius S, %J SS. Medicine. Evidence-based leadership development for physicians: a systematic literature review. 2020;246: 112709.
Barends E, Rousseau DM, Briner RB. Evidence-based management: The basic principles. Amsterdam; 2014. https://research.vu.nl/ws/portalfiles/portal/42141986/complete+dissertation.pdf#page=203 . Accessed 29 June 2024.
Stern C, Lizarondo L, Carrier J, Godfrey C, Rieger K, Salmond S, et al. Methodological guidance for the conduct of mixed methods systematic reviews. JBI Evid Synthesis. 2020;18(10):2108–18. https://doi.org/10.11124/JBISRIR-D-19-00169 .
Lancet T. 2020: unleashing the full potential of nursing. Lancet (London, England). 2019. p. 1879.
Välimäki MA, Lantta T, Hipp K, Varpula J, Liu G, Tang Y, et al. Measured and perceived impacts of evidence-based leadership in nursing: a mixed-methods systematic review protocol. BMJ Open. 2021;11(10):e055356. https://doi.org/10.1136/bmjopen-2021-055356 .
The Joanna Briggs Institute. Joanna Briggs Institute reviewers’ manual: 2014 edition. Joanna Briggs Inst. 2014; 88–91.
Pearson A, White H, Bath-Hextall F, Salmond S, Apostolo J, Kirkpatrick P. A mixed-methods approach to systematic reviews. JBI Evid Implement. 2015;13(3):121–31.
Johnson RB, Onwuegbuzie AJ. Mixed methods research: a research paradigm whose time has come. Educational Researcher. 2004;33(7):14–26.
Hong, Pluye P, Bujold M, Wassef M. Convergent and sequential synthesis designs: implications for conducting and reporting systematic reviews of qualitative and quantitative evidence. Syst Reviews. 2017;6(1):61. https://doi.org/10.1186/s13643-017-0454-2 .
Ramis MA, Chang A, Conway A, Lim D, Munday J, Nissen L. Theory-based strategies for teaching evidence-based practice to undergraduate health students: a systematic review. BMC Med Educ. 2019;19(1):1–13.
Sackett DL, Rosenberg WM, Gray JM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. Bmj. British Medical Journal Publishing Group; 1996. pp. 71–2.
Goodman JS, Gary MS, Wood RE. Bibliographic search training for evidence-based management education: a review of relevant literatures. Acad Manage Learn Educ. 2014;13(3):322–53.
Aromataris E, Munn Z. Chapter 3: Systematic reviews of effectiveness. JBI Manual for Evidence Synthesis. 2020; https://synthesismanual.jbi.global .
Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. 2020;18(10): 2127–33.
Hong Q, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, et al. Mixed methods Appraisal Tool (MMAT) Version 2018: user guide. Montreal: McGill University; 2018.
McKenna J, Jeske D. Ethical leadership and decision authority effects on nurses’ engagement, exhaustion, and turnover intention. J Adv Nurs. 2021;77(1):198–206.
Maxwell M, Hibberd C, Aitchison P, Calveley E, Pratt R, Dougall N, et al. The TIDieR (template for intervention description and replication) checklist. The patient Centred Assessment Method for improving nurse-led biopsychosocial assessment of patients with long-term conditions: a feasibility RCT. NIHR Journals Library; 2018.
Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77–101.
Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, et al. Stakeholder involvement in systematic reviews: a scoping review. Syst Reviews. 2018;7:1–26.
Braye S, Preston-Shoot M. Emerging from out of the shadows? Service user and carer involvement in systematic reviews. Evid Policy. 2005;1(2):173–93.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Reviews. 2021;10(1):1–11.
Porta M. Pilot investigation, study. A dictionary of epidemiology. Oxford University Press Oxford; 2014. p. 215.
Kreis J, Puhan MA, Schünemann HJ, Dickersin K. Consumer involvement in systematic reviews of comparative effectiveness research. Health Expect. 2013;16(4):323–37.
Joseph ML, Nelson-Brantley HV, Caramanica L, Lyman B, Frank B, Hand MW, et al. Building the science to guide nursing administration and leadership decision making. JONA: J Nurs Adm. 2022;52(1):19–26.
Gifford W, Davies BL, Graham ID, Tourangeau A, Woodend AK, Lefebre N. Developing Leadership Capacity for Guideline Use: a pilot cluster Randomized Control Trial: Leadership Pilot Study. Worldviews Evidence-Based Nurs. 2013;10(1):51–65. https://doi.org/10.1111/j.1741-6787.2012.00254.x .
Hsieh HY, Henker R, Ren D, Chien WY, Chang JP, Chen L, et al. Improving effectiveness and satisfaction of an electronic charting system in Taiwan. Clin Nurse Specialist. 2016;30(6):E1–6. https://doi.org/10.1097/NUR.0000000000000250 .
McAllen E, Stephens K, Swanson-Biearman B, Kerr K, Whiteman K. Moving Shift Report to the Bedside: an evidence-based Quality Improvement Project. OJIN: Online J Issues Nurs. 2018;23(2). https://doi.org/10.3912/OJIN.Vol23No02PPT22 .
Thomas M, Autencio K, Cesario K. Positive outcomes of an evidence-based pressure injury prevention program. J Wound Ostomy Cont Nurs. 2020;47:S24.
Cullen L, Titler MG. Promoting evidence-based practice: an internship for Staff nurses. Worldviews Evidence-Based Nurs. 2004;1(4):215–23. https://doi.org/10.1111/j.1524-475X.2004.04027.x .
DuBose BM, Mayo AM. Resistance to change: a concept analysis. Nursing forum. Wiley Online Library; 2020. pp. 631–6.
Lalleman PCB, Smid GAC, Lagerwey MD, Shortridge-Baggett LM, Schuurmans MJ. Curbing the urge to care: a bourdieusian analysis of the effect of the caring disposition on nurse middle managers’ clinical leadership in patient safety practices. Int J Nurs Stud. 2016;63:179–88.
Article CAS PubMed Google Scholar
Martin E, Warshawsky N. Guiding principles for creating value and meaning for the next generation of nurse leaders. JONA: J Nurs Adm. 2017;47(9):418–20.
Griffiths P, Recio-Saucedo A, Dall’Ora C, Briggs J, Maruotti A, Meredith P, et al. The association between nurse staffing and omissions in nursing care: a systematic review. J Adv Nurs. 2018;74(7):1474–87. https://doi.org/10.1111/jan.13564 .
Lúanaigh PÓ, Hughes F. The nurse executive role in quality and high performing health services. J Nurs Adm Manag. 2016;24(1):132–6.
de Kok E, Weggelaar-Jansen AM, Schoonhoven L, Lalleman P. A scoping review of rebel nurse leadership: descriptions, competences and stimulating/hindering factors. J Clin Nurs. 2021;30(17–18):2563–83.
Warshawsky NE. Building nurse manager well-being by reducing healthcare system demands. JONA: J Nurs Adm. 2022;52(4):189–91.
Paez A. Gray literature: an important resource in systematic reviews. J Evidence-Based Med. 2017;10(3):233–40.
McAuley L, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet. 2000;356(9237):1228–31.
Sarah S. Introduction to mixed methods systematic reviews. https://jbi-global-wiki.refined.site/space/MANUAL/4689215/8.1+Introduction+to+mixed+methods+systematic+reviews . Accessed 29 June 2024.
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.
Download references
We want to thank the funding bodies, the Finnish National Agency of Education, Asia Programme, the Department of Nursing Science at the University of Turku, and Xiangya School of Nursing at the Central South University. We also would like to thank the nurses and nurse leaders for their valuable opinions on the topic.
The work was supported by the Finnish National Agency of Education, Asia Programme (grant number 26/270/2020) and the University of Turku (internal fund 26003424). The funders had no role in the study design and will not have any role during its execution, analysis, interpretation of the data, decision to publish, or preparation of the manuscript.
Authors and affiliations.
Department of Nursing Science, University of Turku, Turku, FI-20014, Finland
Maritta Välimäki, Tella Lantta, Kirsi Hipp & Jaakko Varpula
School of Public Health, University of Helsinki, Helsinki, FI-00014, Finland
Maritta Välimäki
Xiangya Nursing, School of Central South University, Changsha, 410013, China
Shuang Hu, Jiarui Chen, Yao Tang, Wenjun Chen & Xianhong Li
School of Health and Social Services, Häme University of Applied Sciences, Hämeenlinna, Finland
Hunan Cancer Hospital, Changsha, 410008, China
Gaoming Liu
You can also search for this author in PubMed Google Scholar
Study design: MV, XL. Literature search and study selection: MV, KH, TL, WC, XL. Quality assessment: YT, SH, XL. Data extraction: JC, MV, JV, WC, YT, SH, GL. Analysis and interpretation: MV, SH. Manuscript writing: MV. Critical revisions for important intellectual content: MV, XL. All authors read and approved the final manuscript.
Correspondence to Xianhong Li .
Ethics approval and consent to participate.
No ethical approval was required for this study.
Not applicable.
The authors declare no competing interests.
We modified criteria for the included studies: we included published conference abstracts/proceedings, which form a relatively broad knowledge base in scientific knowledge. We originally planned to conduct a survey with open-ended questions followed by a face-to-face meeting to discuss the preliminary results of the review. However, to avoid extra burden in nurses due to COVID-19, we decided to limit the validation process to the online discussion only.
Publisher’s note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
Supplementary material 2, supplementary material 3, supplementary material 4, supplementary material 5, supplementary material 6, supplementary material 7, supplementary material 8, supplementary material 9, supplementary material 10, rights and permissions.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Reprints and permissions
Cite this article.
Välimäki, M., Hu, S., Lantta, T. et al. The impact of evidence-based nursing leadership in healthcare settings: a mixed methods systematic review. BMC Nurs 23 , 452 (2024). https://doi.org/10.1186/s12912-024-02096-4
Download citation
Received : 28 April 2023
Accepted : 13 June 2024
Published : 03 July 2024
DOI : https://doi.org/10.1186/s12912-024-02096-4
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
ISSN: 1472-6955
Information & authors, metrics & citations, view options, conclusion:, introduction, search strategy, selection citeria, box 1. summations, limitations, study selection.
Alpha and beta diversity.
| Result | Number of studies | References |
---|---|---|---|
α-diversity | ASD > control group | 8 | – , , , , , |
| ASD < control group | 7 | , , , , , , |
| No significant group difference | 19 | – , , , , , , , , , , , , – , |
β-diversity | Gut microbiota composition significantly different between ASD and control groups | 26 | – , – , – , – , – , , , – , |
| No significant group difference | 2 | , |
Taxonomic rank | Taxa | Abundance in ASD participants compared to controls | Number of studies | References |
---|---|---|---|---|
Phylym | Firmicutes/Bacteroidetes Ratio | ↑ | 5 | , , , , |
| | ↓ | 3 | , , |
Phylym | Firmicutes | ↑ | 2 | , |
| | ↓ | 2 | , , |
Class | Bacilli | ↑ | 2 | , |
Genus | Lactobacillus | ↑ | 4 | , , , |
| | ↑ after intervention | 1 | |
Family | Lachnospiraceae | ↑ | 1 | |
| | ↓ | 3 | , , |
| | ↑ after intervention | 1 | |
Genus | Coprococcus | ↓ | 2 | , |
Genus | Roseburia | ↓ | 2 | , |
Genus | Clostridium | ↑ | 2 | , |
| | ↓ after intervention | 1 | |
Species | Clostridium perfringens | ↑ | 3 | , , |
Genus | Faecalibacterium | ↑ | 2 | , |
| | ↓ | 3 | , , |
Genus | Oscillospira | ↑ | 2 | , |
Genus | Ruminococcus | ↑ | 3 | , , |
| | ↓ | 3 | , , |
| | ↑ after intervention | 1 | |
Genus | Dialister | ↑ | 2 | , |
| | ↓ | 2 | , |
Genus | Veillonella | ↑ | 1 | |
| | ↓ | 2 | , |
Phylym | Bacteroidetes | ↑ | 2 | , |
| | ↓ | 5 | , , , , |
Genus | Bacteroides | ↑ | 4 | , , , |
| | ↓ | 4 | , , , |
Genus | Prevotella | ↑ | 3 | , , |
| | ↓ | 3 | , , |
Genus | Prevotella | ↑ | 3 | , , |
| | ↓ | 3 | , , |
Phylym | Proteobacteria | ↑ | 5 | , , , , |
| | ↑ | 1 | |
Order | Enterobacteriales | ↑ | 2 | , |
Family | Enterobacteriaceae | ↑ | 4 | , , , |
| | ↓ | 1 | |
Genus | Escherichia/Shigella | ↑ | 4 | , , , |
| | ↓ | 1 | |
Species | ↓ | 2 | , | |
Genus | Sutterella | ↑ | 4 | , , , |
Genus | Phyllobacterium | ↑ | 2 | , |
Genus | Flavonifractor | ↓ | 2 | , |
Phylym | Verrucomicrobia | ↓ | 2 | , |
Phylym | Actinobacteria | ↑ | 4 | , , , |
| | ↓ | 1 | |
Genus | Bifidobacteria | ↑ | 4 | , , , |
| | ↓ | 4 | , , , |
| | ↑ after intervention | 2 | , |
Genus | Nitriliruptor | ↑ | 2 | , |
Genus | Collinsella | ↑ | 3 | , , |
| | ↓ | 1 |
Functional characteristics, conclusions, information, published in.
Competing interests, export citations.
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu .
Format | |
---|---|
Citation style | |
Style | |
To download the citation to this article, select your reference manager software.
There are no citations for this item
Login options.
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Subscribe Now / Learn More
PsychiatryOnline subscription options offer access to the DSM-5-TR ® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
Copying failed.
Next article, request username.
Can't sign in? Forgot your username? Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username
Change password, password changed successfully.
Your password has been changed
Can't sign in? Forgot your password?
Enter your email address below and we will send you the reset instructions
If the address matches an existing account you will receive an email with instructions to reset your password.
Your Phone has been verified
You have full access to this open access article
To identify how value is defined in studies that focus on the value of molecular testing in cancer and the extent to which broadening the conceptualisation of value in healthcare has been applied in the molecular testing literature.
A scoping review was undertaken using Joanna Briggs Institute (JBI) guidance. Medline, Embase, EconLit and Cochrane Library were searched in August 2023. Articles were eligible if they reported costs relative to outcomes, novel costs, or novel outcomes of molecular testing in cancer. Results were synthesised and qualitative content analysis was performed with deductive and inductive frameworks.
Ninety-one articles were included in the review. The majority (75/91) were conventional economic analyses (comparative economic evaluations and budget impact assessments) and undertaken from a healthcare system perspective (38/91). Clinical outcomes dominate the assessment of value (61/91), with quality-adjusted life-years (QALYs) the most common outcome measure (45/91). Other definitions of value were diverse (e.g. psychological impact, access to trials), inconsistent, and largely not in keeping with evolving guidance.
Broader concepts of value were not commonly described in the molecular testing literature focusing on cancer. Conventional approaches to measuring the health costs and outcomes of molecular testing in cancer prevail with little focus on non-clinical elements of value. There are emerging reports of non-clinical outcomes of testing information, particularly psychological consequences. Intrinsic attributes of the testing process and preferences of those who receive testing information may determine the realised societal value of molecular testing and highlight challenges to implementing such a value framework.
Avoid common mistakes on your manuscript.
Evidence on the value-for-money of molecular testing in cancer is limited. A clear definition of value in this setting is lacking and necessary to inform decision-makers' choices. |
Consideration of broader concepts of value (e.g., beyond health) rarely feature in studies focusing on the value of molecular testing in cancer. |
Greater attention to the psychological consequences, the testing process as a whole, and preferences of those people who receive testing information may influence the value society gets from these modern cancer diagnostic technologies. |
Molecular testing has a growing role in modern cancer care for diagnosing cancer, predicting responses to genetically targeted drugs, and estimating prognosis. With rapid advancement in the field of precision oncology, the presence of molecular testing in clinical guidelines and demand for molecular testing continues to rise [ 1 , 2 ]. As is the case for all technological advances in health, it is vital to understand how, where, when and to whom molecular tests provide value for money (i.e., in the economic sense, the necessary evidence base for the quantification of the incremental costs relative to the incremental outcomes). Health technology assessment (HTA) across the technology life cycle [ 3 ]—from molecular testing research and development, regulatory approval, pricing and reimbursement, to optimal clinical implementation—requires robust, readily communicated evidence on value to ensure optimal and equitable patient care.
However, existing evidence available to decision-makers on the costs and outcomes of molecular testing in cancer is limited by methodological challenges, including the lack of an agreed definition for value [ 4 ] and inconsistent approaches to quantifying value [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ]. Terkola's editorial [ 4 ] summarised the key challenge in economic evaluation in precision medicine: A lack of high-quality data on costs and health outcomes underscored by the lack of a consensus definition of value.
Conventional approaches to measuring incremental costs and incremental benefits (e.g., the commonly used cost-utility analysis (CUA) with quality-adjusted life-year (QALY) [ 13 , 14 ]) have been criticised as not fit for purpose. This is especially the case in fields like precision oncology where diverse short- and long-term outcomes from cancer genomics information can benefit diverse stakeholders and resource utilisation subsequent and consequent to testing influence cost-effectiveness [ 10 , 15 ].
Recognition of a healthcare intervention's non-health benefits (beyond what can be presented by a QALY) hallmarks the contemporary broadening conceptualisation of value in healthcare [ 16 ] and the consequent attention to societal perspectives of value. For healthcare decision-making to represent preferences of society, requisite evidence generation must capture views on health and non-health outcomes [ 17 , 18 ] from a broad stakeholder group [ 16 ]. Actively involved in this discussion, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published their 2018 “value flower” [ 17 ], which summarises ordinarily underappreciated elements of value. The same narrative has extended to precision medicine and diagnostics, where recent health economics literature has invited a shift towards a more comprehensive definition of value [ 7 ]. For example, the Office of Health Economics (OHE) White Paper 'Improving the HTA of Complementary Diagnostics' called for "a more comprehensive perspective to include the less tangible benefits [of complementary diagnostics] [ 19 ]. Similarly, the Institute for Clinical and Economic Review’s (ICER) 2020–2023 Value Assessment Framework report suggested that "important modifications" to the evaluation of diagnostic tests are required to account for the distinct uses of diagnostic information, including explicit consideration of "other benefits, disadvantages and contextual considerations ” [ 20 ]. For molecular testing in cancer, where assessment has previously focused heavily on analytical validity, clinical validity and clinical utility [ 21 ], this means a shift towards the generation of evidence that includes non-health benefits such as personal utility [ 22 , 23 ] and process outcomes [ 15 ]. These more ‘novel’ elements of value [ 17 , 18 ] are not yet well integrated into healthcare decision-making (e.g., in Australia or the UK [ 24 , 25 ]), likely biasing previous resource allocation decisions. Similarly, investment in innovation may not have been well aligned with future societal value for money [ 26 ] . A recent systematic review on the cost-effectiveness of companion diagnostics for targeted cancer therapies [ 27 ] concluded that studies fail to observe factors that influence value beyond costs and sensitivity/specificity.
To what extent studies that focus on costs and outcomes of molecular testing in cancer reflect this shift toward a broader conceptualisation of value and the representation of value from a range of perspectives is unclear. Issues relating to social and health equity are pertinent, especially in Aotearoa New Zealand where there are stark and unjust existing inequities in health outcomes for indigenous Māori and Pacific peoples (e.g., Māori are 20% more likely to develop cancer than non-Māori and twice as likely to die from cancer [ 28 ]), and germane to molecular testing in cancer where access is notoriously variable. As such, incorporation of equity or viewpoints of indigenous communities in value definitions warrant attention.
This scoping review aims to identify how value is defined in studies that focus on the value of molecular testing in cancer with a key objective to map use of the more ‘novel’ elements of value.
The review sought to answer the following questions:
How is value defined in studies that focus on the value of molecular testing in cancer?
What elements (particularly novel elements) are considered?
What is the range of evidence that focuses on value (particularly novel elements) of molecular testing in cancer?
Since the main purpose of the review was to identify and map definitions from within the available evidence, a scoping review was selected as the most appropriate approach [ 29 , 30 ]. The methods were informed by JBI guidance [ 30 ] and documented in an a priori protocol (review topic registered to the Open Science Framework; Footnote 1 the protocol is available through the corresponding author). Changes to the protocol, in line with the iterative nature of scoping reviews described in JBI’s population, concept and context framework guidelines [ 30 ], are described in Sects. 2.2.2 , 2.3 and 2.4 . The review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist [ 31 ].
The Participant, Concept, Context approach for developing eligibility criteria was adopted.
There were no eligibility criteria relating to participants.
The concept being explored was the definitions of value used in studies focusing on the value of molecular testing in cancer. Value is a ubiquitous but inconsistently used term across healthcare and takes different meanings within clinical and economic domains. Common to most definitions of value are a comparison of resources used (costs) relative to outcomes (consequences or benefits) with respect to perspective and decision-making context. As such, ‘focusing on value’ was defined as the attention given to estimating costs, outcomes, or contextual considerations (referred to collectively as the determinants or elements of value). This was regardless of whether an explicit definition of value is given or implicitly inferred by reporting specific elements.
Consistent with reference to molecular testing across disciplines researching precision oncology (e.g., clinical, health economic, biosciences), the definition for molecular testing was kept broad to include its categorisation by clinical use (e.g., pharmacogenomics test, companion diagnostic), economic properties (e.g., complementary diagnostic), and technology type (e.g., immunohistochemistry, DNA sequencing, whole genome sequencing (WGS)). It is considered a process (as opposed to an event discrete in time or place), so a range of diagnostic or care pathways (e.g., cancer screening, risk stratification, treatment selection), including a molecular testing component, were considered relevant, provided there was sufficient focus on reporting the value of molecular testing. ‘Cancer’ was defined as solid organ or haematological malignancy in humans and not limited by tumour type, morphology or stage. Animal studies, in silico studies, and studies focused on pre-implantation diagnosis were excluded.
Articles from any country and research discipline were eligible.
The review sought to identify primary research studies, including experimental, observational and economic modelling studies published in the past 5 years. This aligned with the publication of the ISPOR’s Special Task Force’s recommendations on value frameworks [ 16 ].
Economic evaluation studies (comparative economic evaluations and budget impact assessments) were included, as well as qualitative, quantitative or mixed methods preference research, which a preliminary review [see Online Supplementary Materials (OSM)] had signposted as key evidence reporting information on personal utility.
Given the interest in identifying novel elements, the review sought to include studies estimating costs relative to outcomes, or costs or outcomes provided that at least one of these was non-clinical. Exclusion criteria were developed to avoid the large body of established literature reporting on molecular testing diagnostic accuracy, predictive or prognostic value, usually without comparison to costs. Although within scope, these types of studies were not included because the preliminary review demonstrated that diagnostic accuracy is an already well-recognised determinant of value for molecular testing in cancer, and inclusion would detract from mapping broader references to value. Similarly, we excluded the literature on microcosting of molecular testing in cancer covered in a recent systematic review [ 32 ].
Reports from health technology organisations in grey literature were considered for inclusion. Editorials, perspective pieces, reviews, abstracts, conference proceedings and protocols were excluded. The review was limited to full text articles published in English.
The search strategy followed JBI’s three-step approach [ 33 ], starting with a limited search (Appendix I) in Embase. The preliminary review identified search terms to support the exclusion of diagnostic accuracy studies (e.g., ‘analytical utility’ and ‘positive predictive value’) and to increase the chance of including studies with a focus on non-clinical elements. Informed by analysis of relevant index terms and descriptors in the titles and abstracts of studies identified through the initial search (OSM), a detailed search strategy was developed with the assistance of a University of Auckland research librarian (Appendix II). One reviewer (AM) translated the search strategy of keywords, MeSH and Embase subject headings to undertake searches across Medline, Embase, EconLit and Cochrane Library on 15 August 2023. Grey literature was searched on websites from organisations listed by the International Network of Agencies for HTA. The reference lists of the most relevant articles were manually searched for additional potentially eligible studies [ 34 ].
Articles were imported into Covidence (Veritas Health Innovation, Melbourne, VIC, Australia) via EndNote X9.3.3 (Clarivate Analytics, PA, USA). Duplicates were removed before entering two-phased screening. Two reviewers (AM and FSG) independently screened titles and abstracts of articles identified through database searching for relevance to the inclusion criteria, and then the full-texts of articles deemed relevant were retrieved and examined for evidence pertaining to the review questions and outcomes of interest. During the two-phased screening, iterative eligibility criteria refinement was made through reviewers' discussions. These iterations aimed to increase the identification of novel value elements and respond to the ambiguity in determining the degree of focus on value of molecular testing (as opposed to the value of a molecularly informed intervention), i.e., the initial definition of ‘focus on value’ proved insufficiently detailed for the attention of this review to identify more novel value elements. Key eligibility criteria refinements were:
Include studies with focus on how testing procedures are implemented, acknowledging that these represent value elements influencing the realised value of molecular testing in cancer.
Include studies even if unclear whether the molecular testing or the molecularly informed intervention has the greater focus, provided there is a clear description of a molecular testing component within a studied intervention.
Exclude studies that primarily aim to estimate the impact of changing a testing eligibility criterion (e.g., expanding the eligible population for population screening where the screening intervention includes molecular testing).
Conflicts arose in the title and abstract and full-text screening processes, as the central concept of focus on value of molecular testing in cancer is not well defined or articulated in the literature. Reasons for excluding full-texts were documented and discrepancies resolved through discussion with two other authors (PL and MW) if necessary, with a return to the definition of value outlined in this article’s introduction.
One reviewer (AM) extracted study characteristics and information relating to review questions from the included articles using a pre-defined standard data extraction table developed in Microsoft Word (Appendix III) and translated into Covidence. The extracted information included data pertaining to bibliographic data, information relating to the molecular test, analysis methodology, and value definitions. For value definitions, explicit or implicit definitions were extracted in textual form, with implicit definitions considered the mention of a cost, outcome or contextual consideration from outside article discussions. Value outcome measures (e.g., QALYs) were extracted.
Value elements were first mapped to a binary yes/no for the inclusion of non-clinical outcomes. Non-clinical outcomes were mapped against the ‘non-core’ elements of value of health technologies as depicted in ISPOR Special Task Force’s Elements of Value [ 17 ] (the earliest and most well-known value framework), and the Office of Health Economics (OHE) ‘non-traditional’ elements of value for complementary diagnostics [ 19 ] (Fig. 1 ). ISPOR’s Elements of Value is the earliest and most well-known of the value frameworks. The OHE framework was selected because it was developed in a different country (UK) and specifically for diagnostics. Textual information of novel costs, benefits or contextual considerations was also recorded. Two reviewers (AM and FSG) piloted the extraction form and modified iteratively to ensure consistency and accuracy. Alterations included clarifying extracted date as the earliest date of publication and country of publication as country of ‘focus’. Some extraction fields proved too subjective (e.g., decision-making context and clinical application) and not suitable for descriptive frequency counts. Similarly, molecular test technology was not clearly defined within studies and so could not be sub-categorised for analysis. Ambiguity of interpretation of study reference to ISPOR or OHE value elements was resolved through discussion and returning to the Special Task Force paper and related references [ 16 , 35 , 36 ]. For example, in the context of cascade screening of relatives it was agreed that outcomes for modelled relatives did not fulfil the definition of family spillover, which relates to the impact that illness can have on informal/unpaid caregivers/family members [ 35 ]. Value of knowing and value of reduction in uncertainty were considered mutually inclusive [ 19 , 37 , 38 ]. The second reviewer (FSG) cross-checked completeness and accuracy of the extracted data of 10% of the articles where clinical outcomes only were identified and 10% of the articles where novel elements were identified (to weight the cross-checking onto articles of greater focus for analysis).
Selected frameworks for mapping of non-clinical outcomes. Left: ‘Non-core’ elements of value of health technologies as depicted in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Special Task Force’s Elements of Value [ 17 ]. Note: Green circles: core elements of value; light blue circles: common but inconsistently used elements of value; dark blue circles: potential novel elements of value; blue line: value element included in traditional payer or health plan perspective; red line: value element also included in societal perspective. Right: Office of Health Economics ‘non-traditional’ elements of value for complementary diagnostics [ 19 ]. Note: Light grey circle: traditional elements of value as considered by health technology assessment (HTA); dark grey circle: expanded value framework (elements not traditionally considered/measured); green line: value from health system perspective; red line: value also included in societal perspective
Descriptive statistics using frequency counts were conducted for study characteristics information to address the mapping of available evidence that focuses on value of molecular testing in cancer objective. Value outcome measures were categorised as ‘conventional economic’ (QALYs, life-years (LYs), disability-adjusted life-years (DALYs), other natural units or a monetary measure (e.g., $)), or ‘non-economic’ and presented with descriptive statistics. A descriptive qualitative context analysis approach was used to collate the extracted value definitions textual data [ 33 ]. The degree to which the available literature has addressed previously proposed novel value elements was made deductively using frequency counts of references (excluding cites in the Discussion section) to value elements from the selected OHE and ISPOR model frameworks. Collaborative and iterative development of an inductive framework to further synthesise the evidence pertaining to novel value definitions was required for those outcomes not readily mapped to the OHE and ISPOR frameworks. The reviewer who had performed the main extraction (AM) undertook open-coding using NVivo (v 14.23.2, QSR International). AM shared these thoughts with the other authors and incorporated their reflections into developing initial categories to describe the extracted data [ 33 ]. After re-presentation of these categories and further iterative modification, a coding framework for organising the data was agreed.
Data are summarised according to review questions using tables, figures and narrative synthesis.
The four database searches returned a total of 1629 results and five articles were identified through grey literature. After removing 556 duplicates, titles and abstracts of the remaining 1086 articles were screened for relevance to the inclusion criteria. Screening resulted in the exclusion of 923 irrelevant articles, and the remaining 163 progressed to full-text review. Of these, 72 were excluded for reasons documented in the PRISMA diagram (Fig. 2 ). Eight relevant articles were identified through hand-searching. In total 91 articles met eligibility criteria for this review.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart of included studies
The main article characteristics are depicted in Table 1 . These comprised 75/91 (82.42%) conventional economic analyses (with the majority cost-effectiveness (CEA) or CUA) and 16/91 (17.58%) other study types (e.g., mixed methods or qualitative studies).
Most molecular testing scenarios considered within articles were based in the USA, followed by Australia, Canada, the UK, Spain, then China (Fig. 3 ). The most examined perspective was the healthcare system, followed by third-party payer. When accounting for studies that considered multiple perspectives, the 91 articles included 102 perspectives, including 12 patient, nine societal, and five public perspectives.
Map showing geographical distribution of article count by country of focus
There were no observed changes over time in study characteristics (not presented).
3.3.1 inclusion of non-clinical outcomes.
A minority (30/91, 33.0%) of articles considered non-clinical outcomes. Two-thirds of articles mentioned clinical outcomes alone. Of the conventional economic analyses, the proportion of studies considering non-clinical outcomes was even less (61/75, 81.3% vs. 14/75, 18.7%). There has been a recent observed increase in the inclusion of non-clinical outcomes within conventional economic analyses (Fig. 4 ).
Inclusion of non-clinical outcomes within conventional economic analyses over time. Note: Conventional economic analyses included comparative economic evaluations and budget impact assessments
Most studies used conventional economic outcome measures to define value; in these economic evaluations cost per QALY was the sole outcome measure in half (45/91) of included articles. Several studies (17/91) used combinations of conventional economic outcome measures to report value, predominantly QALYs or LYs with a natural unit. Five articles presented LYs, and one study presented DALYs alone.
In the 16 articles that were not conventional economic analyses (e.g., qualitative studies, discrete choice experiments (DCEs)), the most common sole outcome was willingness to pay (WTP) (5/16, 31.3%). Other outcomes included attitudes towards, experiences of, interest in, knowledge and understanding of, and preferences for implementation strategies of molecular testing in cancer.
Value of knowing (ISPOR) and reduction in uncertainty (OHE) were commonly identified novel elements, identified 22 times within included articles. Other ISPOR non-core value elements were also identified: equity ( n = 10 articles), productivity ( n = 9), value of hope ( n = 6), family spillover ( n = 6), severity of illness ( n = 5), scientific spillover ( n = 3), insurance value ( n = 2) and real option value ( n = 2). The OHE non-traditional value elements were identified less often: value of hope ( n = 6 articles), cost-savings outside of the health system ( n = 3), scientific spillover ( n = 3), insurance value ( n = 2) and real option value ( n = 2). This mapping of value outcomes is shown in Fig. 5 .
Mapping of value outcomes to International Society for Pharmacoeconomics and Outcomes Research (ISPOR) non-core value elements and Office of Health Economics (OHE) non-traditional value elements
Numerous novel (not conventionally reported clinically related) elements were identified through this review (a proportion of which could be mapped to OHE and ISPOR frameworks). It became evident, through the inductive approach, that these could be grouped into: (1) attributes of tests highly relevant to molecular testing in cancer and not ordinarily considered in conventional economic analyses (herein referred to as ‘novel test attributes’); (2) attributes of the clinical testing indication; (3) intrinsic attributes of people involved with testing (stakeholders) (herein referred to as ‘people attributes’); (4) non-clinical outcomes of testing; and (5) clinical outcomes of testing highly relevant to molecular testing and not ordinarily considered in conventional economic analyses (herein referred to as ‘novel clinical outcomes’). These five categories are presented within an overall framework (Fig. 6 ). While some elements may fit more than one category, each element was placed into one category determined to be the ‘best-fit’ for the purposes of presenting these data.
Overall framework demonstrating grouping of novel value elements identified from included articles developed through inductive analysis. Note: Equity was implicitly considered across other groups, with the majority of examples relating to people attributes (examination of the heterogeneity of preferences for, experiences of, or willingness to pay for molecular testing), novel test attributes, and indication attributes. Elements of value within these five groups were considered at different levels: individual, family, community, health system and society
Many articles sought to examine attributes intrinsic to properties of the molecular testing. These included reference to the clinical purpose for the test (e.g., screening, companion diagnostic) [ 39 ] with suggestion—especially from the patient perspective—that tests informing of treatment choice are of greater importance than others. For example, in one article “ Finding a new treatment was the overriding motivation… [authors comment that]… identification of a germline variant were generally seen as ancillary ” [ 39 ]. While breadth of test result information was considered in another study that examined patient and clinician preference for receiving test results with or without germline information [ 40 ].
Others examined more operational attributes relating to the test process , such as biopsy requirements (e.g., number [ 41 ], ability to use historical tissue [ 42 ] or nature/invasiveness [ 40 ] and the related issue of tissue preservation [ 40 ]), role/extent of healthcare professional (HCP) involvement for pre-test counselling or return of results [ 43 ], format for return of results (e.g., patient-mediated vs. provider-mediated [ 43 ]), and geographic location of tissue acquisition or tissue processing, data interpretation, storage or return of results [ 40 , 42 ]. A frequently recognised element was the turn-around time (linked to the patient-centred wait-time for results) [ 40 , 41 , 44 , 45 , 46 ]. Related to this, one article mentioned that batching tests for processing can directly, but not necessarily predictably, influence turn-around and wait-times [ 45 ].
Another category evident from the included articles related to attributes of the clinical indication for testing. These included clinical seriousness or urgency for decision-making. For example, [study participant comments] “ Why did I have to wait until treatment options were exhausted before being eligible? ” and [authors comment that] “ A subgroup of participants reported…they were running out of…options…a ‘ticking time-bomb’ with death increasingly close ” [ 39 ]. One paper considered the rarity of a clinical condition [ 47 ]. Footnote 2
Many articles brought attention to attributes that are intrinsic to persons, often presented as heterogeneity of preferences for molecular testing. These most related to the person(s) undergoing testing and included socioeconomic (e.g., ethnicity, rurality, social isolation, income) and clinical (e.g., current health status, reproductive characteristics, competing health priorities, family history [ 48 ]) factors. For example, one study reported a participant’s perception of gene testing as “ unnecessary because of current healthiness ” [ 42 ].
Numerous intrinsic factors can be grouped as psychological preferences, perceptions, and behavioural traits . This included sense of desperation [ 39 ], optimism [ 48 ], hopefulness [ 44 , 47 ], degree of trust in oncologists or science[ 39 ], and aversion or tolerance to uncertainty [ 44 , 47 , 49 ]. Regier et al.’s DCE estimated public preferences and demand for molecular testing that informs treatment choice by outcomes in context of uncertainty and found that “ respondents identified uncertainty as among the most important considerations when providing precision medicine that is valued by patients ” [ 49 ]. Five studies looked at individual’s perceived risk for, or severity of, the cancer type of interest [ 39 , 43 , 47 , 50 , 51 ]. High health monitoring behaviour was identified in one study as a determinant of WTP for breast cancer susceptibility testing [ 48 ]. ‘Self-efficacy’, defined as confidence in one's ability to cope (e.g., with risk prevention strategies) with actionable or non-actionable results was examined in a study investigating preferences and WTP for WGS amongst cancer patients and their families [ 47 ]. Another article mentioned the perceived caution or enthusiasm of HCPs towards experimental treatments as an element influencing their experience of genomic and personalised paediatric oncology [ 52 ].
Relational elements were considered in some studies. These included individual’s sense of responsibility to their family to obtain information that could influence their health [ 47 ], likelihood to recommend testing to others [ 50 ], having a locus of control highly attributed to powerful others [ 48 ], nature of relationship with HCPs [ 52 ], and connectedness with the healthcare system [ 43 ].
Specific skills and knowledge were examined, including at individual and system levels. The most identified skillset for individuals undergoing testing was health (or more specifically genomic) literacy, which was considered in seven articles [ 39 , 42 , 43 , 44 , 53 , 54 , 55 ]. Relatedly, two studies examined heterogeneity of WTP for molecular testing by education level [ 47 , 48 ]. Other specific skills examined included quality of an individual’s communication skills to enable them to share results, as well as their ability to process complex information or manage negative emotions [ 43 ].
Some studies gave attention to the skills and knowledge of test providers. These identified genomic literacy [ 53 ], handling of uncertainty [ 49 ], and managing patient expectations [ 52 ] as key skills necessary for clinical implementation of molecular testing.
Healthcare system-level attributes were also identified. Examples relating to system strategy included the degree of future focus, acceptance of uncertainty, or ability of a health system to adapt to evolving evidence [ 49 , 56 ].
The majority of novel consequences of testing identified from the included articles are categorised here as non-clinical outcomes of molecular testing and subcategorised into psychological impacts for those undergoing testing and non-clinical common good outcomes.
Psychological impacts for those undergoing testing The identified psychological outcomes of the person(s) undergoing testing relate to the value of knowing. For example, decreased worry/anxiety [ 54 , 57 ], reduced uncertainty [ 48 ], greater ability to plan (e.g., family planning [ 48 ]), or the value in hope of what the results may lead to [ 39 , 44 , 52 ]. One study identified outcomes from knowing as “ empowering ” [authors comment], providing individuals with an explanation for their diagnosis, absolving the responsibility for causing their own illness, or validation for previous medical decisions [ 57 ]. “ I [study participant comments] just feel like a weight’s been lifted off my shoulders …I was worried about ovarian cancer but I’m not now. I feel really happy about that ” [ 57 ].
In CEAs/CUAs, attempts to quantify the utility of the value of knowing were seen. One study assumed that after receiving a negative test result a woman’s utility increases to that of healthy women [ 58 ]. Another approach was considered within scenario analyses [ 59 , 60 ]. For example, Chandler et al. used utility weighting to assess the possible reassurance or worry about cancer recurrence [ 59 ].
Illustrating the potential disutility of knowing, included studies considered increased worry and anxiety [ 54 ], feeling negative about lack of actionable findings or disutility from receiving an uncertain result [ 61 ], and fear of stigmatisation and guilt [ 62 ]. An identified specific concern was privacy related to who has access to testing results [ 39 ] and implications for insurance [ 51 , 54 ]. “ [If] the final conclusive tests are negative and everything’s fine and then you put your people through two weeks of total terror for not a whole lot of benefits ” [study participant comments] [ 51 ] “ As long as we have a ‘healthy’ political system, this information will probably be used for good. Unfortunately, history shows that humans are able to use such information to harm others ” [study participant comments][ 54 ].
One article highlighted the heterogeneity of value of knowing, with opposition to obtaining molecular testing information on risk “ Leave it in God’s hands and if I get cancer, that’s the card I was dealt ” [study participant comments] [ 51 ] . In contrast, another article included the disutility of not knowing after declining a test [ 63 ]. Another described risk of false reassurance [ 64 ].
Non-clinical common good outcomes An extension of the value of knowing beyond the person(s) undergoing testing was identified in some articles. McMullen et al. gave mention to value of knowing to a whole community and future generations [ 51 ]. Relatedly, two articles examined scientific spillover [ 39 , 44 ].
Implications of time spent undergoing testing, molecularly informed interventions, or with illness were frequently described as productivity gain or loss. These were identified in nine studies [ 56 , 59 , 62 , 64 , 65 , 66 , 67 , 68 ]. An additional two studies linked this to time costs to family [ 62 , 69 ].
Another wider outcome was non-clinical costs-savings such as consideration of informal care costs [ 62 ].
While identifying clinical outcomes was not the objective of this scoping review, some elements were identified as particularly relevant to molecular testing in cancer. They are listed here for their potential novelty because they are not conventionally considered in value assessments.
Magnitude and nature of impact of molecularly informed management on quality of life or life expectancy.
Availability, accessibility, and cost of molecularly informed management.
Access to clinical trials.
Strength of evidence in the face of evolving evidence base.
One article examined preferences for testing dependent on the chance of an actionable outcome [ 40 ].
The concept that molecular testing in cancer’s value is directly connected to access to molecularly informed management was evident in several articles. These considerations spanned cost [ 52 ], public/‘reimbursed setting’ availability [ 40 ], systemic racism [ 51 ], and access to clinical trials [ 45 ]. The strength of evidence for intervention for molecularly informed intervention was represented by factors influencing clinician’s decision-making on the basis of scientific evidence [ 52 ] and extent of medical agreement on changing care [ 49 ].
4.1 summary of findings and attention to broadening conceptualisation of value.
This scoping review sought to identify how value is defined in studies that focus on the value of molecular testing in cancer and to map the literature addressing this topic. Because of the diversity in molecular testing technologies and applications, this review was not limited to any molecular testing type or clinical setting, instead taking a broad definition to molecular testing in cancer. This review pragmatically defined ‘focus on value [of molecular testing in cancer]’ to answer the review questions. The scoping review was designed to strike a balance between identifying the most common approaches to measuring value for money and identifying novel costs or novel benefits at the same time. As such, the review included studies focusing on costs relative to outcomes (to map trends of this core body of research) and studies that focused on describing at least one novel cost or outcome. Molecular testing in cancer diagnostic accuracy was not the focus of this review, given an extensive established body of literature and general acceptance that this is part of value assessment of molecular testing in cancer [ 70 ]. A wide range of value definitions was identified, but the overriding focus was on molecular testing's clinical outcomes, with 30/91 (33.0%) studies considering non-clinical outcomes. Attention to non-clinical outcomes was primarily seen within qualitative research, for example, in preference studies, but a minority of conventional economic evaluations also included non-clinical outcomes. The data from 2022 suggest that non-clinical outcomes may be increasingly reported within conventional economic evaluations.
This review used two published value frameworks, namely ISPOR Special Task Force’s Elements of Value [ 17 ] and the OHE’s ‘non-traditional’ elements of value for complementary diagnostics [ 19 ], to examine the degree to which existing literature has included contemporarily recognised novel value elements. These frameworks have been designed for general pharmaceuticals (ISPOR) and (non-cancer specific) companion diagnostics (OHE), and so were not designed to accommodate the uniqueness of molecular testing in cancer. For the included molecular testing in cancer studies, the value of knowing and the comparable value of reduction in uncertainty were the most featured, followed by equity and productivity. There was little reference to the remaining six ISPOR and four OHE novel elements, suggesting that some of these previously described value elements may not be relevant to molecular testing in cancer, or alternatively, there remain hurdles to operationalising the assessment and measurement of these novel elements [ 35 ].
The review identified other non-clinical outcomes and contextual considerations suggesting that molecular testing in cancer likely requires a bespoke approach. For these value elements not ordinarily considered in conventional economic analyses, and therefore considered novel, an inductive approach to analysis resulted in grouping of the elements into five categories representing intrinsic and extrinsic factors: (1) novel test attributes; (2) indication attributes; (3) people attributes; (4) non-clinical outcomes of testing; and (5) novel clinical outcomes. The final category was included as despite pertaining to clinical outcomes, these were considered highly specific to molecular testing in cancer, or previously underappreciated. This inductive framework identified a triad of intrinsic test properties, intrinsic clinical indication properties, and attributes of people (stakeholders) involved with testing as contextual considerations likely to influence the realised value of molecular testing in cancer. The two remaining categories relate to consequences of testing information with particular emphasis on psychological utility or disutility of knowing and spillover effects beyond the individual undergoing testing.
There were notable gaps identified from the examined literature. Given the important focus on addressing inequities in cancer outcomes, especially for indigenous populations, this review aimed to identify elements relating to equity or viewpoints of indigenous communities within value definitions. Equity was not explicitly described within value definitions of included articles. Even when equity was considered broadly (recognizing that different people with different levels of advantage require different approaches and resources to get equitable health outcomes [ 71 ]), it rarely featured. Where it did feature, equity was implicitly considered, with the majority of examples relating to examination of the heterogeneity of preferences for, experiences of, or WTP for, molecular testing, which in the inductive framework is mostly embedded within the intrinsic attributes of people category.
Another category where equity was implicitly considered was within test attributes with regards to test process. Specifically, articles identified the barriers to testing (e.g., financial, complexity of navigating health system in context of health literacy or racism) as well as the inequitable distribution of these barriers. Finally, equity is implicitly mentioned in the clinical indication for testing category where attention to rarity was mentioned. This interpretation of equity has been previously used in the context of value assessment with the connection between rarity and unmet need aligning with DrugAbacus’ definitions [ 72 ]. There is debate on whether rarity of disease warrants consideration as an independent determinant of value. The National Institute for Health and Care Excellence (NICE) has not yet included rarity of disease as a modifier, commenting on the “complex interactions between the severity of the diseases, current diagnostic and treatment options, clinical knowledge, research and development, and health service design and delivery” [ 73 ]. The related issue of rarity of molecular testing results is so far unexplored.
Value assessment frameworks for health technologies have received heightened attention in the past decade [ 16 , 74 ]. Aside from a few exceptions designed for diagnostics (e.g. [ 19 , 75 ]), these have mostly been for pharmaceuticals. ISPOR’s value flower was developed for drugs. Unsurprisingly, it was the flower’s value of information petal that featured most prominently in this review. The earliest descriptions of this value element, now more than 30 years ago, related to diagnostics where a test is valued for the prognostic information it provides apart from its effect on patient management [ 38 ]. The attention to this element suggests that further developments toward more holistic molecular testing in cancer value assessments could take direction from the emerging approaches to broaden the value assessment for diagnostics, especially consideration of the value gained from reduction in uncertainty. On the other hand, identified novel elements emerging from this review (consideration of rarity, observed heterogeneity of preferences based on genomic literary, issues relating to variants of uncertain significance, and likelihood of individuals to share information on germline findings with family) are less specific to diagnostics and more linked to precision medicine. As such, value assessment frameworks developed for precision medicines (e.g., value assessment of orphan drugs for rare diseases [ 76 ]) may provide more helpful guidance. Another alternative is that development of value assessment tools for molecular testing in cancer forges its own path, although arguably this is not the most practical or efficient approach for health technology assessors [ 35 ].
The attention to attributes of the entire testing process and preferences for these attributes suggests that how molecular testing in cancer is implemented likely influences its realised value. Importantly, this signals the need for greater attention to where cost-effectiveness of molecular testing in cancer can be improved with changes in access to genetic counselling, genomics education, etc. One of the included articles emphasised this, highlighting the importance of culturally and linguistically appropriate testing services [ 42 ].
First, this review may have missed non-English studies that have focused on value of molecular testing in cancer, particularly grey literature, and studies without full text on the net (i.e., FUTON bias [ 77 ]). Second, search strategy could not incorporate all studies exploring potentially relevant determinants of value, especially the heterogenous body of implementation and preferences literature for which keywords are not consistent. This would include a large body of qualitative literature on genomic testing in cancer (e.g., information preferences [ 78 , 79 , 80 ]), which was not identified in this review because the search strategy required the term ‘value’ (or a related word) in an article’s title. Findings from this review should be considered alongside other molecular testing literature including that focusing on analytical validity, clinical validity and clinical utility. Third, the eligibility criteria adopted could not overcome the inherent ambiguity of the ‘focus on value of molecular testing in cancer’ criterion. The extent to which molecular testing comprises a healthcare intervention is not always clear, and the degree to which a study was focused on value proved very subjective. Fourth, the mapping to emerging guidance was limited to ISPOR and OHE, with potential that review conclusions would have differed had alternative deductive frameworks, for example, Augustovski et al.’s Value framework for the Assessment of Diagnostic Technologies [ 81 ], been selected, especially since ISPOR is not designed for diagnostics.
The dominance of clinical value elements and prevalence of use of the QALY concluded from this review demonstrates the tendency for studies estimating molecular testing in cancer 's value to focus on quantifiable and commensurable elements. Combined with the fact this review identified no multi-criteria decision analyses, this suggests a gap in the literature with respect to trialling methods that more deliberatively assess value, like the approach increasingly seen in the HTA of pharmaceuticals [ 82 ].
It is likely that the design of studies that focus on the value of molecular testing in cancer are dictated by the market they are trying to receive reimbursement from. For jurisdictions where the decision and reimbursement of molecular testing and targeted medicines or preventative strategies may be independent of each other (e.g., different decision-making bodies), evidence may be interpreted without due attention to complementarity [ 18 ].
A next logistical step is the further exploration of the non-clinical elements of value important to the range of relevant stakeholders, with attention to the complex interplay and joint influences of psychological consequences of knowing, value of reduced uncertainty, and spillover outcomes in the context of precision oncology’s heterogeneity of outcomes. Once these are better understood the field can move onto the quantification and commensuration of the conventional and novel elements of value. It is not known whether the identified novel elements are reflective of indigenous peoples’ values as this research has not been undertaken, highlighting a priority focus for future research. Also, while this is a scoping exercise to map how value is defined for molecular testing in cancer, our review findings suggest that once elements of value are identified, data for these must be collected.
Molecular testing in cancer has increased clinical attention, necessitating robust approaches to value assessment to support optimal and equitable implementation. Published studies that focus on the value of molecular testing in cancer highlight the lack of an agreed definition of value in this setting. Ongoing research is warranted to clarify how value is defined in a way that accounts for molecular testing as a process, and with a breadth of outcomes through an equity lens, including psychological benefits and benefits beyond the tested individual.
OSF Registries | Definitions and elements of value used in the assessments of value in molecular testing in cancer: A scoping review.
(Perceived) severity of condition has been allocated to people attributes because it was largely documented as a perception rather than an objective clinical descriptor.
The Business Research Company. Oncology molecular diagnostics global market report 2022. 2022. https://www.businesswire.com/news/home/20220830005582/en/Oncology-Molecular-Diagnostics-Global-Market-Research-Report-2022-PCR-ISH-INNAT-Chips-Microarrays-Sequencing-Mass-Spectroscopy-TMA-Analysis-Forecasts-2016-2021-2021-2026F-2031F---ResearchAndMarkets.com . Accessed 19 Nov 2023.
Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:497–530.
Article PubMed Google Scholar
Regier DA, Pollard S, McPhail M, Bubela T, Hanna TP, Ho C, Weymann D. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. NPJ Precis Oncol. 2022;6(1):76.
Terkola R, Antoñanzas F, Postma M. Economic evaluation of personalized medicine: a call for real-world data. Eur J Health Econ. 2017;18(9):1065–7.
Akhmetov I, Bubnov RV. Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine. EPMA J. 2015. https://doi.org/10.1186/S13167-015-0041-3 .
Article PubMed PubMed Central Google Scholar
Burris HA, Saltz LB, Yu PP. Assessing the Value of next-generation sequencing tests in a dynamic environment. Am Soc Clin Oncol Educ Book. 2018:139–146.
Faulkner E, Holtorf AP, Walton S, et al. Being precise about precision medicine: what should value frameworks incorporate to address precision medicine? A report of the personalized precision medicine special interest group. Value Health. 2020;23:529–39.
Marshall DA, Grazziotin LR, Regier DA, Wordsworth S, Buchanan J, Phillips K, Ijzerman M. Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling. Value Health. 2020;23:566–73.
Patrinos G, CM-CP. Measuring the value of pharmacogenomics evidence. Wiley Online Library. 2017;102:739–741.
Payne K, Gavan SP, Wright SJ, Thompson AJ. Cost-effectiveness analyses of genetic and genomic diagnostic tests. Nat Rev Genet. 2018;19:235–46.
Article CAS PubMed Google Scholar
Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang S-Y, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2014;16:251–7.
Berm EJJ, De Looff M, Wilffert B, Boersma C, Annemans L, Vegter S, Van Boven JFM, Postma MJ. Economic evaluations of pharmacogenetic and pharmacogenomic screening tests: a systematic review. Second update of the literature. PLoS ONE. 2016. https://doi.org/10.1371/JOURNAL.PONE.0146262 .
Pliskin JS, Weinstein MC, Shepard DS. Utility functions for life years and health status. Oper Res. 1980;28:206–24.
Article Google Scholar
Zeckhauser R, Shepard D. Where now for saving lives. Law Contemp Probl. 1976;40:5.
Pollard S, Weymann D, Chan B, et al. Defining a core data set for the economic evaluation of precision oncology. Value Health. 2022;25:1371–80.
Neumann PJ, Willke RJ, Garrison LP. A health economics approach to US value assessment frameworks—introduction: an ISPOR special task force report [1]. Value Health. 2018;21:119–23.
Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. Defining Elements of value in health care—a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21:131–9.
Riley R, Lesteven D, Plun-Favreau J, Ferrara J, Kapitein P, Collins P. The value of knowing and knowing the value: improving the health technology assessment of complementary diagnostics. 2016.
Garrison L, Mestre-Ferrandiz J, Zamora B. The value of knowing and knowing the value: improving the health technology assessment of complementary diagnostics. 2016.
ICER 2020–2023 value assessment framework ICER.
Pitini E, De Vito C, Marzuillo C, D’andrea E, Rosso A, Federici A, Maria ED, Villari P. How is genetic testing evaluated? A systematic review of the literature. Eur J Hum Genet. 2018;26:605–15.
Article CAS PubMed PubMed Central Google Scholar
Goranitis I, Best S, Christodoulou J, Stark Z, Boughtwood T. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet Med. 2020;22:1311–9.
Kohler JN, Turbitt E, Biesecker BB. Personal utility in genomic testing: a systematic literature review. Eur J Hum Genet. 2017;25:662–8.
NICE. Diagnostics assessment programme manual. 2011. https://www.nice.org.uk/media/default/about/what-we-do/nice-guidance/nice-diagnostics-guidance/diagnostics-assessment-programme-manual.pdf . Accessed 19 Nov 2023.
MSAC. Medical Services Advisory Committee process framework. 2016.
Cook JP, Golec J. How excluding some benefits from value assessment of new drugs impacts innovation. 2017. https://doi.org/10.1002/hec.3507 .
Seo MK, Cairns J. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review. BMC Cancer. 2021. https://doi.org/10.1186/S12885-021-08725-4 .
Te Aho o Te Kahu. He Pūrongo Mate Pukupuku o Aotearoa 2020: the state of cancer in New Zealand. 2020.
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:1–7.
Peters M, Godfrey C, McInerney P, Munn Z, Trico A, Khalil H. Chapter 11: scoping reviews. JBI Man Evid Synth. 2020. https://doi.org/10.46658/JBIMES-20-12 .
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.
Santos Gonzalez F, Mordaunt D, Stark Z, Dalziel K, Christodoulou J, Goranitis I. Microcosting diagnostic genomic sequencing: a systematic review. Genet Med. 2023;25: 100829.
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18:2119–26.
Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011;92:2041–56.
Neumann PJ, Garrison LP, Willke RJ. The history and future of the ISPOR value flower: addressing limitations of conventional cost-effectiveness analysis. 2022. https://doi.org/10.1016/j.jval.2022.01.010 .
Crummer E, Neumann PJ, Cohen JT, Kim DD. Use of novel and social elements of value in cost-effectiveness analysis. 2022. https://cevr.tuftsmedicalcenter.org/news/2022/use-of-novel-elements-of-value-in-cost-effectiveness-analyses . Accessed 19 Nov 2023.
Neumann PJ, Cohen JT, Hammitt JK, Concannon TW, Auerbach HR, Fang C, Kent DM. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ. 2010;21:238–51.
Asch DA, Patton JP, Hershey JC. Knowing for the sake of knowing: the value of prognostic information. Med Decis Mak. 1990;10:47–57.
Article CAS Google Scholar
Best MC, Bartley N, Jacobs C, Juraskova I, Goldstein D, Newson AJ, Savard J, Meiser B, Ballinger M, Napier C. Patient perspectives on molecular tumor profiling: “Why wouldn’t you?” BMC Cancer. 2019;19:1–9.
Fifer S, Ordman R, Briggs L, Cowley A. Patient and clinician preferences for genetic and genomic testing in non-small cell lung cancer: a discrete choice experiment. J Pers Med. 2022. https://doi.org/10.3390/jpm12060879 .
Weymann D, Veenstra DL, Jarvik GP, Regier DA. Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment. Eur J Hum Genet. 2018;26:1257–65.
Wong XY, Groothuis-Oudshoorn CG, Tan CS, van Til JA, Hartman M, Chong KJ, Ijzerman MJ, Wee H-L. Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment. Patient Prefer Adher. 2018;12:1837–52.
Sarki M, Ming C, Aissaoui S, et al. Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the Swiss CASCADE cohort. Cancers (Basel). 2022;14:1636.
Butow P, Davies G, Napier CE, et al. Assessment of the value of tumor variation profiling perceived by patients with cancer. JAMA Netw Open. 2020;3: e204721.
de Alava E, Pareja MJ, Carcedo D, Arrabal N, Garcia J-F, Bernabe-Caro R. Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective. Expert Rev Pharmacoecon Outcomes Res. 2022;22:1033–42.
Hurry M, Eccleston A, Dyer M, Hoskins P. Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops. Int J Technol Assess Health Care. 2020;36:104–12.
Butow P, Davies G, Napier CE, et al. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study. J Genet Couns. 2022;31:96–108.
Blouin-Bougie J, Amara N, Bouchard K, Simard J, Dorval M. Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Quebec (Canada). BMJ Open. 2018;8: e016662.
Regier DA, Veenstra DL, Basu A, Carlson JJ. Demand for precision medicine: a discrete-choice experiment and external validation study. Pharmacoeconomics. 2020;38:57–68.
Mayer M, Selig K, Tuttelmann F, Dinkel A, Gschwend JE, Herkommer K. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy. Fam Cancer. 2019;18:221–30.
McMullen C, Holup J, Davis JV, Foley P, Jacob L, Cottrell E, Bui DP, Wilfond B, Goddard KA. Discordant patient and clinician perspectives on the potential value of genetic services in safety-net clinics. J Health Care Poor Underserv. 2020;31:1347–63.
McCarthy MC, De Abreu LR, McMillan LJ, Meshcheriakova E, Cao A, Gillam L. Finding out what matters in decision-making related to genomics and personalized medicine in pediatric oncology: developing attributes to include in a discrete choice experiment. Patient. 2020;13:347–61.
Chow-White P, Ha D, Laskin J. Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists. Hum Resour Health. 2017;15:1–9.
Clasen K, Gani C, Schroeder C, Riess O, Zips D, Schoffski O, Clasen S. Patient views on genetics and functional imaging for precision medicine: a willingness-to-pay analysis. Per Med. 2022;19:103–12.
Guo F, Hirth JM, Fuchs EL, Cofie LE, Brown V, Kuo Y-F, Fernandez ME, Berenson AB. Knowledge, attitudes, willingness to pay, and patient preferences about genetic testing and subsequent risk management for cancer prevention. J Cancer Educ. 2022;37:362–9.
Sun L, Cui B, Wei X, Sadique Z, Yang L, Manchanda R, Legood R. Cost-effectiveness of genetic testing for all women diagnosed with breast cancer in China. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14071839 .
Young M-A, Forrest LE, Rasmussen V-M, James P, Mitchell G, Sawyer SD, Reeve K, Hallowell N. Making sense of SNPs: women’s understanding and experiences of receiving a personalized profile of their breast cancer risks. J Genet Couns. 2018;27:702–8.
Lourencao M, Simoes Correa Galendi J, Galvao HDCR, et al. Cost-Effectiveness of BRCA 1/2 genetic test and preventive strategies: using real-world data from an upper-middle income country. Front Oncol. 2022;12:951310.
Chandler Y, Schechter CB, Jayasekera J, et al. Cost effectiveness of gene expression profile testing in community practice. J Clin Oncol. 2018;36:554–62.
Eccleston A, Bentley A, Dyer M, Strydom A, Vereecken W, George A, Rahman N. A cost-effectiveness evaluation of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer. Value Health. 2017;20:567–76.
Asphaug L, Melberg HO. The cost-effectiveness of multigene panel testing for hereditary breast and ovarian cancer in Norway. MDM Policy Pract. 2019;4:2381468318821103.
PubMed PubMed Central Google Scholar
Majem M, Alvarez R, Ortega AL, Ruiz de Alda L, Gordo R, Garcia JF, Ivanova-Markova Y, Gonzalez-Dominguez A, San Cristobal RS, Rojo F. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain. Glob Region Health Technol Assess. 2022;9:82–90.
Snowsill T, Coelho H, Huxley N, Jones-Hughes T, Briscoe S, Frayling IM, Hyde C. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess. 2017;21:1–238.
Pereira C, Areia M, Dinis-Ribeiro M. Cost-utility analysis of genetic polymorphism universal screening in colorectal cancer prevention by detection of high-risk individuals. Dig Liver Dis. 2019;51:1731–7.
Simons MJHG, Retel VP, Ramaekers BLT, et al. Early cost effectiveness of whole-genome sequencing as a clinical diagnostic test for patients with inoperable stage IIIB, C/IV non-squamous non-small-cell lung cancer. Pharmacoeconomics. 2021;39:1429–42.
Ibarrondo O, Alvarez-Lopez I, Freundlich F, Arrospide A, Galve-Calvo E, Gutierrez-Toribio M, Plazaola A, Mar J. Probabilistic cost-utility analysis and expected value of perfect information for the oncotype multigenic test: a discrete event simulation model. Gac Sanit. 2020;34:61–8.
Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. ClinicoEcono Outcomes Res. 2018:189–199.
Wei X, Cai J, Sun H, Li N, Xu C, Zhang G, Sui Y, Zhuang J, Zheng B. Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients. Pharmacogenomics. 2019;20:241–9.
Kunst N, Stout NK, O’Brien G, Christensen KD, McMahon PM, Wu AC, Diller LR, Yeh JM. Population-based newborn screening for germline TP53 variants: clinical benefits, cost-effectiveness, and value of further research. J Natl Cancer Inst. 2022;114:722–31.
Neumann PJ, Thorat T, Shi J, Saret CJ, Cohen JT. The changing face of the cost-utility literature, 1990–2012. Value Health. 2015;18:271–7.
Achieving equity | Ministry of Health NZ. https://www.health.govt.nz/about-ministry/what-we-do/achieving-equity . Accessed 7 Dec 2023.
Drug Abacus—Drug Pricing Lab. https://www.drugpricinglab.org/tools/drug-abacus/ . Accessed 7 Dec 2023.
Public board meeting agenda and papers: January 2022 | Public board meetings | Board | Who we are | About | NICE.
Zhang M, Bao Y, Lang Y, Fu S, Kimber M, Levine M, Xie F. What is value in health and healthcare? A systematic literature review of value assessment frameworks. Value Health. 2022;25(2):302–17.
Anonychuk A, Beastall G, Shorter S, Kloss-Wolf R, Neumann P. A framework for assessing the value of laboratory diagnostics. Healthc Manage Forum. 2012:25(3):S4–11.
Blonda A, Denier Y, Huys I, Simoens S. How to value orphan drugs? A review of European value assessment frameworks. Front Pharmacol. 2021;12:631527.
Lancet RW-T. Visibility of research: FUTON bias. 2002. thelancet.com.
Bartley N, Best M, Jacobs C, et al. Cancer patients’ views and understanding of genome sequencing: a qualitative study. J Med Genet. 2020;57:671–6.
Fisher ER, Pratt R, Esch R, Kocher M, Wilson K, Lee W, Zierhut HA. The role of race and ethnicity in views toward and participation in genetic studies and precision medicine research in the United States: a systematic review of qualitative and quantitative studies. Mol Genet Genomic Med. 2020. https://doi.org/10.1002/MGG3.1099 .
Lau-Min KS, Varughese LA, Nelson MN, Cambareri C, Reddy NJ, Oyer RA, Teitelbaum UR, Tuteja S. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation. BMC Cancer. 2022. https://doi.org/10.1186/S12885-022-09171-6 .
Augustovski F, Alfie V, Alcaraz A, García Martí S, Drummond MF, Pichon-Riviere A. A value framework for the assessment of diagnostic technologies: a proposal based on a targeted systematic review and a multistakeholder deliberative process in Latin America. Value Health. 2021;24:486–96.
Gongora-Salazar P, Rocks S, Fahr P, Health OR-A-V. The use of multicriteria decision analysis to support decision making in healthcare: an updated systematic literature review. Amsterdam: Elsevier; 2023.
Google Scholar
Download references
Open Access funding enabled and organized by CAUL and its Member Institutions.
Authors and affiliations.
University of Auckland, Auckland, New Zealand
Alice Minhinnick, Michelle Wilson & Paula Lorgelly
University of Melbourne, Melbourne, VIC, Australia
Francisco Santos-Gonzalez
You can also search for this author in PubMed Google Scholar
Correspondence to Alice Minhinnick or Paula Lorgelly .
The research was conducted during AM’s tenure of a Health Research Council of New Zealand Clinical Research Training Fellowship and so the research was supported (in part) by funding from the Health Research Council of New Zealand.
AM, FGS, MK and PL have no conflicts of interest that are relevant to the content of this article.
The study is a literature review and hence does not require ethical approval.
Not applicable.
Data availability.
The datasets used and/or analysed during this scoping review are available from the corresponding author on reasonable request.
Author contributions.
AM, MW and PL conceived and designed the analysis. AM and FGS collected the data. AM, FGS, MW and PL performed the analysis. AM, FGS, MW and PL wrote the paper.
Below is the link to the electronic supplementary material.
Rights and permissions.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ .
Reprints and permissions
Minhinnick, A., Santos-Gonzalez, F., Wilson, M. et al. How is Value Defined in Molecular Testing in Cancer? A Scoping Review. Appl Health Econ Health Policy (2024). https://doi.org/10.1007/s40258-024-00901-4
Download citation
Accepted : 18 June 2024
Published : 09 July 2024
DOI : https://doi.org/10.1007/s40258-024-00901-4
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
COMMENTS
Using a stepwise, structured approach, we reviewed the literature on the use of this method in biodiversity, ecology and conservation research. We used a combination of "Focus Group Discussion*" AND "conserv*," OR "ecology," OR "biodivers*," where "*" denotes a wild card to search for alternative word endings, in a search ...
Five focus group discussions were conducted, with an average of six students in each focus group. Thematic analysis was used to explore and analyse study participants' schooling experiences.
Despite increased use of focus groups in the research literature, ... Citation 2000), we could find little to no discussion about how the focus group process or group dynamics influence what information is obtained within research. Focus group research, as a stand-alone endeavor, or as an intentional means of data collection within a research ...
Literature Review Online Versus In-Person Focus Groups. ... Methodological considerations for online focus group discussions. Qualitative Health Research, 28(10), 1658-1673. Crossref. PubMed. Web of Science. Google Scholar. Schneider S. J., Kerwin J., Frechtling J., Vivari B. A. (2002). Characteristics of the discussion in online and face-to ...
Traditionally, focus group research is "a way of collecting qualitative data, which—essentially—involves engaging a small number of people in an informal group discussion (or discussions), 'focused' around a particular topic or set of issues" (Wilkinson, 2004, p. 177).Social science researchers in general and qualitative researchers in particular often rely on focus groups to ...
The purpose of this integrative literature review was to describe the use and the relevant factors related to conducting focus group interviews with children, youths, and parents. ... Lúcio J. (2015). Talking about the city: Focus group discussions about the city and the community as developmental grounds with children aged 5-17. European ...
Focus groups have been widely used in health research in recent years to explore the perspectives of patients and other groups in the health care system (e.g., Carr et al., 2003; Côté-Arsenault & Morrison-Beedy, 2005; Kitzinger, 2006).They are often included in mixed-methods studies to gain more information on how to construct questionnaires or interpret results (Creswell & Plano Clark, 2007 ...
The number of focus group discussions per study greatly varied with the minimum being one focus group (n = 5) and a maximum of 42 focus groups (n = 1), with a median of 5 (Fig. 4c). Usually there ...
Aims: This integrated literature review seeks to identify the key considerations in conducting focus groups and discusses the specific considerations for focus group research with culturally and linguistically diverse groups. Background: The focus group method is a technique of group interview that generates data through the opinions expressed by participants.
English language articles were selected for the review if they discussed the following issues: (i) methodological implications of the focus group method; (ii) strengths and limitations of the focus group method; (iii) recommendations for researchers and (iv) use of the focus group in culturally and linguistically diverse groups.
A focus group discussion is a qualitative research tool ori ginated in sociology and. popular in business, marketing, and education (Sagoe, 2012). Focus group discussion is used. to gather data ...
A focus group is a moderated group discussion on a pre-defined topic, ... For example, the schedule will usually be informed by the review of the literature and study aims, and will merely provide ...
Here, we reviewed the applications of focus group discussion within biodiversity and conservation research between 1996 and April 2017. We begin with a brief explanation of the technique for first ...
tion literature. In addition, there are no comprehensive reviews of the use of focus group discussion in conservation to the best of our knowledge. Here we assess the strength and weaknesses of the focus group discussion technique based on a review of its application in conserva-tion in the last two decades. We first briefly explain the ...
The quality of data obtained through Focus Group Discussions (FGDs) is highly dependent on appropriate design and facilitation. In low-income settings steep power gradients between researcher and participants, as well as conversational norms, could reduce the ability of participants to voice personal opinions. Activity-oriented exercises have been suggested as a way overcoming these challenges ...
A systematic literature review (Hart, 1998; Melnyk & Fineout-Overholt, 2011) was used as a design for this study. Those articles using focus group discussion (FGD) methods within the field of workplace health, stress, and coping among health professionals were included. To be selected
Here, we reviewed the applications of focus group discussion within biodiversity and conservation research between 1996 and April 2017. We begin with a brief explanation of the technique for first-time users. We then discuss in detail the empirical applications of this technique in conservation based on a structured literature review (using ...
This study aimed to discuss the key success factors in focus group discussions among the elderly as a means of supporting novice researchers and also to share the experiences of novice researchers with focus group discussions.,This study used a literature review of previous studies that revealed three themes regarding the key success of focus ...
During the focus group, one student said, "I haven't really seen many materials that do represent multiracial groups, and I think that would be great for increasing our sense of belonging." Others agreed with the statement and talked about how more awareness of the topic and resources could help themselves and other students.
The article discusses how developments within the domain of focus group literature and practice have brought a greater alignment between the two spheres in terms of both approach and practice. ... In her discussion of focus group research in a social work ... Linhorst D. M. (2002). A review of the use and potential of focus groups in social ...
Focus group discussion 3 (n = 9) consisted of women with a history of intended pregnancies resulting in one or more children. Purposeful sampling created homogeneous focus group discussions regarding pregnancy intentions, ultimately benefiting the willingness of women to engage in discussions . Due to the anonymous nature of the survey, it was ...
Each focus group discussion was composed of six to seven participants (Masadeh, 2012), of whom 52 % were male and 48 % female, aged between 23 and 69 years. During the focus group, a broad range ...
The central component in impactful healthcare decisions is evidence. Understanding how nurse leaders use evidence in their own managerial decision making is still limited. This mixed methods systematic review aimed to examine how evidence is used to solve leadership problems and to describe the measured and perceived effects of evidence-based leadership on nurse leaders and their performance ...
Focus groups are a popular research method for the collection and analysis of qualitative data and are useful for helping researchers obtain a deeper sociological and psychological understanding of participant experience (Krueger, 2014; Merton, 1987).They can be distinguished through their explicit use of group discussion, generally held in familiar, comfortable, and/or non-threatening ...
Objective: Autism spectrum disorders (ASD) are a varying group of disorders characterized by deficiency in social interaction and restrictive patterns of behavior and interests. While there are several studies focusing on the neuro-psychiatric pathogenesis of ASD, its etiology remains unclear. The role of gut-brain-axis in ASD has been studied increasingly and a correlation between symptoms ...
Steps to conduct a focus group retrieved from (Focus Groups, 2 01 7). Besides, Anderson et al. (1998) also recommended some tips for data collection in the focus group discussion.
Objective To identify how value is defined in studies that focus on the value of molecular testing in cancer and the extent to which broadening the conceptualisation of value in healthcare has been applied in the molecular testing literature. Methods A scoping review was undertaken using Joanna Briggs Institute (JBI) guidance. Medline, Embase, EconLit and Cochrane Library were searched in ...
Based on focus group interviews with 43 sophomores and juniors Roehling, Vander Kooi, Dykema, Quisenberry, ... For example, based on their review of the literature on discussion in K-12 classrooms, Mercer and Howe (2012) conclude that "there is now comprehensive evidence to support [the] view that talk amongst teachers and students, if of the ...